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Abstract 
The term “carbasugar” is used to describe a class of compounds, structurally 
analogous to natural and synthetic carbohydrates in which the ring oxygen has 
been replaced by a methylene group. Being similar in shape to sugars, these 
derivatives are of value in the investigation of biological metabolism, and of 
potential use for diabetics and anticancer therapy. However the effectiveness of 
the carbasugars as sugar mimetics is compromised by electronic effects associated 
to this replacement. To overcome this disadvantage we envisaged the synthesis of 
gem-difluorinated analogues which would hopefully induce conformational bias 
through stereoelectronic effects as well as provide key polar groups for the 
interaction with potential receptors. 
In this work the synthesis of both α and β isomers of gem-difluorocarbamannose 
and –galactose is presented. The strategy is based on a Lewis acid induced 
rearrangement of a gem-difluoroalkene derivative containing an original cobalt 
cluster as electron donating group. 
 
 
The synthesis starts from the corresponding natural sugars and involves 4 major 
steps: construction of the triple bond in C-6, introduction of the gem-
difluoroalkene in anomeric position, rearrangement sequence, and final 
deprotection. 
It is also described the synthesis of the mono-fluorinated analogues of the (+)-
MK7607, a patented compound possessing herbicidal activity, serendipitously 
obtained from the aldehyde reduction step in the gem-difluorocarbagalactose 
derivative. 
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All the gem-difluorinated deprotected sugars and the fluorinated analogues of the 
(+)-MK7607 were assessed as glycosidase inhibitors, however, no interesting 
activity was detected. 
Finally, several approaches aiming at the preparation of gem-difluorocarbalactose 
and –lactosamide, valuable scaffolds for elucidation of the role of the endocyclic 
oxygen in carbohydrate-enzyme interactions, are investigated. However, all the 
methodologies tried for the coupling of gem-difluorocarbocyclic products with a 
suitable protected molecule employing anomeric O-alkylation, cyclic sulfates, 
orthoesters and bromine activation, failed. For that reason, we envisaged an 
alternative strategy by construction of the gem-difluoroalkene moiety at C-5, 
followed by the TIBAL induced rearrangement. This approach was applied on a 
monosaccharide scaffold and succeeded to transform the gem-difluoroalkene 
scaffold into the expected gem-difluorocarbocyclic product with retention of the 
anomeric information.  These results allowed to accurate the reliability of this 
strategy, which applied now to the lactose natural sugar should provide the target 
disaccharides. 
 
Keywords: gem-difluorocarbasugars, pseudo-carbasugars, (+)-MK7607, sugar 
mimics, TIBAL-induced rearrangement  
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Resumo 
Os carbaaçúcares, análogos de açúcares nos quais o oxigénio endocíclico está 
substituído por um grupo CH2, têm despertado grande interesse em químicos e 
bioquímicos devido às suas potenciais propriedades biológicas. A capacidade dos 
carbaaçúcares para mimetizar o tamanho, a estrutura e a polaridade dos açúcares 
parentais, bem como a sua estabilidade à hidrólise, torna-os potenciais candidatos 
a inibidores de glicosidases. No entanto, esta substituição tem a desvantagem de 
suprimir qualquer possibilidade de ligações por pontes de hidrogénio que 
envolvam o átomo electronegativo do anel. Esta desvantagem está bem patente no 
caso da carbalactose, um mimético da lactose, a qual já não é reconhecida pelo 
enzima β-galactosidase. Um modelo posterior mostrou que o átomo de oxigénio 
endocíclico da unidade D-galactose está envolvido na interacção com grupos 
dadores de protões nos centros activos do enzima. Uma forma de ultrapassar este 
problema consiste em substituir o átomo de oxigénio endocíclico por outro grupo, 
também ele capaz de proporcionar ligações de hidrogénio. Seria ainda importante 
conseguir diferenciar os dois pares de electrões não-ligantes e verificar se algum 
destes pares, e qual deles, está envolvido em ligações de hidrogénio com o centro 
activo do enzima. Os átomos de flúor não são aceitadores de ligações de hidrogénio 
tão fortes como o átomo de oxigénio, mas são suficientemente electronegativos 
para exibirem esta propriedade. Os derivados fluorados possuem um interesse 
acrescido em virtude de terem o isótopo 19F activo em espectroscopia de RMN-19F, 
pelo que alguns deles têm vindo a ser utilizados como sondas moleculares em 
centros activos de enzimas. É assim razoável pensar que a substituição do grupo 
CH2 endocíclico pelo grupo CF2 num carbaaçúcar irá conduzir a um avanço 
significativo no âmbito do desenvolvimento desta família de miméticos de açúcar. 
As vantagens destes novos compostos resultam de vários factores, nomeadamente 
da sua eventual capacidade para serem aceites por enzimas, visto que o grupo CF2 
pode mimetizar o átomo de oxigénio endocíclico e ainda da possibilidade do 
estudo da sua complexação por espectroscopia de RMN.  
No presente trabalho é apresentada a primeira síntese de ambos os isómeros α e β 
gem-difluorocarbamanose e –galactose. A estratégia adoptada centrou-se no 
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rearranjo induzido por um ácido de Lewis de um gem-difluoroalceno contendo um 
complexo hexacarbonílico de cobalto como grupo dador de electrões.  
 
 
 
Os correspondentes açúcares naturais serviram de material de partida e o 
esquema sintético foi dividido em 4 etapas fundamentais: construção da ligação 
tripla em C-6, introdução do gem-difluoroalceno na posição anomérica, sequência 
de rearranjo e desprotecção final.  
 
 
 
Desta forma, os primeiros passos da síntese foram direccionados para a protecção 
ortogonal da posição anomérica com o grupo p-methoxifenilo (OpMP), seguindo-se 
uma sequência de protecções e desprotecções que permitiram proteger os grupos 
hidroxilo secundários com grupos benzilo, deixando a função álcool primária livre 
para posterior funcionalização. A introdução da ligação tripla, crucial para o 
rearranjo após complexação com o octacarbonilo de dicobalto, foi conseguida 
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através de uma oxidação de Swern do álcool primário seguida de uma reacção de 
Corey-Fuchs e metilação. 
Introduzida a ligação tripla, o próximo passo consistiu na introdução do gem-
difluoroalceno na posição anomérica. A desprotecção selectiva do grupo OpMP 
com nitrato de amónio e cério (CAN) conduziu à formação dos correspondentes 
lactóis. No entanto, no caso do derivado galactose, esta etapa revelou-se bastante 
complicada e os seus rendimentos dependentes da quantidade de material de 
partida utilizado. Visto este ser um precursor para a preparação dos produtos 
carbocíclicos com a estereoquímica da gem-difluorogalactose, que serão 
intermediários importantes para a investigação da síntese dos dissacáridos, 
decidiu-se substituir o grupo OpMP pelo grupo SPh. Esta substituição revelou-se 
bastante vantajosa, melhorando substancialmente a preparação do lactol derivado 
da galactose. De seguida os lactóis foram oxidados a lactonas, que por sua vez 
foram convertidas nos gem-difluoroalcenos precursores utilizando o método de 
Motherwell.  
Sintetizados os precursores-chave, procedeu-se então à crucial e delicada reacção 
de rearranjo que consiste numa sequência de 2 passos reaccionais. A primeira 
etapa envolveu a complexação do alcino pelo octacarbonilo de dicobalto, seguindo-
se o rearranjo redutivo induzido por TIBAL (ácido de Lewis). A descomplexação do 
“cluster” de cobalto com CAN levou à formação da mistura de isómeros α e β dos 
produtos carbocíclicos desejados. Posteriormente foram estudados outros ácidos 
de Lewis com vista ao melhoramento da estereoselectividade da reacção. Contudo, 
não foi possível optimizar estes resultados. 
A última etapa do esquema de síntese delineado consistiu na desprotecção final da 
molécula. Assim, a função CH2OH foi restaurada após hidrogenação controlada da 
ligação tripla utilizando o catalisador de Lindlar, seguida de uma ozonólise 
redutiva. Finalmente os grupos benzilo foram removidos através de uma 
hidrogenação clássica usando paládio sobre carvão como catalisador.  
Inesperadamente, no caso do derivado com a configuração da D-galactose, a 
redução do aldeído, obtido após a etapa de ozonólise, conduziu não só à formação 
dos produtos gem-difluorados, como também dos produtos resultantes da 
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eliminação de HF. A mistura de produtos difluorados/monofluorados só se 
revelaram cromatograficamente separáveis após acetilação dos grupos hidroxilo 
livres. A semelhança estrutural destes compostos com o produto natural 
patenteado (+)-MK7607, que possui uma elevada actividade herbicida, levou-nos a 
investigar a sua síntese para posteriores ensaios biológicos. Desta forma, foram 
investigadas várias tentativas visando a síntese destes produtos via eliminação α,β 
do aldeído intermediário. De todos os reagentes testados, LiAlH4 foi o único que 
permitiu melhorar ligeiramente o rendimento da molécula-alvo, apesar do produto 
maioritário continuar a ser o composto gem-difluorado. Os produtos 
monofluorados totalmente desprotegidos foram finalmente obtidos após remoção 
dos grupos benzilo com BCl3 e desacetilação.  
Todos os gem-difluorocarbaaçúcares e pseudo-carbaaçúcares monofluorados 
foram testados como inibidores de glicosidases. No entanto, nenhum deles 
apresentou uma actividade relevante. 
Sintetizados os isómeros α e β gem-difluorocarbamanose e –galactose, iniciou-se a 
preparação do gem-difluorocarbalactose e gem-difluorocarbalactosamida, os quais 
serão interessantes candidatos com vista à elucidação do papel do oxigénio 
endocíclico no mecanismo de reconhecimento biológico açúcar-proteina. Foram 
delineadas várias estratégias tendo como base o acoplamento directo entre os 
produtos carbocíclicos obtidos após a etapa de rearranjo e outra molécula, 
convenientemente protegida e com a estereoquímica pretendida. A primeira 
estratégia centrou-se na O-alquilação do produto carbocíclico através de um 
ataque nucleófilo a um triflato. No entanto, todas as reacções falharam tanto em 
triflatos derivados da galactose nas conformações 4C1 e 1C4, esta última conhecida 
por ser mais reactiva em virtude da orientação equatorial do substituinte em C-4. 
O passo seguinte consistiu em colocar o triflato na posição anomérica do produto 
carbocíclico e testar o ataque nucleófilo de uma molécula de glucose 
convenientemente protegida. Mais uma vez esta estratégia mostrou-se infrutífera. 
Falhada a possibilidade de acoplamento via triflatos, foi realizada a reacção de 
acoplamento através do ataque nucleófilo do precursor carbocíclico a um sulfato 
cíclico, uma metodologia desenvolvida por Sharpless e descrita como sendo mais 
eficiente do que um ataque nucleófilo a um epóxido. No entanto, não foi possível 
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obter o produto pretendido. Como alternativa, decidiu-se investigar uma 
metodologia desenvolvida por Ikegami e colaboradores que consiste numa 
modificação engenhosa da clivagem regioselectiva de acetais de tipo 4,6-O-
benzilideno. Assim, investigou-se a formação do acetal entre a cetona gem-
difluorocarbocíclica e uma molécula de glucose contendo os grupos hidroxilo nas 
posições 4 e 6 livres. Apesar de todos os esforços, não foi obtido nenhum resultado 
prático na formação do produto pretendido. De forma a verificar a 
reprodutibilidade deste método efectuou-se a reacção descrita na literatura entre a 
glucono-1,5-lactona perbenzilada e 2.3-di-O-benzilglucopiranósido de metilo, 
tendo-se obtido o respectivo ortoéster com bom rendimento. A estratégia seguinte 
consistiu na alquilação de um derivado carbocíclico bromado na posição 
anomérica através da activação com HFIP, uma metodologia utilizada por Bonnet-
Delpon na alquilação de um derivado da artemisinina possuindo um grupo CF3 
vicinal. Mais uma vez, a estratégia mostrou-se ineficaz não se verificando qualquer 
alteração nos materiais de partida. 
Em virtude da reactividade anomérica estar severamente comprometida pela 
presença do grupo CF2, decidiu-se investigar uma estratégia de rearranjo 
alternativa tendo em vista a síntese do dissacárido. Nesta metodologia a 
construção do gem-difluoroalceno faz-se ao nível do carbono 5 de forma a reter a 
informação anomérica. Inicialmente esta abordagem foi aplicada a um 
monossacárido, facilmente acessível, de forma a verificar a validade do método. 
Assim, o composto 2,3-di-O-benzil-α-D-glucopiranósido de metilo foi transformado 
no derivado 2,3,4-tri-O-benzil-6-desoxi-6,6-difluoro-α-D-xylo-hex-5-enopiranósido 
de metilo em 5 passos. O rearranjo reductivo induzido por TIBAL deste precursor 
deu origem ao álcool gem-difluorocarbocíclico desejado com retenção do grupo e 
configuração anoméricos. A aplicação desta metodologia à lactose e à lactosamida 
permitirá alcançar a síntese dos gem-difluorocarbaaçúcares-alvo. 
 
Palavras-chave: gem-difluorocarbaaçúcares, pseudo-carbaaçúcares, (+)-MK7607, 
miméticos de açúcares, rearranjo induzido por TIBAL 
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Bz Benzoyl 
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The carbohydrates are the most abundant of the four major classes of 
biomolecules, which also include nucleic acids, lipids and proteins. As their name 
implies, carbohydrates (derived from the French “hydrate de carbone”) were 
originally believed to consist solely of carbon and water and thus were commonly 
designated by the generalized formula Cn(H2O)n. Nowadays, the definition of what 
is a carbohydrate has been much expanded to comprise compounds derived from 
monosaccharides by reduction of the anomeric carbonyl group (alditols), oxidation 
of one or more terminal groups to carboxylic acids or replacement of the hydroxyl 
group(s) by a hydrogen (deoxy derivatives), amino, thiol group(s) or a similar 
heteroatomic functionality. Due to the presence of multiple functional groups, 
carbohydrates contain several chiral centres and thus form many stereoisomers. 
They include the monosaccharides, which are the simplest compounds, as they 
cannot be further hydrolyzed to smaller constituent units, and saccharides which 
are formed by two or more monosaccharides via an acetal (glycosidic) linkage and 
can be split into the former by acidic hydrolysis. 
 
In the past, carbohydrates were considered to be solely of use for energy storage 
(starch, glycogen) and as structural components (cellulose in plants and chitin in 
animals). However, this naïve view was challenged in 1969[1] when a protein was 
isolated from Canavalia ensiformis that demonstrated ability to bind to 
carbohydrates in leukocytes. The study of carbohydrates within biological systems 
has shown that they are present in a wide range of fundamental biological 
functions such as cell-cell recognition and cell-external agent interactions.[2-4] 
These interactions can initiate beneficial biological events such as fertilization, cell 
growth and immune responses, as well as undesired disease processes, such as 
inflammation, viral and bacterial infections and cancer metastasis. Therefore, the 
total comprehension of carbohydrates biochemistry, particularly of recognition 
processes would not only contribute towards better understanding of 
carbohydrate processing enzymes but also may result in future therapeutic 
agents.[5] 
 
Despite being potential candidates for future drug development, carbohydrates 
progressed slowly in this direction. Especially oligosaccharides have always 
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remained unattractive targets for synthesis, due to the large number of reactions 
that are usually involved and the difficulty of the stereochemical control. 
Moreover, their biological function when conjugated with a particular protein is 
not always well established. 
 
Within this stimulant background, the current efforts are focused towards the 
design and syntheses of small molecules which can mimic the function of complex 
carbohydrates involved in important signaling and recognition events, but have 
improved properties in terms of stability, specificity and practical availability. 
Carbohydrate mimics can be defined as those molecular entities, which resemble 
the carbohydrates in structure, size, shape and thereby mimic their function. Over 
the past few years, several groups have been engaged in design and synthesis of 
such carbohydrate mimics. Inside the various strategies involved, some of them 
have focused their attention on the replacement of the endocyclic oxygen by some 
other heteroatom, which increases the stability of these new compounds towards 
hydrolysis; other groups have used modifications of the anomeric hydroxyl group 
as their central investigations (Figure 1). 
 
 
 
Figure 1. Different strategies involved in the construction of new carbohydrate mimics. 
 
Carbasugars, a family of carbohydrate mimics, have attracted great interest in 
recent years among chemists and biochemists due to their potential biological 
properties. The ability of carbasugars to mimic the size, structure and polarity of 
parent sugars and its stability towards hydrolysis make them potential candidates 
for the competitive inhibition of glycosidases and glycosyltransferases. 
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1.1 – Carbasugars 
1.1.1 – General Considerations  
 
Carbasugars are carbohydrate analogues in which the endocyclic oxygen has been 
replaced by a methylene group. This means that the acetal linkage of a sugar is 
formally transformed into a non-hydrolysable ether in a carbasugar (Figure 2). 
Natural and synthetic carbasugars, either as single molecules or as subunits of 
more complex molecules, have shown to display interesting biological activities,[6, 
7] mainly as enzymatic inhibitors. 
 
 
 
Figure 2. Structure of a sugar and of a carbasugar. 
 
The carbasugars were introduced about forty years ago when McCasland and co-
workers[8] first synthesized the talopyranose analogue 1, followed by two new 
isomeric compounds 2 and 3[9, 10] (Figure 3). The term pseudosugar has been 
coined by him to designate any such analogues. 
 
 
 
Figure 3. First three carbasugars synthesized by McCasland’s group. 
 
In the very first paper describing a carbasugar, McCasland[8] stated: “it is hoped 
that pseudosugars may be found acceptable in place of corresponding true sugars 
to some but not all enzymes or biological systems, and thus might serve to inhibit 
growth of malignant or pathogenic cells.” This subtle change constituted an 
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appealing possibility, since, while guaranteeing a high similarity with the true 
sugar, it would lead to compounds more stable toward degradative enzymes.  
 
As time passed, the term “pseudosugar” was besmirched and employed for a large 
variety of sugar analogues, thus requiring a specification of the definition for 
different subclasses of mimetics. S. Ogawa[11] proposed the use of the prefix 
“carba”, preceded, where considered necessary, by the appropriate locant (“4a” for 
an aldopyranose, “5a” for an aldopyranose), followed by the name of the sugar 
(Figure 4). 
 
 
 
Figure 4. Carbasugar structures. 
 
However, even this deﬁnition is misconstrued by many authors, who include 
carbocyclic polyols containing a non-substituted carbon, which should be called 
pseudo-carbasugars because they do not have a homomorphic sugar associated.[12, 
13] This implies that there are only thirty-two 5a-carba-aldohexopyranoses and 
sixteen 4a-carba-aldopentofuranoses. So far, from the thirty-two isomers of 5a-
carba-aldopyranoses theoretically possible, all sixteen of the racemic forms have 
already been synthesized[14], as well as twenty-five of the possible thirty-two pure 
enantiomers. 
 
 
1.1.2 – Natural Occurring Carbasugars and Biological Significance 
 
The carbasugars are not very abundant in Nature, at least the “real” ones. The 5a-
carba-α-D-galactopyranose (2) is the only “genuine” carbasugar isolated as a weak 
antibiotic against Klebsiella pneumonia MB-1264, from the fermentation broth of 
Streptomyces sp. MA-4145.[15] Curiously, it was isolated seven years after its first 
synthesis.[10] There are however, a large number of highly oxygenated cyclohexane 
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and cyclohexene derivatives, closely related to carbasugars (some authors[16-19] 
insist on calling such compounds as carbasugars, we, for the reason presented 
above, call them pseudo-carbasugars) which have been isolated from Nature, 
presenting interesting biological properties. In this category are included the 
inositols,[20, 21] components of the cell-membrane and second messengers; the 
glycosidase inhibitors conduritols[22, 23] and cyclophellitols[24, 25]; 
aminocarbasugars derivatives, such as valienamine[26-32] 7, validamine[33] 8, 
hydroxyvalidamine[33] 9 and valiolamine[33] 10, which are components of natural 
aminoglycoside antibiotics[34, 35]; and the shikimic[36] 11 and quinic[37] 12 acids, 
important biochemical intermediates in plants and microorganisms (Figure 5). 
 
 
 
Figure 5. Examples of naturally occurring pseudo-carbasugars. 
 
Among them the (+)–cyclophellitol 6 and the (+)–MK7067 13 have relevant 
biological activities. (+)–Cyclophellitol 6, isolated from the culture filtrate of a 
mushroom strain, Phellinus sp.[25, 38-40] is a potent inhibitor of β-glucosidases with 
potential inhibition of the human immunodeficiency virus (HIV) and with possible 
antimetastic therapeutic activity.[41] The (+)-MK7607 13, isolated from the 
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fermentation broth of Curvularia eragrostidis D2452,[42] is a patented naturally 
occurring unsaturated pseudo-carbasugar possessing herbicidal activity. 
 
But the most important and appealing carbasugar derivatives from a biological 
point of view are the aminocarbasugars. Some of them have become clinically 
successful to combat diseases in humans and plants. In 1970, during the screening 
for new antibiotics from the fermentation culture of Streptomyces hygroscopicus 
subsp. Limoneus, researchers at Takeda Chemical Company discovered the 
agricultural antibiotic Validamycin A[43] 14 (Figure 6). Extensive studies on 
isolation of minor components of the fermentation broth have led to the discovery 
of seven homologous antibiotics Validamycins B – H[44, 45] 15 – 21 (Figure 6). The 
core of these antibiotics is composed by a valienamine 7 unit and another 
aminoalcohol unit, which are linked through a single nitrogen atom. 
 
 
 
Figure 6. Validamycins antibiotics. 
 
The Validamycin A 14 is the most active compound of the complex and has been 
widely used in China and many other eastern Asia countries as a prime control 
reagent against sheath blight disease of rice plants caused by the fungus 
Rhizoctonia solani. 
 
Soon afterwards, the α-amylase inhibitor acarbose 22 (Figure 7) was isolated in a 
screening of strains of various Actinomycete genera.[46] Structurally acarbose, one 
of the most clinically important compounds containing carbasugar units, is a 
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pseudo-carbatrisaccharide comprising the units valienamine 7, a deoxyhexose and 
maltose. In addition to its α-glucosidase activity, acarbose also displays potent 
inhibitory activity against sucrase, maltase, dextrinase and glucoamilase.[47] This 
pronounced inhibitory effect has resulted in its use as a clinical drug for the 
treatment of type II non insulin dependent diabetes in order to enable patients to 
better control blood sugar contents while living with starch-containing diets. 
 
 
 
Figure 7. Acarbose 22 and Acarviosine 23 structures. 
 
The glycosidase inhibitory activities of acarbose 22 and related carba-
oligosaccharides have been ascribed to their acarviosine 23 moiety, in which the 
valienamine portion mimics the glucopyranosyl cation intermediate at the active 
site of the enzymes.[48] 
 
 
1.1.3 – Synthetic Carbasugars and Biological Significance 
 
An interesting property of the carbasugars that demonstrates their similarity with 
sugars is the fact that they taste sweet. Humans cannot differentiate synthetic 5a-
carba-α-D-glucopyranose (24) and D-glucose by their taste,[49] and synthetic 6a-
carba-β-D-fructopyranose showed to be almost as sweet as D-fructose.[50] 
 
It was also found that carbasugar 24 inhibited both glucose–stimulated insulin 
release and glucokinase activity whereas the β-anomer 25 showed no activity.[51] 
Moreover, these two carbasugar isomers were used in the elucidation of the 
stereochemical selectivity of the reverse reaction of the cellobiose phosphorylase 
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of Cellvibrio gilvuse,[52] where in this case, only the 5a-carba-β-D-glucopyranose 
(25) was a substrate of the reaction – not the α anomer (Figure 8). This study was 
of course unrealizable with D-glucose itself because of mutarotation. 
 
 
 
Figure 8. Carbasugars as stable chemical probes. 
 
The pronounced biological activity of the aminocarbasugars as glycosidase 
inhibitors prompted the scientists to synthesize and evaluate several derivatives. 
And in the search for new bioactive compounds, the valiolamine 10 played an 
important role since it was found that it has a more potent α-glucosidase inhibitory 
activity against porcine intestinal sucrase, maltase and isomaltase than 
valienamine 7, validamine 8 and hydroxyvalidamine 9.[45] This information 
stimulated the synthesis and screening of a series of N-substituted valiolamines, 
resulting in the preparation of the glycosidase inhibitor voglibose[53] 26 (Figure 9), 
which is used as a therapeutic agent since 1994 to control diabetes mellitus type II. 
The voglibose 26 competes with saccharides as enzyme substrate, suppressing the 
elevation of the glucose concentration in blood after oral sucrose, maltose or 
starch administration.  
 
 
 
Figure 9. Voglibose structure. 
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Since then, several pseudo-aminocarbasugar derivatives have been synthesized, 
and in this field much credit has to be given to S. Ogawa who prepared and 
evaluated an important number of compounds. Among them are: carbocyclic 
analogues of glycosylamides[54] 27 and 28, structurally related to 
glycosphingolipids and glycoglycerolipids (Figure 10), which showed similar 
potencies as immunomodulators, comparable to those of the corresponding true 
sugar analogues; and N-linked carbocyclic analogues of glycosylceramides[55-57] 
(Figure 10), where it was demonstrated that the unsaturated derivatives 31 and 
32 inhibited β-gluco- or β-galactocerebrosidase more strongly and selectively than 
the saturated counterpart 29 and 30. This result suggests that the unsaturated 
analogues should more efficiently mimic the transition state of the natural 
substrate during the enzymatic reaction. 
 
 
 
Figure 10. Carbocyclic analogues of glycosylamides and glycosylceramides. 
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Later then, attempting to develop a similar type of glycosidase inhibitors 
structurally more simple, they prepared several N-alkyl valienamine derivatives [58, 
59] (Figure 11), where the N-octyl derivative 33 presented the highest inhibitory 
activity (IC50 = 3 x 10-8 M) against rat liver β-glucocerebrosidase. 
 
In the search for new types of inhibitors of α-L-fucosidase, Ogawa and co-workers 
prepared and evaluated several carbafucopyranoside derivatives.[60-62] Among 
them, 5a-carba-α-DL-fucopyranosylamine (DL-34) and 5a-carba-β-L-
fucopyranosylamine (35) (Figure 11) showed to be very potent and specific 
inhibitors of α-L-fucosidase (bovine kidney), being the effect of the former DL-34 
essentially comparable to that of mammalian α-L-fucosidase 
deoxyfuconojirimicin[63, 64] 36, the most powerful inhibitor identified so far. 
Finally, they also evaluated a series of N-alkyl and phenylalkyl derivatives, 
verifying a considerable improvement of the inhibitory activity against α-L-
fucosidase, reaching a maximum again with an octyl chain, which seems to act as a 
structurally efficient hydrophobic spacer. 
 
 
 
Figure 11. N-alkyl valienamine and carbafucopyranosylamines analogues. 
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Carbasugar derivatives have also been envisaged as potential entities for the 
elucidation and/or control of biological events involving sugar moieties. The 
construction of enzyme substrate analogues, in which part of their structure has 
been replaced by a carbasugar unit, is expected to be useful in the elucidation of 
the mode of action of sugar transferases. 
 
An area of recent interest is the design of potential substrates and inhibitors of 
fucosyl and sialyl transferases involved in the last steps of the biosynthesis of 
Lewis oligosaccharide antigens. These antigens include Sialyl LewisX (SLeX) 38, 
which is a tumor-associated structure and a ligand of E-selectin mediated 
inflammatory processes.[65, 66] In this context, Ogawa and co-workers carried out 
studies envisaging the discovery of efficient substrates for α-(1→3/4)-
fucosyltransferase, since the presence of the fucose moiety was established to be 
crucial for the recognition of the SLeX 38 determinant by E-selectin.[67-70] They 
prepared ether- and imino-linked N-acetyl-5a’-carba-β-lactosaminides and               
–isolactiminides[71] (Figure 12) and tested them against fucosyltransferases. 
 
 
 
Figure 12. Carbasugar analogues of N-acetyl-5a’-carba-β-lactosaminides and –isolactiminides. 
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Compounds 39 and 40 were found to be acceptor substrates for human-milk α-
(1→3/4)-fucosyltransferase with kinetic parameters comparable to those for 
standard true disaccharides.[72] Small-scale reaction of 39 and 40 with GDP-fucose 
and milk fucosyltransferase resulted in conversion to trisaccharides 43 and 44, 
respectively (Figure 13). Surprisingly, compounds 41 and 42 were neither 
acceptors nor inhibitors for milk fucosyltransferase suggesting that α-(1→4) 
transfer is not possible. The milk preparation contains a mixture of two different α-
(1→3/4)- and α-(1→3)-fucosyltransferase enzymes. These two enzymes were 
separated and it was shown that both forms utilized compounds 39 and 40 as 
acceptor substrates, whereas 41 and 42 were neither substrates nor inhibitors for 
the enzyme. This was the first demonstration of a specific substrate for an α-
(1→3)-fucosyltransferase. 
 
 
 
Figure 13. Enzymatic synthesis of the 5a’-carbatrisaccharides. 
 
The biological significance of carbasugars has stimulated the scientific community 
to synthesize them and their analogues either in racemic or in chiral form and 
several approaches have been developed.[73] The most prominent strategies make 
use of Diels-Alder reaction of cyclic dienes, carbanionic and radical cyclizations, 
ring closing metathesis (RCM), cycloaddition reactions, rearrangement of cyclic 
sugars and manipulations on quinic[74] and shikimic acids. 
 
In the next section it will be presented an overview of carbasugars preparation, 
starting with the pioneer work of Prof. McCasland, which led to the first synthesis 
of a carbasugar. 
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1.1.4 – Synthesis of Carbasugars 
 
1.1.4.1 – Diels-Alder approach 
 
The Diels-Alder reaction between some oxygen containing dienes and dienophiles, 
nowadays highly diastereoselective, provides hydroxylated cyclohexenes in a 
single step, which after further transformation allow the preparation of 
appropriately functionalised carbocycles. 
 
The first synthesis of a carbasugar, performed by prof. McCasland[8] group, was 
carried out based on the Diels-Alder reaction of 2-acetoxyfuran (45) and maleic 
anhydride 46 (Scheme 1). syn-Hydroxylation with OsO4 and hydrolysis of the 
oxanorbornene intermediate 47 gave the diol diacid 48, which on prolonged 
reaction with water undergoes a series of transformations (acetyl migration, 
opening of the 1,4-oxacyclic ring, carbonyl liberation, and decarboxylation) leading 
to 49. Sodium borohydride reduction of 49 and subsequent esterification with 
methanol and trifluoroacetic acid, followed by acetylation gave the tetraacetate 50, 
which was converted into the target carbasugar 1 by reduction with lithium 
aluminum hydride followed by hydrolysis. 
 
 
 
Scheme 1. Synthesis of 5a-carba-α-DL-talopyranose, the first synthetic carbasugar (only D-
enantiomers are shown). 
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The 5a-carba-α-DL-galactopyranose (2) (Scheme 2) was prepared by deacetylation 
of pentaacetate 53, which in turn was readily obtained from 5a-carba-α-DL-
talopyranose pentaacetate (51) by acid-induced epimerization at C-2 through an 
intermediary cyclic acetoxonium ion 52, which was formed by anchimeric 
assistance of the neighboring acetoxyl group.[10] 
 
 
Scheme 2. Epimerization of the 5a-carba-α-DL-talopyranose pentaacetate (51) into 5a-carba-α-DL-
talopyranose (2) (only D-enantiomers are shown). 
 
The 5a-carba-α-DL-gulopyranose (3) (Scheme 3) was synthesized by syn-
hydroxylation of the intermediate 56, obtained by Diels-Alder cycloaddition of 1,4-
diacetoxy-1,3-butadiene (54) and allyl acetate (55). Successive acetylation and 
hydrolysis afforded the free carbasugar in 33% overall yield.[9] 
 
 
 
Scheme 3. Synthesis of 5a-carba-α-DL-talopyranose (3) (only D-enantiomers are shown). 
 
After the pioneering work of McCasland and co-workers, 7-oxanorbornene 
derivatives were extensively used as starting materials for the synthesis of 
carbapyranoses and derivatives.[75] An impressive contribution in this field was 
given by Profs. S. Ogawa and T. Suami who extensively used this methodology to 
prepare a large number of carbasugars.  
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The key intermediate in their approach, 7-oxabicyclo-[2.2.1]hepten-5-ene-2-
carboxylic acid (60), readily prepared by Diels-Alder cycloaddition of furan (58) 
and acrylic acid 59 (Scheme 4), was shown to be an ideal starting material for the 
forthcoming synthesis of carbasugars, and eleven of the original sixteen racemic 
syntheses have made use of it.  
 
 
 
Scheme 4. S. Ogawa and T. Suami precursors for carbahexopyranoses (only D-enantiomers are 
shown).   
 
When acid 60 was treated with hydrogen peroxide and formic acid, the 
hydroxylactone 61 was formed. This compound was the key intermediate for the 
syntheses of β-DL-gluco-,[76, 77] α-DL-galacto-,[76, 77] β-DL-allo-,[78] and α-DL-
gulocarbapyranoses.[79] The majority of the remaining carbapyranoses, α-DL-
manno-,[76, 77] β-DL-manno-,[76, 77] β-DL-altro-,[76, 77] α-DL ido-,[76, 77] α-DL-gluco-[78] 
and α-DL-allopyranose,[78] were derived from the bromo lactone 62, prepared by 
treatment of the acid 60 with hydrobromous acid (Scheme 4). An example of 
carbasugar synthesis using this methodology is shown in Scheme 5.   
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Scheme 5. Synthesis of 5a-carba-β-DL-glucopyranose (25) and 5a-carba-α-DL-galactopyranose (2) 
from the hydroxylactone 61 (only D-enantiomers are shown). 
Introduction 
18 
Reduction of the lactone 61 with LiAlH4 followed by peracetylation afforded the 
triacetate 63, which under acidic conditions underwent a non-regioselective 
cleavage of the 1,4-oxa-bridge to yield 5a-carba-β-DL-glucopyranose pentaacetate 
(64) and 5a-carba-α-DL-galactopyranose pentaacetate (53).[76, 77] 
 
Alternatively, reduction, acetylation, and acetolysis of the lactone 62 gave a 
mixture of bromo derivatives 65 and 66 (Scheme 6), which were independently 
subjected to a substitution reaction with acetate ion to furnish 5a-carba-α-DL-
galactose (2), carba-5a-α-DL-idopyranose (68), 5a-carba-α-DL-mannopyranose 
(71) and 5a-carba-β-DL-altropyranose (72).  
 
 
 
Scheme 6. Synthesis of carba-DL-hexopyranosides from bromo lactone 62 (only D-enantiomers are 
shown). 
 
The Diels-Alder adduct 60 has also been used in the synthesis of optically active 
series of carbahexopyranoses. Acid 60 is readily resolved by the fractional 
recrystallization of the mixture of salts formed with optically active                           
R-(+)-methylbenzylamine to give the (–)-adduct 60. The analogous procedure with 
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(S)-(–)-methylbenzylamine and 60 afforded the optically pure (+)-adduct 60 
(Scheme 7).[80]  
 
 
 
Scheme 7. Enantiomeric resolution of (±)-60. 
 
In this way, all enantiomeric carbasugars will be accessible either in D or L forms, 
starting from the optical pure acids (–)-60 or (+)-60 by the same strategies 
employed in the synthesis of racemic carbasugars.  
 
These strategies have also been applied to the preparation of aminocarbasugars in 
both racemic and enantiomerically pure forms. The synthesis of DL-validamine 8 
(Scheme 8) was reported[76] in the mid-1970s using as starting material 63, easily 
prepared from the hydroxylactone 61 (scheme 5).[81]  
 
 
 
Scheme 8. Synthesis of (±)-validamine 8 (only D-enantiomers are shown). 
 
Treatment of triacetate 63 with 20% hydrogen bromide at 80 °C afforded the 
dibromide 73. The primary bromide was then selectively replaced by an acetoxy 
group and the secondary bromo function was displaced with azide ion to give 75, 
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which was hydrogenated and acetylated to afford, after deprotection, racemic 
validamine 8. Since then, DL-valienamine,[82-85] DL-hydroxyvalidamine,[86] DL-
valiolamine,[87] 2-amino-5a-carbadeoxy-DL-pyranoses, [88, 89] 3-amino-5a-deoxy-DL-
pyranoses,[90] DL-hydroxyvalidamine,[91] DL-1-epi-validamine,[92] DL-2-epi- 
validamine,[77] DL-2-amino-2-deoxyvalidamine having α- and β-gluco and α- and β-
manno configurations,[93] 5a-carba-α-DL-fucopyranosylamine,[60] 5a-carba-α-DL-
galactopyranosylamine,[60] and fucose-type α- and β-valienamine derivatives,[62] all 
in racemic form, have also been synthesized using Diels-Alder adduct 60 as 
starting material.  
 
Enantiopure (+)-validamine 8[94] and (+)-valienamine 7[95] were later prepared 
from chiral (–)-60 following the same procedure previously employed for the 
synthesis of their racemates. 
 
As we have seen, the Diels-Alder approach constitutes a valuable tool in organic 
synthesis for the preparation of cyclohexene derivatives, and more specifically a 
useful methodology for the synthesis of carbasugars and derivatives. However 
carbohydrates are much more attractive and widely used starting materials for the 
preparation of carbasugars, since they are generally inexpensive, with all the 
requisite stereochemistry in place and no need of extensive functionalizations. 
 
 
1.1.4.2 – Carbanionic Cyclizations  
 
The generation of anionic species and their use as nucleophiles in the formation of 
C-C bonds is well established in the field of organic chemistry. As applied to the 
formation of carbasugars, various stabilizing groups have gained particular 
attention, namely malonates, nitro groups, phosphorous ylides and aldol 
precursors.  
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1.1.4.2.1 – Malonates 
 
The use of malonate anions to recyclize open-chain sugars was first introduced by 
Suami et al.[96, 97] in the course of their extensive studies towards the synthesis of 
new carbasugars. After conversion of the starting material L-arabinose into the 
diethyl dithioacetal open form, the sugar was protected by selective tritylation of 
the primary alcohol and subsequent benzylation of the secondary hydroxyl groups. 
Replacement of the trityl by a tosyl group afforded compound 78 (Scheme 9). 
 
 
 
Scheme 9. Synthesis of carbasugars using malonates. 
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The aldehyde function was restored and the tosylate was substituted by iodide, 
giving the key iodo-aldehyde 79. Reaction of 79 with dimethyl malonate anion and 
spontaneous cyclisation, followed by further acetylation provided the cyclohexane 
derivative 82 and a secondary pyranose derivative 83 in the ratio of 5:3. The 
formation of compound 83 could be explained by the initial addition of the 
malonate anion to the carbonyl followed by the displacement of the iodo group by 
the resulting alkoxide. Krapcho decarboxylation of 82 in aqueous dimethyl 
sulfoxide with NaCl proceeded with simultaneous β-elimination of the acetoxyl 
group to give the cyclohexene derivative 84. Reduction of the unsaturated ester 
with LiAlH4, followed by hydroboration-oxidation and final deprotection gave a 
mixture of 5a-carba-α-D-glucopyranose (24) and 5a-carba-β-L-altropyranose (L-
72). The main drawback of this strategy is the low yield of the carbocyclization 
step, because of the competition between addition to the carbonyl and substitution 
of the iodide. To circumvent this problem, an alternate pathway incorporating the 
malonate moiety prior to the transformation of the primary hydroxyl group into a 
leaving group was explored. This alternative method was used, for instance, in the 
preparation of 5a-carba-β-L-mannopyranose pentaacetate[98] (L-91) (Scheme 10).  
 
 
 
Scheme 10. Improved synthesis of a carbasugar using malonates. 
 
As illustrated, the silylated derivative 87 was synthesized following a similar 
strategy reported for 79 (Scheme 9). Then compound 87 underwent a 
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Knoevenagel condensation in the presence of an excess of dimethyl malonate in a 
mixture of acetic anhydride and pyridine to afford an α,β-unsaturated diester. This 
product was hydrogenated and desilylated to give the alcohol 88. The crucial 
cyclization into a cyclohexane derivative was accomplished by oxidation of 
compound 88 with PCC followed by acetylation to afford 89 as a single 
diastereoisomer. Applying the same concluding sequence described in Scheme 9, 
only the 5a-carba-β-L-mannopyranose pentaacetate (L-91) was isolated, which 
means that in this case the hydroboration step was selective. This strategy was 
extended to different carbasugars (Scheme 11). D-Arabinose diethyl acetal[99] 92 
was converted into cyclohexene 93 (C-1 epimer of 90) from which 5a-carba-α-L-
mannopyranose pentaacetate (L-69) was stereoselectively obtained.  
 
 
Scheme 11. Synthesis of carbasugars using malonates.  
 
On the other hand, D-xylose diethyl dithioacetal[99] 94 was transformed into 
cyclohexene 95, which was used in the preparation of 5a-carba-β-L-glucopyranose 
pentaacetate (L-64) and 5a-carba-α-D-altropyranose pentaacetate (96). 
 
 
1.1.4.2.2 – Nitro groups 
 
Nitro groups are commonly used to stabilize carbanions on adjacent carbon atoms. 
Kitagawa and co-workers[100] showed that reactions involving cyclization of 
nitrosugars are useful processes in the enantioselective preparation of 
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carbasugars. As shown is Scheme 12, benzylated diacetone-D-glucose, easily 
obtained from D-glucose, was selectively deprotected and the resulting diol 
reprotected at the primary position. Swern oxidation, followed by addition of 
nitromethane, afforded two alcohols 98 and 99.  
 
 
Scheme 12. Synthesis of carbasugars using nitro sugar precursors. 
 
The application of identical reaction sequences to each diastereoisomer led to 5a-
carba-α-D-glucopyranose (24) and 5a-carba-β-L-idopyranose (L-104). According 
to this sequence, the reductive deacetoxylation, on 98 and 99, with NaBH4 
proceeded stereoselectively to provide SN2-type reaction products 100 and 102, 
respectively. Cyclization under basic conditions and re-introduction of the 
isopropylidene group yielded the nitro pyranose derivatives 101 and 103, 
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respectively. Finally, radical-mediated denitration and subsequent removal of the 
di-O-isopropylidene group gave 24 and L-104. 
 
The same key nitrofuranose intermediates 100 and 102 were used for the 
synthesis of the amino carbasugars validamine 8 and 5-epi-validamine 109, 
respectively (Scheme 13).  
 
 
 
Scheme 13. Synthesis of aminocarbasugars using a nitro group. 
 
Accordingly, treatment of the nitrofuranose derivatives 100 and 102 with KF in 
DMF in the presence of 18-crown-6 and subsequent acetylation of the products 
yielded the nitro olefins 105 and 107. These compounds were then subjected to a 
Michael-type addition with liquid NH3 to introduce the “anomeric” amino group. 
Radical elimination of the nitro group in 106 and 108 with tributyltin hydride 
followed by removal of protecting groups provided validamine 8 and 5-epi-
validamine 109, respectively. 
 
 
1.1.4.2.3 – Phosphorous Ylides 
 
The cyclization of carbanions, which are stabilized by phosphonate neighboring 
groups, have been of particular value in the synthesis of carbapyranoses from 
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carbohydrates. In this context, Paulsen et al. paid special attention to the 
intramolecular Horner-Wadsworth-Emmons olefination (Scheme 14).[101]  
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Scheme 14. Synthesis of carbasugars using phosphorous ylide. 
 
The reaction of aldehyde 110, easily prepared from D-glucose, with lithium 
dimethyl methyl phosphonate and further manipulation of protecting groups 
yielded the intermediate 111. Subsequent Swern oxidation provided the 
intermediate dicarbonyl derivative 112, which spontaneously cyclised into enone 
113. Posterior treatment of the enone 113 with sodium borohydride furnished the 
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alcohols 114 and 115. O-Desilylation, catalytic hydrogenation, O-debenzylation, 
and acetylation converted 114 into 5a-carba-β-D-glucopyranose pentaacetate (64) 
and 5a-carba-α-L-idopyranose pentaacetate (L-67). Similarly, 115 was 
transformed into 5a-carba-α-D-glucopyranose pentaacetate (116) and 5a-carba-β-
L-idopyranose pentaacetate (L-117). 
 
Horii and co-workers also used the intramolecular Horner-Wadsworth-Emmons 
reaction starting from tetra-O-benzyl-D-glucono-1,5-lactone (118), readily 
available from D-glucose, in their synthesis of valienamine 7 (Scheme 15).[102]  
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Scheme 15. Synthesis of valienamine 7 via phosphorous ylide. 
 
Lactone 118 was treated with 2 equivalents of lithium dimethyl methyl 
phosphonate to yield dimethoxyphosphoryl derivative 119. The pyranose ring was 
reductively opened with sodium borohydride to give the heptitol derivative 120, in 
which the 2-OH and 6-OH groups were oxidized with a reagent combination of 
DMSO, trifluoroacetic anhydride, and triethylamine. The intramolecular cyclization 
reaction of the resulting 2,6-heptodiulose derivative 121 was accomplished with 
potassium carbonate in the presence of 18-crown-6 to give the branched 
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unsaturated inosose derivative 122. Next, the carbonyl group of 122 was reduced 
stereoselectively to an allylic equatorial hydroxyl group with NaBH4-CeCl3 in 
ethanol. The resulting alcohol 123 was then converted to an axial amino group 
employing a Mitsunobu reaction to afford tetra-O-benzylvalienamine 124, which 
after cleavage of the benzyl protected groups with sodium in liquid ammonia 
provided the unsaturated amino pseudo-carbasugar valienamine 7. 
 
Toyokuni et al. have also utilized the intramolecular Horner-Wadsworth-Emmons 
reaction for the conversion of L-fucose 125 to its carbocyclic analogue L-133 
(Scheme 16).[103] 
 
 
 
Scheme 16. Synthesis of 5a-carba-α-L-fucopyranose (L-133) via phosphorous ylide. 
 
The synthesis started from the benzylated hemiacetal 135, readily accessible from 
L-fucose in three steps. Oxidation to the 1,5-lactone 136 followed by a nucleophilic 
attack with lithium dimethyl methyl phosphonate afforded the heptulopyranose 
127 as a single isomer. Reductive ring opening of 127 with NaBH4 and subsequent 
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Swern oxidation yielded the unstable dioxo phosphonate 128. The ensuing 
intramolecular olefination occurred smoothly by treatment with NaH in diglyme to 
give the unsaturated inosose 129. The copper (I) hydride hexamer allowed the 
stereoselective conjugate reduction of 129, yielding the inosose 130 as the only 
diastereomer. The NaBH4-CeCl3 reduction in MeOH produced an almost 
quantitative conversion of 130 to the equatorial alcohol 131, which is a protected 
form of carba-β-L-fucopyranose. In the absence of CeCl3, the same reduction 
resulted in poor selectivity, giving a mixture of 131 and its epimeric alcohol 132 in 
a 1.3:1 ratio. Hydrogenolysis of 132 yielded 5a-carba-α-L-fucopyranose (L-133).  
 
 
1.1.4.2.4 – Aldol Cyclizations 
 
Aldol condensations are important in organic synthesis, providing a good way to 
form carbon–carbon bonds. Tadano et al. have extended this methodology for the 
preparation of carbasugars.[104, 105] Thus, Wittig olefination of the known 
compound 134 with acetylmethylenetriphenylphosphorane gave a 3:1 mixture of 
(E/Z)-diastereoisomers, which underwent successive catalytic hydrogenation, in 
the presence of Raney®-Ni, and reoxidation of the generated alcohol providing the 
ketone 135. Selective hydrolysis of the 5,6-O-isopropylidene, followed by oxidative 
cleavage of the diol with sodium periodate afforded the di-carbonyl compound 
136. The crucial intramolecular aldol condensation was achieved by refluxing the 
product 136 in benzene in the presence of DBU, and a subsequent elimination with 
acetic anhydride and pyridine gave 137 (Scheme 17), the key intermediate for the 
synthesis of carbasugars of the α-L-altro, β-D-gluco, β-L-allo, and α-D-manno series.. 
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Scheme 17. Synthesis of key intermediate 137 by intramolecular aldol cyclisation. 
 
In order to introduce oxygen functionalities to the 2-cyclohexenone ring, 
epoxidation of 137 was carried out with hydrogen peroxide to give, almost 
quantitatively, the β-epoxide, which was reduced with sodium borohydride to give 
the epoxy alcohols 138 and 139 in a 5:1 ratio (Scheme 18). Epoxide opening of 
138 with hydroxyde anion gave exclusively the diaxial opening product. On the 
other hand, the nucleophilic ring opening of the isomeric epoxide 139 also 
produced triol 140, which can be rationalized by a migration of the epoxide and 
subsequent hydroxide ring opening in a diaxial manner. Benzylation of the free 
alcohols in 140, acid hydrolysis of the acetal moiety, and successive sodium 
borohydride reduction of the released aldehyde provided the branched 
cyclohexane triol 141. Glycol cleavage in 141, reduction, removal of the protecting 
groups, and final acetylation furnished 5a-carba-α-L-altropyranose pentaacetate 
(L-96).[104, 105] 
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Scheme 18. Synthesis of 5a-carba-α-L-altropyranose pentaacetate (L-96) from key intermediate 
137. 
 
In another set of experiments, cyclohexenone 137 was reduced with DIBAL-H to 
yield an inseparable mixture of allylic alcohols, which were acetylated and treated 
with osmium tetroxide to give, stereoselectively, diols 142 and 143 (53% and 6% 
yield, respectively) (Scheme 19). O-Deacetylation of 142, successive benzylation, 
hydrolysis of the O-isopropylidene group and reduction with NaBH4 gave the 
carbaheptopyranose 144. Glycol cleavage on 144 with sodium periodate, followed 
by reduction of the resulting aldehyde and acetylation, provided the fully protected 
5a-carba-β-L-allopyranose. Finally, cleavage of the benzyl protecting group 
followed by acetylation afforded 5a-carba-β-L-allopyranose pentaacetate (L-
145).[106]  
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Scheme 19. Synthesis of 5a-carba-β-L-allopyranose pentaacetate (L-145) from key intermediate 
137. 
 
D-Glyceraldehyde, the smallest of the sugars, was also used to synthesize 
carbasugars.[107] As shown in Scheme 20, it was ﬁrst protected with an acetal and 
the carbonyl group in 147 was submitted to a vinylogous cross aldolisation with a 
furan silyloxy diene to selectively give the key alcohol 148. Reduction of the double 
bond, followed by silylation of the free hydroxyl gave rise to the substituted 
furanose 149. Removal of the isopropylidene protecting group afforded 150, 
which then underwent a two-stage protocol, consisting in a full protection of the 
free hydroxyl with silyl groups, followed by the selective desilylation of the 
primary hydroxyl. Subsequently, Swern oxidation afforded the di-carbonyl 153, 
which under basic conditions was transformed into the bicyclic lactone 154 in a 
single stereoisomer. Silylation of the generated alcohol, reduction of the lactone 
with LiAlH4, and desilylation furnished 5a-carba-β-D-gulopyrnose (3).  
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Scheme 20. Synthesis of a carbasugar using an aldol reaction on D-glyceraldehyde. 
 
Transformation of compound 148 into its isomer 155 under basic conditions 
(Scheme 21) led to the synthesis of 5a-carba-β-L-mannopyranose (L-156) using 
the same synthetic pathway.[108] 
 
 
 
Scheme 21. Isomerization of 148 and synthesis of an isomeric carbasugar. 
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1.1.4.3 - Radical Cyclizations  
 
Free radical cyclizations have been used extensively to convert carbohydrates into 
carbocycles.[109, 110] The general strategy consists of opening the sugar, 
transforming the carbonyl into a radical acceptor (alkene or alkyne) and 
converting one of the hydroxyl groups into a nucleophilic radical suitable to 
achieve cyclization. The intermediate radical employed in the preparation of 
carbapyranoses has been generated mostly by the use of tributyltin hydride. 
 
 
1.1.4.3.1 – 6-exo-trig Radical Cylization 
 
The use of Wittig reaction on a reducing sugar is a handy method to generate a 
double bond, which can then be used as a radical acceptor. One such example, 
depicted in Scheme 22, incorporates the classical dithioacetal opening of D-glucose. 
As illustrated, selective benzoylation of the primary hydroxyl, followed by di-
acetalization and debenzoylation, afforded alcohol 157.  
 
 
Scheme 22. Synthesis of carbasugars using a 6-exo-trig radical cyclization. 
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The primary alcohol in 157 was displaced by bromine and the ethyldithioacetal 
cleaved. Oleﬁnation of the resulting aldehyde 158 gave the radical acceptor enol 
ether 159, as a (Z/E)-mixture (1:1). Radical cyclization promoted by a tributyltin 
hydride afforded 160 as a major compound. Finally, acid hydrolysis of the 
acetonides yielded 6-O-methyl-5a-carba-α-L-glucopyranose (161).[111]  
 
Redlich and co-workers[112] published in 1992 a comprehensive study on the scope 
of the radical cyclization of hept-1-enitols for the preparation of 5a-carbasugars. 
They reported the preparation and radical ring closure of twelve differently 
substituted hept-1-enitols, leading to several 6-deoxy-5a-carbapyranoses. Starting 
from D-ribose (Scheme 23) derivative 162, they prepared five different substrates 
for radical cyclization which differed either on the halogen (165 and 166) or on 
the protecting groups (166, 168, 169 and 170). 
 
 
 
Scheme 23. Synthesis of precursors for radical cyclization. 
 
A different behavior was found in the reaction of bromo and iodo derivatives 165 
and 166 under typical radical cyclization conditions (Bu3SnH, AIBN and Benzene). 
As presented in Scheme 24, whereas 166 reacted to give a mixture of 5a-carba-α-L-
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allo derivative 172 and reduced compound 173, the reaction of 165 resulted in 
the formation of substituted tetrahydrofuran 171, presumably via an ionic rather 
than a radical mechanism. 
 
 
 
Scheme 24. Substituent effects in radical cyclizations.  
 
A prominent effect of the protecting groups on the outcome of the radical 
cyclization is observed when comparing radical cyclization of iodides 166 and  
168 – 170. Thus, radical cyclization of acyl derivatives 169 and 170 was 
completely stereoselective, whereas reaction of diol 168 yielded a mixture of α-L-
allo 174, β-D-talo 175 and reduced 176 derivatives. 
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1.1.4.3.2 – 6-exo-dig Radical Cylization 
 
Carbasugars have also been synthesized through 6-exo-dig radical cyclizations. One 
example is the work of Wightman et al. where they reported the conversion of D-
ribose to carba-β-D-rhamno- and carba-α-L-gulopyranose pentaacetates (186) and 
(L-188).[113] Thus, treatment of the protected silyl-D-ribose derivative 162 with 
lithium phenylacetylide afforded an inseparable diastereomeric mixture of the 
diols 179, which were protected with MOM ethers to afford a 7:2 separable 
mixture of isomers (Scheme 25). Both of these diastereomers were processed 
separately to the primary iodides 181 and 183 via desilylation and iodination of 
the resulting alcohol. Radical cyclization of 181, with the loss of a MOM group, 
afforded cyclohexene 182 as the only isomer. On the other hand radical ring 
closure of 183 furnished a mixture of 182 and exo-methylenecyclohexane 184.  
 
 
 
Scheme 25. Synthesis of carbasugars using 6-exo-dig radical cyclization. 
 
Hydroboration-oxidation of 182 and 184 was regio- and stereoselective and 
subsequent cleavage of the protecting groups and acetylation, yielded 5a-carba-β-
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D-rhamno- and 5a-carba-α-L-gulopyranose pentaacetates (186) and (L-188), 
respectively (Scheme 26). 
 
 
 
Scheme 26. Synthesis of 5a-carba-β-D-rhamno- and 5a-carba-α-L-gulopyranose pentaacetates 
(186) and (L-188). 
 
After that, Gómez et al.[114] developed a strategy for the synthesis of 5a-carba-β-D-
mannopyranose pentaacetate (91) using a variation of the strategy illustrated in 
Scheme 25, in which C-5a was retrosynthetically correlated with the exocyclic 
double bond of an exo-methylenecyclohexane produced by 6-exo-dig radical 
cyclization of an alkyne (radical acceptor) and a thionocarbonate (radical 
precursor) derived from D-mannose (Scheme 27). 
 
 
 
Scheme 27. Gómez et al. retrosynthesis of 5a-carba-β-D-mannopyranose pentaacetate (91). 
 
Therefore, mannose diacetonide 189 (Scheme 28), prepared in one step from D-
mannose, was treated with lithium phenylacetylide to yield, as a very major 
isomer, diol 190. This diol was then converted, in two steps, into phenyl 
thionocarbonate 191, whose radical cyclization afforded a 3:2 mixture of exo-
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methylenecyclohexanes 192 and 193. Compound 193 was separated from its 
isomer and the silyl ether was changed to a benzyl ether in 194. Reductive 
ozonolysis of the double bond yielded the alcohol 195, which then underwent a 
Barton-McCombie radical deoxygenation, followed by cleavage of protecting 
groups, and final acetylation to give 5a-carba-β-D-mannopyranose pentaacetate 
(91). 
 
 
 
Scheme 28. Synthesis of 5a-carba-β-D-mannopyranose pentaacetate (91) using 6-exo-dig radical 
cyclization. 
 
The extension of this approach, by the same authors[115], using the intermediates 
192 and 193, led to the synthesis of 5a-carba-α-D-allo-, 5a-carba-α-L-gulo- and 5a-
carba-β-L-talopyranose pentaacetate derivatives (Scheme 29). 
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Scheme 29. Synthesis of 5a-carba-α-D-allo-, 5a-carba-α-L-gulo- and 5a-carba-β-L-talopyranose 
pentaacetate derivatives. 
 
 
1.1.4.4 – Ring Closing Metathesis 
 
The ring closing metathesis (RCM) has emerged as a powerful tool for the 
construction of carbocyclic ring systems, and in particular of carbasugar 
derivatives, through reaction of a diene precursor followed by appropriate 
manipulation of the cyclohexene derivatives. 
 
Vasella[116] and co-workers took advantage of this methodology to prepare the α-
glucosidase inhibitor (+)-valienamine 7 (Scheme 30). The addition of 
vinylmagnesium bromide to ketone 198, readily obtained from 2,3,4,6-tetra-O-
benzyl-D-glucopyranose, yielded the epimeric dienes 199a,b. Ring-closing alkene 
metathesis, with Grubbs catalyst, of the major epimer gave the cyclohexene 200. 
The transformation of 200 into (+)-valienamine also included conversion of its 
tertiary allylic alcohol moiety to an allylic amine by a [3,3] sigmatropic 
rearrangement of an intermediate allylic cyanate 202. Finally, benzyl carbamate 
204, readily obtained from isocyanate 203 by treatment with benzyl alcohol, was 
deprotected under Birch conditions to give (+)-valienamine 7. 
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Scheme 30. Synthesis of (+)-valienamine 7 by RCM. 
 
Some years later, Kim and co-workers[117] reported an alternative synthetic 
pathway for the synthesis of valienamine 7 using the RCM as key step and a similar 
ketone 205 as starting material (Scheme 31). After Wittig or Tebbe methylenation 
of 205 followed by aldehyde deprotection and vinylmagnesium bromide addition 
to the carbonyl group, diene 208 was obtained as an inseparable 70:30 epimeric 
mixture. The ring-closing metathesis reaction of 208 in the presence of second 
generation Grubbs ruthenium catalyst gave cyclohexenol 209 (61% yield) along 
with its (1S)-diastereomeric derivative (25% yield). Treatment of the alcohol 209 
with diphenylphosphoryl azide (DPPA) in the presence of DBU, followed by 
addition of 1 equiv of sodium azide, afforded azide 210, which was reduced to the 
related allylic amine by reaction with triphenylphosphane-ammonium hydroxide. 
Debenzylation using sodium in liquid ammonia, in order to preserve the double 
bond, provided valienamine, which was characterized as pentaacetate 211. 
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Scheme 31. Synthesis of penta-N,O-acetyl-valienamine 211 via RCM. 
 
In 1998 Ziegler’s[118] group reported a formal synthesis of the potent β-glucosidase 
inhibitor (+)-cyclophellitol 6 via RCM (Scheme 32). Dithioacetal 212, derived from 
D-xylose, was converted into aldehyde 213 in three steps after selective silylation 
of the primary alcohol, benzylation and further cleavage of the dithioacetal 
protecting group. Methylenation of 213 under Tebbe’s condition provided alkene 
214, which was transformed into the α,β-unsaturated ester 215 after removal the 
silyl group, Swern oxidation and Wittig reaction. Conjugated addition of 
magnesium-based vinyl cuprate, using conditions previously described by 
Hanessian,[119] afforded diene 216 with both high yield and selectivity. RCM 
reaction of 216 followed by iodolactonization gave the iodide 218, which was 
converted into the β-epoxide 220 according to the Suárez[120, 121] procedure; 
reduction of the lactone 218 by action of DIBAL-H followed by irradiation in the 
presence of PhI(OAc)2/I2 afforded diiodoformate 219. Subsequent base treatment 
gave iodo epoxide 220 without compromising the alkyl iodide portion of the 
molecule. Radical oxygenation led to replacement of the iodide by a hydroxyl 
group giving a mixture of epoxyalcohol 221a and epoxydiol 221b. Finally, 
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hydrogenolysis of the benzyl groups in epoxyalcohols 221a and 221b, afforded 
(+)-cyclophellitol 6. 
 
 
 
Scheme 32. Synthesis of (+)-cyclophellitol 6 by RCM. 
 
 
1.1.4.5 – Rearrangement of Cyclic Sugars 
 
A straightforward approach to carbasugars makes use of the direct rearrangement 
of cyclic sugars to carbocycles. These reactions generally rely on the fact that a 
cyclic sugar carries both a masked electrophilic center – the anomeric carbon, and 
a nucleophilic function, which allows the execution of a direct carbocyclization 
when simultaneously liberated.[122]  
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1.1.4.5.1 – The Ferrier-II Rearrangement 
 
The first breakthrough for this class of reactions was disclosed by Ferrier in 
1979,[123] when he demonstrated that treatment of hex-5-enopyranoside 
derivatives with mercury(II) chloride (1.0 eq.) in aqueous acetone afforded the 
corresponding cyclic ketones in good yield. The mechanism of the transformation 
is depicted in Scheme 33. The key to the success of the reaction is the 
regioselective hydroxymercuration to give unstable acetal 224 that decomposes to 
the ketoaldehyde 225 via the loss of methanol. This intermediate then takes part 
in an intramolecular aldol-cyclisation to generate cyclohexanone 223 in high yield, 
and as a single diastereomer in most cases. The stereochemistry of the newly 
formed stereogenic center linked to the hydroxyl group was found to be dependent 
on the stereochemistry of the C-3 substituent, whereby the two groups are 
generally trans-disposed.[124]  
 
 
 
Scheme 33. Ferrier type II reaction. 
 
This transformation has proven to be a very useful synthetic tool in carbohydrate 
chemistry and has provided a pratical route to a large variety of bioactive 
substances such as carbasugars[125-127] (and pseudo-carbasugars), pseudo-
aminocarbasugars,[128-130] and inositols.[131, 132] 
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The first implementation of this approach for the synthesis of a carbasugar was 
reported in 1987 by Ferrier in the preparation of 5a-carba-α-D-glucopyranose (24) 
(Scheme 34).[133] 1,2,3,4-Tetra-O-benzoyl-6-deoxy-β-D-xylo-hex-5-enopyranose 
(226)[134] was converted to deoxyinosose 227 by treatment with mercury(II) 
acetate. Protection of the ketone as the dithiane 228 and further manipulation of 
the hydroxyl protecting groups gave the di-O-isopropylidene analogue 229. 
Removal of the thioacetal protecting group followed by reaction of the ensuing 
ketone 230 with the Lombardo methylenating reagent[135] yielded 
methylenecyclohexane derivative 231. Hydroboration of the latter afforded a 
mixture of 5a-carba-β-L-idopyranose derivative 232 (81% yield) and the isomeric 
5a-carba-α-D-glucopyranose derivative 233 (4% yield). The thermodynamically 
preferred minor product 233 was obtained from the major product 232 by an 
oxidation-epimerization-reduction sequence. Finally, hydrolysis of the diacetal 
233 gave 5a-carba-α-D-glucopyranose (90). 
 
 
Scheme 34. Synthesis of 5a-carba-α-D-glucopyranose (24) from the product of Ferrier 
rearrangement. 
 
One year later, Barton and co-workers[136] reported the stereodivergent 
preparation of α-D-gluco-, β-L-ido-, 6-deoxy-β-L-ido-, and β-L-altrocarbapyranoses 
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from a single cyclohexanone precursor 234, previously prepared by Ferrier 
carbocyclization of a D-glucose derivative[125] (Scheme 35). Wittig reaction of 234 
with methylenetriphenylphosphorane afforded methylenecyclohexane 235, which, 
upon catalytic hydrogenation, gave almost exclusively 5a-carba-6-deoxy-β-L-
idopyranose (236).  
 
 
 
Scheme 35. Stereodivergent synthesis of carbasugars from a product of Ferrier II rearrangement.  
 
Wittig reaction of 234 with benzyloxymethylenetriphenylphosphorane afforded 
benzyloxy-vinyl ether 237, which was submitted to catalytic hydrogenation to give 
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a mixture of 5a-carba-α-D-glucopyranose (24) and 5a-carba-β-L-idopyranose (L-
104) in 65:35 ratio and 75% yield (Scheme 35). Wittig reaction of 234 with 
methoxymethylenetriphenylphosphorane yielded vinyl ether 238 as a mixture of 
(E/Z)-diastereomers. Treatment of 238 with mercury(II) nitrate followed by 
sodium borohydride reduction yielded exclusively the unsaturated alcohol 240, by 
β-elimination from the mercurial intermediate 239. Hydroboration of 240 with 
diborane followed by oxidative workup of the resulting organoborane afforded a 
46:54 mixture (78% yield) of α-D-gluco- and β-L-altro-dibenzyl derivatives, which 
were submitted to hydrogenolysis to yield 24 and 5a-carba-β-L-altropyranose (L-
72) (Scheme 35). Oxymercuration of 238 with mercury(II) acetate provided a 
mixture of three products: α,β-unsaturated alcohol 240 (52%) and two minor tri-
O-benzyl diastereoisomers (7% α-D-gluco and 27% β-L-ido), which after removal 
of the benzyl ethers afforded 5a-carba-α-D-glucopyranose (24) and 5a-carba-β-L-
idopyranose (L-104) (Scheme 35). More recently the Ferrier rearrangement 
proved to be useful for the preparation of carbaglucose-1-phosphate[137] and of a 
novel carbasugar amino acid dipeptide isostere.[138] 
 
 
1.1.4.5.2 – Endocyclic Cleavage Induced Rearrangement 
 
In 1997 Prof. Pierre Sinaÿ and co-workers[139] reported an alternative and direct 
conversion of hex-5-enopyranosides into highly functionalized cyclohexane 
derivatives, by reductive rearrangement induced by triisobutylaluminium (TIBAL).  
 
The key step in this transformation is the endo-cleavage of the glycosidic bond to 
form an acyclic oxacarbenium ion intermediate 244 (Scheme 36), which then 
undergoes intramolecular recyclization through a chair-like six-membered ring 
246 and is followed by reduction of the formed ketone to yield the carbocyclic 
product 242. With this methodology both the aglycon moiety and its 
stereochemistry are retained, being therefore a complement of the Ferrier II 
carbocylization reaction, which inherently requires exo-glycosidic cleavage to eject 
the aglycon. 
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Scheme 36. Mechanism proposed for TIBAL-promoted rearrangement: endo-glycosidic cleavage. 
 
Alternatively, Sinaÿ and Sollogoub also demonstrated that the titanium-based 
Lewis acid Ti(OiPr)Cl3 was also able to mediate the rearrangement of O-glycosides 
under milder conditions. However in this case the rearrangement was not followed 
by carbonyl reduction and ketone 247 was isolated in excellent yield[140] (Scheme 
37). 
 
 
 
Scheme 37. Rearrangement induced by titanium-based Lewis acid. 
 
Further studies revealed that the rearrangement was favoured if the intermediate 
carbenium ion could be stabilized by an electron donating group to avoid the 
preferential reductive cleavage of the endocyclic C5–O bond.[141] On the basis of 
these observations, Sinaÿ and Sollogoub formulated a synthetic strategy in which a 
C-furyl glycoside, derived from D-glucose, was converted to a partially protected 
carba-β-D-idopyranoside[142] (Scheme 38). The furyl aglycon was thus used as a 
masked form of the hydroxymethyl moiety at C-5. The preparation of C-furyl 
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glycoside 249 from 1,6-di-O-acetyl-2,3,4-tri-O-benzyl-D-glucopyranose (248) was 
carried out by routine transformations including TMSOTf-mediated                           
C-glycosylation with furan, deacetylation, iodination, and elimination. Alcohol 250, 
which was obtained by reductive rearrangement of alkene 249 induced by TIBAL, 
was methylated and submitted to oxidative cleavage of the furan with ozone to 
reveal the masked carboxylic acid, which was immediately methylated to give the 
fully protected methyl carba-β-D-iduronate 251. Reduction of the ester with 
lithium aluminum hydride gave methyl carba-β-D-idopyranoside (252). 
 
 
 
Scheme 38. Synthesis of methyl carba-β-D-idopyranoside 252 by rearrangement induced by 
TIBAL. 
 
As previously stated, a distinct feature of this rearrangement is the retention of the 
anomeric information. This advantage was nicely illustrated by Sinaÿ and co-
workers in the direct synthesis of a carbadisaccharide from a disaccharide[142, 143] 
(Scheme 39). 
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Scheme 39. Synthesis of a carbadisaccharide using the TIBAL induced rearrangement. 
 
Hex-5-enopyranoside derivative 253 was synthesized from D-maltose by common 
reactions in carbohydrate chemistry. TIBAL induced rearrangement of 253 
afforded the carbadisaccharide precursor 254 as a 3:2 mixture of two isomers. 
This mixture was then oxidized, and subsequent methylenation of the resulting 
ketone provided hex-5’-enopyranoside 255, which was transformed into methyl 
5’a-carbamaltoside (256) after hydroboration and deprotective hydrogenolysis.  
 
In this chapter a brief overview of the most used synthetic methods for the 
preparation of carbasugars was presented. In the work carried out during this 
thesis we have focused our attention in the Lewis acid induced rearrangement 
developed by Profs. Sinaÿ and Sollogoub, and the work that will be presented here 
reflects our efforts in the synthesis of gem-difluorocarbasugars for further 
biological and structural studies. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Results and Discussion
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2.1 – Motivation 
 
Carbasugars have attracted great interest as stable mimetics of true sugars in the 
elucidation of biological mechanisms involving carbohydrates (Section 1.1.3). 
However, the effectiveness of carbasugars as sugar mimetics is compromised by 
electronic effects associated with the replacement of the endocyclic oxygen by a 
methylene group, and for that reason we have seen (Section 1.1.2) that nature has 
selected instead carbasugar-based inhibitors by adding an amine or a double bond 
in the cycle to mimic transition states of these enzyme substrates. Moreover, such 
replacement has the inherent disadvantage to suppress any possible hydrogen 
bond formation involving the electronegative atom. This drawback clearly 
appeared in the case of carbalactoside a close mimetic of lactoside which is no 
longer recognized by the enzyme β-galactosidase.[144] A model developed by 
Jiménez-Barbero’s group showed that the endocyclic oxygen of the galactose 
moiety was involved in key interactions with the active site of the enzyme.[145] 
One way to overcome part of these disadvantages is to replace the endocyclic 
oxygen not by a CH2 group, but by a CF2. Indeed the fluorine atom is capable to 
interact (for d< 2.35 Å) with a hydrogen atom carried by an atom of oxygen or 
nitrogen (hydrogen bond) or a carbon atom (non-polar interactions such as Van 
der Waals forces). Theoretical calculations also permitted to evaluate the energy of 
the hydrogen bonds. Thus, for F--H the mean energy is around 2 to 3.2 kJ.mol-1 and 
for O--H about 5 to 10 kJ.mol-1. An encouraging finding of this study was that the 
substrate/enzyme interactions may offer an environment for optimal F--H 
bonding.[146] 
 
The replacement of an oxygen atom by a CH2 group to give a cyclohexane alters the 
shape of the chair conformation slightly by replacing two 1.42 Å C–O bonds by two 
1.53 Å C–C bonds,[147] but the main disadvantage of such substitution is the 
suppression of the anomeric effect. It describes the tendency of electronegative 
substituents adjacent to a heteroatom within a cyclohexane ring to prefer the axial 
orientation instead of the less hindered equatorial orientation that would be 
expected from steric considerations. This orientation effect is generally valid for all 
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molecules with two (or more) heteroatoms linked to a tetrahedral centre, i.e. 
compounds containing the C–X–C–Y moiety, where X = N, O or S, and Y = Br, Cl, F, 
N, O or S. The magnitude of the anomeric effect is fairly close related to the polarity 
of the –C–Y bond, which increases in proportion to the electronegativity of the Y 
substituent.  
 
According to the stereoelectronic interpretation, the nonbonding electrons of the 
endocyclic oxygen atom (the p-orbital of which is axially oriented) are 
synperiplanar to the antibonding orbital of the anomeric substituent when it is in α 
position. As a result, a n→σ* interaction is established, which results in a 
shortening of the ring–O–C1 bond and a lengthening of the C1–X bond (Figure 
14).[148] 
 
 
 
Figure 14. The anomeric effect: interaction of the endocyclic oxygen electron lone pair with the 
non-bonding orbital. 
 
The exo-anomeric effect of glycosides can be similarly explained. In this case, the 
electron density of the lone pair of the exocyclic oxygen atom is transferred to the 
antibonding orbital of the endocyclic C–O bond. Essentially this effect is maximized 
when the p-orbital for an unshared pair of electrons is periplanar to the ring–O–C1 
bond. As we can see from Figure 15, the exo-anomeric effect is present in both α 
and β anomers. Thus, the α anomer can be stabilized by two anomeric effects (exo 
and endo) and the β by only one (exo). Even though two conformations (E2 and E3) 
for the equatorial substituted anomer can be identified that are stabilized by an 
exo-anomeric effect, only E2 experiences unfavorable steric interaction between 
the aglycon and the ring moiety. In the case of α anomer also two conformations 
are stabilized by an exo-anomeric effect (A2 and A3) but A3 is strongly disfavored 
for steric reasons. 
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Figure 15. Exo-anomeric effect. 
 
The fluorine atom is electronegative enough to induce these important 
stereoelectronic effects and thus influence the conformation of molecules. This 
characteristic is very important since it was observed that the glycosidic linkage in 
carbaoligosaccharides[144] and C-glycosyl compounds[149] (Figure 16) is more 
flexible than those of parent sugars, which pose limitations in their use as 
therapeutic agents since an entropy penalty has to be paid, and thus the binding 
energy will decrease. 
 
 
 
Figure 16. Theoretical energy values for the transition between minimum A (the global minimum) 
and minimum B (characterized by a non-exo-anomeric orientation): The conformational change is 
favored for α-C-man-(1→1)-β-gal. 
 
∆E = -0.14 Kcal.mol-1
∆E = 2.61 Kcal.mol-1
α-O-man-(11)-β-gal
α-C-man-(11)-β-gal
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When the endocyclic oxygen is replaced by a CH2 group in a carbasugar, the new σ* 
C-C has a smaller coefficient on the anomeric carbon than in the case of the σ* C-O, 
due to the polarity of the C-O bond which is lost in a C-C bond. If the endocyclic 
oxygen is now replaced by a CF2 group the polarity is at this stage in the same 
direction as in the presence of a C-O bond. Hence it is hoped that the σ* C-CF2 will 
have a larger coefficient on the anomeric carbon and consequently the interaction 
between σ* CF2–C and the lone pairs of the exo-oxygen will be stronger than in a 
carbasugar, allowing to restore the exo-anomeric effect. A recent work[150] showed 
that the substitution of the linker CH2 by a CF2 in C-glycosyl compounds confers 
greater rigidity to the structure and it is also observed a pronounced exo-anomeric 
effect in the “selection” of the more stable conformer. 
In addition, the fluorine atom is an active nucleus for NMR, and has been used as 
reporter group of the active site of enzymes through 19F-NMR spectroscopy.[151] 
The understanding of the role of each fluorine atom of a CF2 group could, by 
analogy, to determine which of the electron lone pairs of the oxygen atom, or if 
both, are involved in key interactions with the enzymes. It is therefore foreseeable 
that replacement of the endocyclic CH2 group by a CF2 moiety in a carbasugar 
(Figure 17) would constitute a step further in the utilization of this family of sugar 
mimetics by enhancing their ability to be accepted by enzymes, which key 
interactions involve the endocyclic oxygen, by inducing important stereoelectronic 
effects, and allowing the study of their complexation by NMR spectroscopy. 
 
 
 
Figure 17. Galactopyranose and its carbocyclic analogues. 
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2.2 – Synthesis of 5a-gem-difluorocarbamannose 
 
The strategy for the synthesis of gem-difluorocarbasugars is based on the 
rearrangement of an enol-ether induced by a Lewis acid, developed in Prof. Sinaÿ’s 
group in 1997[139] and already introduced in section 1.1.4.5.2. Summarizing, the 
proposed key step in this transformation (Scheme 40) is the opening of the ring to 
give a carbenium ion intermediate, which then recyclizes to give the carbocycle 
product, where the anomeric group and stereochemistry are retained. 
 
 
 
 
Scheme 40. General scheme for the Lewis acid induced rearrangement. 
 
Later studies[141] demonstrated that only stronger stabilization of the carbenium 
intermediate would kinetically favor endo cleavage and subsequent 
rearrangement, otherwise the product resulting from the reductive cleavage of the 
endocyclic C5–O bond was preferentially obtained (Scheme 41).  
 
 
 
Scheme 41. TIBAL-promoted rearrangement. Increasing electron-donating ability of the 
substituent at C1 favors carbocyclization over reductive cleavage of the endocyclic C5-O bond. 
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For the synthesis of the gem-difluoromannose and having these considerations in 
mind, the input question is now which electron-donating group to choose. 
Harrity[152] and co-workers showed that a triple bond complexed with cobalt 
hexacarbonyl could act as electron-donating group in similar rearrangements due 
to their ability to stabilize positive charges at α-position. In addition the triple 
bond is also a good precursor of the CH2OH function which will be needed later on 
in the synthesis. Thus, our strategy, as depicted in Scheme 42, relies on a Lewis 
acid induced rearrangement of a gem-difluoroalkene derivative containing an 
original cobalt cluster as electron-donating group. 
 
2
6
2
6
 
 
Scheme 42. Retrosynthesis of gem-difluorocarbasugars. 
 
To accomplish the synthesis of the gem-difluorocarbamannose and starting from 
the corresponding natural sugar D-mannose, our approach includes four major 
steps: construction of the triple bond in C-6, introduction of the gem-
difluoroalkene in anomeric position, rearrangement sequence, and final 
deprotection (Scheme 43). 
 
 
 
Scheme 43. Strategy to accomplish the synthesis of gem-difluorocarbamannose. 
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2.2.1 – Construction of the triple bond in C-6 
 
Starting from the natural sugar, the first steps were directed to the protection of 
the anomeric position. In order to avoid future problems concerning to the 
cleavage of the methoxyl group (the usual anomeric group) encountered in glucose 
series by Sollogoub’s group,[153] we decided to use an orthogonal anomeric 
protecting group, stable to the reaction conditions used for the functionalization of 
the carbon atom at C-6, and that could be easily deprotected. We thought that the 
p-methoxyphenyl (pMP) group could a priori ensure these requirements. Thus, p-
methoxyphenyl mannoside 259 was prepared in two steps: acetylation followed 
by reaction of D-mannose pentaacetate 258a,b with p-methoxyphenol using 
trifluoromethanesulfonic acid as promoter (Scheme 44). The reaction proceeded 
with neighboring group participation to give exclusively the α-anomer.  
 
 
 
Scheme 44. Formation of p-methoxyphenyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (259). 
 
Introduction of the triple bond at C-6 required the selective manipulation of this 
position. Hence, we proceeded with a protection and deprotection sequence in 
order to obtain the conveniently protected molecule with the primary alcohol free 
for further functionalization. After removal of the acetyl groups (Scheme 45), the 
primary hydroxyl was selectively protected with the bulky tert-butyldimethylsilyl 
group. The three remaining secondary alcohols were then benzylated, using a 
typical Williamson reaction, to yield the fully protected derivative 262. Treatment 
of the silyl ether 262 with TBAF in THF gave the desired primary alcohol 263 in 
68% overall yield from 260. 
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Scheme 45. Synthesis of primary alcohol derivative 263. 
 
Swern oxidation of the free hydroxyl group at C-6 proceeded smoothly to give the 
aldehyde 264, which was then converted into alkyne 266 through Corey-Fuchs 
reaction[154] and methylenation (Scheme 46).  
 
 
 
Scheme 46. Synthesis of alkyne precursor 266. 
 
The two steps Corey-Fuchs methodology involved a Wittig type reaction of the 
aldehyde 264 with the phosphorous ylide, generated in situ from reaction of 
triphenylphosphane and carbon tetrabromide, to afford the gem-dibromoalkene 
265 in 68% yield from 263. Subsequent reaction of compound 265 with 
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buthyllithium generated a bromoalkyne intermediate via dehydrohalogenation, 
which underwent lithium-halogen exchange to form an alkynyllithium. The direct 
treatment of this species with MeI (20 equivalents) and HMPA (4 equivalents), 
after tunning the reaction conditions (Table 1, Entry 4), afforded exclusively the 
desired methylated alkyne 266 in 79% yield. It should be emphasized that both 
the methylated and terminal alkyne had the same Rf with all the eluent systems 
tried. The proportion of each compound in the mixture was easily determined by 
1H-NMR spectroscopy considering the doublet at δ 1.90 ppm corresponding to the 
methyl group and the doublet at δ 2.50 ppm assigned to the proton of the terminal 
alkyne. 
Table 1. Attempts for alkyne methylation. 
 
Entry MeI (eq) HMPA (eq) 
Non-methylated 
alkyne (%) 
Methylated 
alkyne (%) 
1 6 2 40 60 
2 9 3 43 57 
3 12 4 40 60 
4 20 4 0 100 
 
 
2.2.2 – Introduction of the gem-difluoroalkene unit 
 
Installed the triple bond, the next step consisted on the introduction of the gem-
difluoroalkene at the anomeric position. Accordingly, the anomeric deprotection 
was first investigated. Usually, the p-methoxyphenyl group is oxidized to 
benzoquinone by ammonium cerium (IV) nitrate (CAN) in the presence of water. 
Regrettably, when the experimental conditions described in literature[155], were 
applied to our scaffold, poor yields were obtained. Further investigations revealed 
that the choice of the solvent is quite important to the success of this reaction. In 
Table 2 the yield obtained for each solvent system used in the OpMP cleavage is 
presented. 
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Table 2. Experimental conditions for anomeric deprotection. 
 
Entry CAN (eq) Solvent Time Temperature Yield 
1 3 CH3CN/H2O 10:1 10 min 0 ºC 34% 
2 5 
CH3CN/sat. NaHCO3 
4:1 2 min 0 ºC 47% 
3 10 
Toluene/CH3CN/H2O 
1:1:1 45 min 0 ºC to rt 70% 
 
After optimization of the reaction conditions, the methylated alkyne 266 was 
converted in 45 min into the hemiacetal 267a,b (Scheme 47) using CAN (10 
equivalents)  in a two-phase solvent system composed by equal quantities of 
water, toluene and acetonitrile (Table 2, Entry 3). 
 
 
 
Scheme 47. Synthesis of hemiacetal 267a,b by cleavage of anomeric protecting group. 
 
The diastereomeric mixture of α and β anomers was directly engaged in the next 
step after filtration through a silica gel column in order to remove the cerium salts. 
Then, oxidation of the anomeric mixture of lactols 267a,b in the presence of PCC 
gave smoothly the lactone 268, which was isolated in good yield (Scheme 48). 
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Scheme 48. Synthesis of lactone 268. 
Wittig approaches have been used for the conversion of aldehydes, ketones and 
even lactones to the corresponding difluoroalkenes. The ylide is usually generated 
through the reaction of a difluorocarbene with a phosphate. In our case, we choose 
to adapt Burton’s[156] dibromodifluoromethane/tris(dimethylamino)phosphane 
(HMPT)/zinc ylide chemistry (Scheme 49), which has proven utility in the 
difluoromethylenation of relatively unreactive carbonyl compounds. 
 
 
 
Scheme 49. Ylide formation catalyzed by zinc. 
 
Mottherwell[157] and co-workers observed that the yields in these type of reactions 
can be variable. They considered that the problems of irreproducibility might well 
rely on the use of a heterogeneous system employing zinc. It is also known that 
debromination of the salt I can be performed in the absence of zinc by the addition 
of an equivalent of HMPT to give the ylide. The toxicity of HMPT and specially its 
oxide (HMPA) generally make zinc the more practicable choice. Nevertheless, our 
experience showed that reduction of the resultant tris(dimethylamino)phosphane 
dibromide I is more efficient with HMPT than with zinc. Hence, after optimization 
of the reaction conditions and careful manipulation of the reactants, considering 
the high sensitivity to solvent dryness, among other parameters, the gem-
difluoroalkene 269 was obtained in very good yield using initially 5 equivalents of 
each CBr2F2 and HMPT, with 10 equivalents of HMPT (Scheme 50) being added 
later on. In practical terms it is also worth noting the use of aqueous copper(II) 
sulphate during the work-up to remove HMPA. 
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Scheme 50. Synthesis of the gem-difluoroalkene 269 precursor. 
 
The success of this transformation was easily confirmed by 19F NMR spectroscopy 
by the presence of 2 signals at δ –111.76 and –96.01 ppm, integrating each one for 
one fluor, with a JF,F’ of 61.2Hz that is typical of gem-difluoroalkene systems. 
 
 
2.2.3 – Rearrangement Sequence 
 
Synthesized the gem-difluoroalkene 269 precursor we were now able to proceed 
with the rearrangement. The key reaction of our strategy consists in a two steps 
one pot procedure which begins with the activation of the triple bond by the cobalt 
octacarbonyl followed by the reductive rearrangement induced by the Lewis acid 
(Scheme 51). 
 
The stabilization of a cationic charge at a propargylic center by a cobalt carbonyl 
cluster is now well-established and allows efficient carbon-carbon bond formation 
to take place especially when π-nucleophiles are employed. 
 
Results and Discussion 
65 
 
Scheme 51. Alkyne activation and rearrangement step. 
 
The formation of the hexacarbonyl cobalt cluster 270 was easily achieved, 
typically in 1 h, by addition of cobalt octacarbonyl to a solution of the alkyne 269 
precursor in dichloromethane (Scheme 52). After total consumption of starting 
material, detected by TLC, the product was directly engaged in the next step. 
 
 
 
Scheme 52. Hexacarbonyl cobalt cluster formation. 
 
Surprisingly, the rearrangement revealed to be fairly complicated and in sharp 
contrast with that of the D-glucose derivative.[153] So, the carbonyl cluster 270 was 
isolated to clearly ensure that the problem did not come from the activation of the 
alkyne. The structure of compound 270 was confirmed by the deshielding of the 
methyl group both in 1H and 13C NMR, as well as by the presence of six signals 
around 199 ppm relative to the quaternary C=O of the hexacarbonyl cobalt. 
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Established the structure of the cluster 270, and in order to accomplish the 
synthesis of the desired carbocyclic products, several reaction conditions using 
different Lewis acids were investigated. Table 3 contains the most relevant results 
obtained using triisobutylaluminum (TIBAL) as Lewis acid.  
 
Table 3. Rearrangement essays induced by TIBAL. 
 
Entry 
TIBAL 
(eq) 
Solvent Temperature Time Results 
1 5 (t=0) +  3 
(t=30 min) 
Solution of TIBAL in 
Hexane  
Reaction in CH2Cl2 
–78 ºC to 40 ºC 2 h 
De-O-benzylation 
(275, 16%) 
2 
5 (t=0) +  3 
(t=30 min) 
Solution of TIBAL in 
Toluene  
Reaction in CH2Cl2 
–78 ºC to 40 ºC 3 h No reaction 
3 
5 (t=0) +  5 
(t=30 min) 
Solution of TIBAL in 
Toluene  
Reaction in Toluene 
–78 ºC to rt 2.5 h 
De-O-benzylation 
(275, 15%) 
4 
5 (t=0) +  5 
(t=30 min) 
Solution of TIBAL in 
Toluene  
Reaction in CH2Cl2 
rt 3 h 
Rearrangement 
(11%)  
De-O-benzylation 
(275, 29%) 
5 10 
Solution of TIBAL in 
Toluene  
Reaction in CH2Cl2 
rt 1 h 
Rearrangement 
(58%) 
 
 
A very curious result was the de-O-benzylation at position 3 of the intermediate 
270 (Table 3, Entries 1, 3 and 4). The correct structure of compound 275 (Scheme 
53), obtained after decomplexation of the cobalt cluster by CAN, was assigned by 
NMR spectroscopy. The direct addition of trichloroacetyl isocyanate (Scheme 53, 
step iii)) inside the NMR tube (1 drop) allowed, through comparison of the 1H NMR 
spectra before and after addition of the isocyanate, to determine unambiguously 
the structure of 275. The deshielding of the chemical shift of H-3 from 3.69 to 4.87 
after addition of the trichloroacetyl isocyanate suggests that the formation of the 
carbamate occurred at C-3, and consequently indicates that de-O-benzylation took 
place at this position.  
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Scheme 53. Synthesis of the de-O-benzylated derivative 275 and its carbamate analogue 276 for 
structural elucidation purposes. 
 
This result was not totally surprising since the regioselective de-O-benzylation of 
carbohydrates bearing a 1,2-cis system promoted by TIBAL had already been 
described.[158] However, it was an unexpected one according to our knowledge, 
since the rearrangement reaction always proved to occur faster when compared to 
the de-O-benzylation. 
 
In the proposed mechanism for this transformation, the two 1,2-cis oxygen atoms 
first react with an equivalent of TIBAL to afford the chelate complex 277. Then, the 
second equivalent induces the regioselectivity of the de-O-benzylation by 
coordinating preferentially with the electron lone pair of the less hindered oxygen 
atom and therefore weakening the C–O bond; the de-O-benzylation is then 
achieved by hydride transfer (Scheme 54). 
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Scheme 54. Proposed mechanism for the TIBAL-mediated de-O-benzylation. 
 
This result confirms the model proposed by Sollogoub’s group to explain the 
regioselectivity of the debenzylation mediated by TIBAL. 
 
The best conditions that serve our purposes were obtained using 10 equivalents of 
a 1 M solution in toluene of TIBAL at room temperature (Table 3, Entry 5). 
Remarkably, besides the temperature, the slow addition (typically during 30 min) 
of TIBAL (10 eq.) seems to be important to the success of the reaction, yielding 
exclusively the desired carbocyclic products. On the other hand, the “fast” addition 
of TIBAL (5 eq.) followed by additional 5 equivalents after 30 min, afforded a 
mixture of rearranged and de-O-benzylation products. It should be emphasized 
that the carbocyclic ketone, formed during the rearrangement, is reduced in situ by 
TIBAL to give a chromatographically irresoluble mixture of the equatorial and the 
axial alcohols 273a,b (Scheme 55). These two products could be isolated only after 
regeneration of the alkyne, which was achieved by treatment of the alcohols 
273a,b with CAN in acetone and in the presence of triethylamine (1 eq.). This 
transformation was followed by means of 19F-NMR spectroscopy through a 
variation of the geminal coupling constant from 61.8 Hz in the starting material 
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270 to 259.6 Hz for the α-isomer 280 and 248.4 Hz for the β-isomer 281. This 
result was supported by the literature,[159] where it is stated that the coupling 
constant 2JF,F for aliphatic CF2 groups range from 200 to 350 Hz and for =CF2 from 
10 to 100 Hz. 
 
 
 
Scheme 55. Synthesis of the desired carbocyclic products 280 and 281. 
 
The achievement of this diastereomeric mixture contrasts with the D-glucose 
series where the action of TIBAL led exclusively to the alcohol in axial position. 
This stereoselective reduction is classically explained by the attack of the hydride 
ion, which is attached to the isobutyl group, on the less-hindered face of the 
molecule to provide the axial hydroxyl group (Scheme 56).  Rationalizing for D-
mannose, it could be expected the exclusive formation of the β-anomer. However, 
the loss of stereoselectivity may be related to the presence of the axial benzyl 
group in position 2 promoting a stereochemical hindrance to the new β-OH bond.  
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Scheme 56. Stereoselectivity of the reduction of the transient D-glucose ketone derivative by 
TIBAL.  
 
Due to the modest yield and poor stereoselectivity obtained for the rearrangement 
induced by TIBAL, other Lewis acids were investigated. Taking advantage of Profs. 
Sinaÿ and Sollogoub’s group background in this thematic, we decided to use 
TiCl3(OiPr), which proved to be a more suitable Lewis acid for this type of 
reactions,[140] since it is less reactive than other titanium counterparts. Accordingly 
the first assays were performed with a 0.5 M solution of TiCl3(OiPr) in 
dichloromethane, freshly prepared from the reaction of TiCl4 with Ti(OiPr)4. 
Disappointingly, all the attempts to convert derivative 270 into the desired 
carbocyclic products 280 and 281 failed. Unlike observed in the glucose series, at 
low temperatures (usually –78 °C) the starting material 270 revealed unreactive 
(Table 4, Entry 1). As the temperature increased to room temperature only 
decomplexation of the cobalt cluster was observed (Table 4, Entry 2 and 3); no 
trace of rearranged product was ever detected. 
 
In spite of these discouraging results we decided to employ a stronger titanium-
based Lewis acid. The TiCl4 was thus investigated but unfortunately did not 
conduct to the expected results. Once again at low temperature the starting 
material remained unaffected (Table 4, Entry 4 and 5) and as the temperature 
increased the product resulting from decomplexation of the cobalt cluster was 
obtained as the major compound. The main difference between these two 
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titanium-based promoters was the formation of the de-O-benzylation product at C-
3 when the reaction was accomplished with TiCl4 as Lewis acid (Table 4, Entry 6). 
 
Table 4. Rearrangement trials with titanium based Lewis acids. 
 
Entry Reagent Equivalents Temperature Time Results 
1 TiCl3(OiPr) 2 –78 ºC 3 h No reaction 
2 TiCl3(OiPr) 2 –78 ºC to rt 3 h Decomplexation  
3 TiCl3(OiPr) 2 rt 1 h Decomplexation 
4 TiCl4 
1.2 (t=0) + 
0.8 (t=30 
min) 
–78 ºC 3 h No reaction 
5 TiCl4 
1.2 (t=0) +  
2 (t=30 min) 
–78 ºC 2 h No reaction 
6 TiCl4 
1.2 (–78 ºC) 
then 1.2 (rt) 
–78 ºC to rt 3 h 
De-O-benzylation  
(275, 20%)  
Decomplexation  
(269, 52%) 
7 TiCl4 5 –78 ºC to rt 2.5 h No reaction 
8 TiCl4 2 –78 ºC to rt 19 h Decomplexation 
 
 
The debenzylation with TiCl4 had already been observed[160] in perbenzylated 
sugars bearing 3 oxygen atoms cis-oriented, in order to allow the complexation 
with the titanium according to the model presented in Scheme 57. The titanium 
atom first forms a six-coordinated bipyramidal complex 282 with two suitable 
located oxygen atoms. One of the four chlorine atoms on the complexed metal is 
then replaced by a third benzyloxy oxygen atom suitably situated to attack the 
metal atom, resulting in the formation of a new oxygen-metal bond 283, and 
consequent release of benzyl chloride. The metal alkoxide is hydrolyzed with 
water to give the de-O-benzylated alcohol 284. 
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Scheme 57. Debenzylation mechanism promoted by TiCl4. 
 
In our case this analogy is not clear, since only two oxygen atoms cis-oriented are 
present in the molecule.  The formation of the six-coordinated bipyramidal 
complex could be explained throughout the participation of an oxygen atom from 
the hexacarbonyl cobalt cluster (Scheme 58). 
 
 
 
Scheme 58. Proposed intermediate to explain the de-O-benzylation induced by TiCl4. 
 
As these titanium promoters have unexpectedly proved to be ineffective, we 
sought other Lewis acids in the pursuit of a better stereoselectivity and yield. 
Hence, BF3.Et2O which has already been reported as promoter in similar type of 
reactions[152], and SnCl4 were investigated. Regrettably both acids were not able to 
induce the rearrangement. Instead, compound 269 resulting from the 
decomplexation of the cobalt cluster was the single product obtained. 
 
It seems that probably for steric reasons, derived from the presence of the axial 
benzyl protecting group at position 2, the approach of these Lewis acids to the 
endocyclic oxygen is difficult, preventing thereby the rearrangement step. 
 
In summary, despite the modest yield and the loss of stereoselectivity relatively to 
the D-gluco derivative, TIBAL proved to be the only effective Lewis acid that 
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conducted to the desired diastereoisomers, both equatorial and axial alcohols at C-
1, of the gem-difluorocarbamannose. 
 
 
2.2.4 – Final Deprotection 
 
Accomplished the key step of our strategy, the final steps were focused on the 
reconstruction of the primary alcohol at C-6 and final deprotection. Therefore the 
gem-difluorocarbocyclic alkynes 280 and 281 were independently reduced to the 
alkenes 286 and 288 through hydrogenation in the presence of Lindlar catalyst. 
Subsequent ozonolysis followed by reduction of the corresponding aldehydes with 
NaBH4 in EtOH allowed reinstalling the CH2OH function and produced the 
derivatives 287 and 289 in 38% and 62% yield over 3 steps, respectively (Scheme 
59). 
 
 
 
Scheme 59. Reconstruction of the CH2OH function from the carbocyclic alkynes 280 and 281. 
 
Deprotective hydrogenolysis of precursors 287 and 289 using palladium on 
charcoal (Pd/C) as catalyst proceeded smoothly to give the target molecules, both 
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5a-difluoro-5a-carba-α-D-mannopyranose[161] (290) and 5a-difluoro-5a-carba-β-D-
mannopyranose[161] (291) (Scheme 60). 
 
 
 
Scheme 60. Cleavage of the benzyl protecting groups to yield the target molecules 290 and 291. 
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2.3 – Synthesis of 5a-gem-difluorocarbagalactose 
 
Completed the synthesis of both gem-difluorocarbamannose isomers, our efforts 
were then focused on the synthesis of the α- and β- gem-difluorocarbagalactose. 
Due to the satisfactory results obtained in the construction of the difluoroalkene 
precursor 269, the same methodology was applied in order to achieve the 
galactose counterpart. 
 
 
2.3.1 – Construction of the triple bond in C-6 
 
Treatment of commercial D-galactose with acetic anhydride in pyridine afforded 
the galactose pentaacetate 293a,b in a quantitative yield as a 5:2 mixture of the α- 
and β- anomers (Scheme 61). The introduction of the anomeric p-methoxyphenyl 
protecting group revealed to be more effective using BF3.Et2O as promoter than 
with CF3SO3H, which was employed in the preparation of the mannose derivative. 
However, an anomeric mixture in proportion of 2:1 in favor of the β isomer was 
obtained from glycosylation of galactose pentaacetate 293a,b with p-
methoxyphenol, unlike reported in the literature,[162-164] where this reaction 
afforded exclusively the β-derivative. Additionally, it should be noticed that all 
promoters tested (CF3SO3H, PTSA, BF3.Et2O, CF3COOH) furnished a 
chromatographically irresoluble α/β mixture of anomers, and the best yields were 
always obtained when the reaction was carried out using BF3.Et2O as Lewis acid. 
This result suggests that either the neighboring group participation is not so 
pronounced in this case or the reaction undergoes a SN1 type mechanism. 
 
 
 
Scheme 61. Introduction of p-methoxyphenol as anomeric protecting group. 
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After cleavage of the acetyl esters with sodium methoxide in methanol, the primary 
hydroxyl group has to be selectively protected. Silyl ethers, like esters, may 
migrate to the neighboring free hydroxyl group under basic conditions.[165] It is 
well known that placing negatively charged oxygen in proximity of a TBDMS ether 
will almost always result in some level of silyl migration, which is largely 
unpredictable and is a function of spatial, electronic, and steric effects.[165] Since 
galactose has the hydroxyl group axially oriented at position 4, we opted to use 
trityl chloride under weak basic conditions to protect the primary alcohol 296a,b 
(Scheme 62) rather than the tert-buthyldimethylsilyl chloride employed in the case 
of mannose derivative. 
 
With the trityl galactose derivative 296a,b in hands, the free secondary hydroxyl 
groups were benzylated using benzyl bromide and sodium hydride in DMF to 
afford the fully protected derivative 297a,b. The subsequent cleavage of the trityl 
ether was easily achieved under acidic medium. The experimental conditions 
tested included TsOH in a 1:1 mixture of CH2Cl2/MeOH; FeCl3.6H2O in CH2Cl2; 
BF3.Et2O in a 1:1 mixture of CH2Cl2/MeOH and reaction times from 1 to 2h. All of 
them afforded the conveniently protected precursors 298 and 299 for further 
functionalizations at C-6. As the two anomers were easily separated by column 
chromatography (Rf = 0.21 α-anomer, Rf = 0.37 β-anomer in cyclohexane/EtOAc 
2:1), at this stage the further synthetic strategy was carried out with both isomers 
separately. 
 
 
 
Scheme 62. Synthesis of the primary alcohols 298 and 299. 
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Both primary alcohols 298 and 299 were subsequently oxidized to aldehydes 300 
and 303, respectively, by means of Swern oxidation. The conversion of the 
aldehydes 300 and 303 into the alkynes 302 and 305 was achieved through the 
Corey-Fuchs methodology[154]. In the first step, the reaction of the corresponding 
aldehydes with triphenylphosphane and carbon tetrabromide in dichloromethane 
furnished, after column chromatography, the corresponding dibromoalkenes 301 
and 304 (Scheme 63). Then, treatment of the dibromoalkenes with buthyllithium 
in tetrahydrofuran at –78 °C, followed by methylenation, using methyl iodide and 
HMPA, of the transient alkynyllithium species afforded the desired alkynes 302 
and 305. 
 
 
 
Scheme 63. Synthesis of the alkyne precursors 302 and 305. 
 
The formation of the alkynyllithium species showed great sensitivity to the amount 
of buthyllithium used and to the temperature control. Too high temperature 
(around –30 °C or higher) and/or excess of buthyllithium led to the formation of 
the side product 306, derived from the elimination of benzyl alcohol (Scheme 64).  
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Scheme 64. Side product obtained in alkyne formation. 
 
The introduction of the methyl group to the alkynyllithium intermediate also 
required optimization of the conditions used with the mannose derivative. When 
employing the same experimental conditions a mixture of methylated and terminal 
alkynes was formed. The methylated alkynes 302 and 305 were achieved using a 
large excess of MeI (10 eq.) and HMPA (10 eq.) at –78 °C and prolongated time 
reaction (72 hours).  
 
 
2.3.2 – Introduction of the gem-difluoroalkene unit 
 
Installed the triple bond, our attention was afterwards directed to the introduction 
of the gem-difluoroalkene at the anomeric position. The cleavage of the p-
methoxyphenyl group (Scheme 65) proved to be once again strongly dependent on 
the choice of the solvent (Table 5). Furthermore, it was also observed that the yield 
could be quite variable depending on the quantity of starting material used. For 
small quantities, usually until 100 mg and after tuning of experimental conditions, 
the yield ranged between 60 – 72%, whilst for amounts above 100 mg the yields 
dropped off to a range between 15 – 32%.  
 
 
 
Scheme 65. Synthesis of hemiacetal 307a,b by cleavage of anomeric protecting group. 
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We considered that the yield decrease was related to the difficulty found in the 
purification of the product when a considerable amount of CAN was present. It 
seemed that the product remained retained in the cerium salts during column 
chromatography. 
 
Table 5. Cleavage of the p-methoxyphenyl protecting group with CAN. 
 
Entry CAN (eq) Solvent Time Temperature Yield 
1 7 CH3CN/H2O 4:1 30 min 0 ºC 32 – 72% 
2 7 
CH3CN/sat. NaHCO3 
4:1 20 min 0 ºC 23 – 60% 
3 7 
Toluene/CH3CN/H2O 
1:1:1 60 min 0 ºC to rt 15 – 63% 
4 7 Acetone/H2O 3:1 45 min 0 ºC to rt 25 – 71% 
 
Since compounds 307a and 307b are starting materials for the gem-
difluorogalactose carbocyclic products 320 and 321, the key scaffolds for further 
disaccharide synthetic studies, large amounts of these compounds should be 
synthesized. Hence, replacement of the OpMP as anomeric protecting group was 
investigated. Regarding the literature, the SPh protecting group appeared to be the 
better choice since it is easily introduced, stable along the synthesis of the triple 
bond and can be removed under mild conditions. 
 
 
2.3.2.1 - Alternative approach to the lactol 307a,b precursor 
 
The introduction of SPh at the anomeric position was achieved in 82% yield 
through glycosylation of the galactose pentaacetate 293 and thiophenol using 
BF3.Et2O as promoter (Scheme 66). It is worth noting the stereoselectivity of this 
reaction, leading to the β anomer, which contrasts with the p-methoxyphenol 
derivative. This result can be associated with the lower nucleophilicity of the  
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sulphur atom relatively to the oxygen atom; hence after the loss of the anomeric 
group, the formation of the cyclic oxonium ion resulting from the neighboring 
group participation is faster than the direct nucleophilic attack to the glycosyl 
cation. The net result is that the newly formed anomeric linkage is necessarily 
trans to the protecting group at C-2.  
 
 
 
Scheme 66. Protection of the anomeric position with a thiophenyl group. 
 
Accomplished the protection of the anomeric position with the thiophenyl group, 
the synthetic pathway used to construct the triple bond was identical to that 
applied for the p-methoxyphenyl derivative. Thus, after cleavage of the acetyl 
protecting groups, the primary alcohol at C-6 was selectively protected with a trityl 
group to afford 310. Benzylation of the remaining secondary alcohols and acidic 
cleavage of the trityl ether gave precursor 312 in a 67% overall yield from 308. 
Oxidation of the free hydroxyl group led to the aldehyde 313 which was then 
converted into the alkyne 315 through Corey-Fuchs methodology (Scheme 67). 
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Scheme 67. Alternative approach for the synthesis of galactose alkyne precursor. 
 
The cleavage of the thiophenyl group was then investigated. Among the several 
methods available in the literature for the hydrolysis of thioglycosides, we decided 
to exploit the use of N-bromosuccinimide (NBS) in aqueous acetone, which is 
known to be a gentle, versatile and efficient procedure.[166] Mechanistically this 
reaction involves initial electrophilic activation of sulfur generating a reactive 
sulfonium species which is rejected prior to final OH bond formation.[167] Thus, 
treatment of the thioglycoside precursor 315 with NBS in a 90% aqueous acetone 
afforded, after column chromatography, a 5:3 diastereomeric mixture of the α and 
β lactols 307a,b in 86% yield (Scheme 68). The reliability of the reaction was 
independent of the quantity of the starting material used. Thus, replacement of the 
p-methoxyphenyl protecting group by a thiophenyl proved to be a good choice 
which permitted to improve the synthesis of the lactol precursor. The success of 
this synthetic route is strongly related to the fact that a single anomer has been 
obtained in the glycosylation step and to the efficient SPh cleavage.  
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Scheme 68. Synthesis of the lactol 307a,b precursor. 
 
The conversion of the hemiacetal 307a,b into lactone 316 was accomplished by 
Swern oxidation. The subsequent treatment of the lactone 316, which was used 
without further purification, with the ylide generated in situ from the reaction of 
dibromodifluoromethane with HMPT gave the gem-difluoroalkene precursor 317 
(Scheme 69). Special attention should be given to the preparation of this reaction 
which is very sensitive to solvent dryness and purity of the starting material. 
Significantly different reaction yields were obtained when using the product 
resulting from the cleavage of the p-methoxyphenyl and thiophenyl groups. This 
two step one-pot procedure, when applied to the lactol obtained from the cleavage 
of the OpMP group (orange oil, contaminated with CAN) always led to lower yields, 
usually between 30-45%, when compared to those obtained with the lactol derived 
from the hydrolytic cleavage of the SPh (colorless oil) which usually ranged 55 to 
69% yield. 
 
 
 
Scheme 69. Synthesis of the gem-difluoroalkene 317 precursor. 
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2.3.3 – Rearrangement Sequence 
 
The gem-difluoroalkene precursor 317 was subsequently submitted to the three 
steps one-pot rearrangement sequence. Treatment of 317 with Co2(CO)8 in 
dichloromethane afforded the activated alkyne 318 which was directly engaged in 
the next step, after completion of the reaction detected by TLC (Scheme 70). 
TIBAL was our first choice to promote the rearrangement. After optimization of 
the experimental conditions, the formation of the carbocycles 319a,b proceeded 
smoothly after careful addition of TIBAL (10 eq.) at –78 °C during 15 min. At this 
stage it is important to note that both carbocyclic products have the same Rf. The 
existence of two products was only detected after regeneration of the triple bond, 
which was achieved by treatment with CAN in acetone containing 1 equivalent of 
Et3N (Scheme 70). Once again the success of this transformation was followed by 
19F-NMR spectroscopy through the variation of the geminal coupling constant. 
 
 
 
Scheme 70. Rearrangement sequence of the galactose gem-difluoroalkene derivative. 
 
The formation of the carbocyclic alcohol anomeric mixture in the gem-
difluorocarbamannose series is probably due to the presence of the axial 
benzyloxy group at C-2. However, in the case of the gem-difluorocarbagalactose 
derivative,  the anomeric mixture obtained may result from the  hindrance 
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promoted by the axial benzyloxy group at C-4 to TIBAL approach to the upper face 
of the molecule, leading to an anomeric mixture unlike observed in the gem-
difluorocarbaglucose series. 
 
In the search for better stereoselectivity we decided to investigate the 
rearrangement mediated by the titanium-based Lewis acid TiCl3(OiPr). Hence, 
treatment of the activated alkyne 318 with this promoter at low temperature 
(around –20 °C) afforded, after aqueous work-up and further decomplexation of 
the cobalt cluster, not the expected ketone but the product resulting from the 
hydration of the latter (Scheme 71). This result may be explained by the electronic 
impoverishment of the ketone α carbon due to the proximity of two fluorine atoms. 
 
 
 
Scheme 71. Rearrangement of the galactose derivative 318 promoted by TiCl3(OiPr). 
 
In order to avoid the formation of diol 322, it was decided to perform the 
reduction of the ketone prior to the work-up. Among the several reducers 
commercially available we selected the super-hydride® which demonstrated to be 
very effective in the reduction of the gem-difluorocarbaglucose ketone 
counterpart.[153] Thus, after quenching the Lewis acid with THF, the transient 
ketone was reduced in situ with a 1 M solution of Et3BHLi in THF at –78 °C. 
Subsequent regeneration of the triple bond with CAN afforded a mixture of the 
carbocyclic products 320 and 321 in a 3:1 ratio in favor of the β isomer. 
 
Although a slight increase of selectivity has been obtained, this result was not  as 
pronounced as those observed in the carbaglucose derivative, in which the 
reduction of the carbocyclic ketone with super-hydride® led exclusively to the β 
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isomer. This preferential tendency to the formation of the equatorial alcohol is 
explained by the Ahn-Eisenstein effect.[168] According to this model, the most stable 
transition-state structure has the axial C–F[169, 170] bond in the antiperiplanar 
position with respect to the forming H–C bond. This model implies a selective 
attack of the hydride ion to form the equatorial hydroxyl group as shown in Figure 
18, which depicts the late transition state of the reduction step.  
 
 
 
Figure 18. Ahn-Eisenstein effect to obtain the axial reduction. 
 
 
2.3.4 – Final Deprotection 
 
Synthesized both α and β galactose carbocyclic products the next steps were 
directed to the reconstruction of the CH2OH function. Accordingly, the gem-
difluorocarbocyclic alkynes 320 and 321 were independently reduced to the 
alkenes 324 and 325 through hydrogenation in the presence of Lindlar catalyst. 
Reaction time control proved to be important for the selectivity of the product 
obtained. During the optimization of the reaction conditions it was observed that 
hydrogenation overnight led to the formation of a mixture of the alkene 325 and 
the alkane 326 (Scheme 72).  
 
Results and Discussion 
86 
 
 
Scheme 72. Synthesis of the alkene 325 and 326 precursors. 
 
Subsequent ozonolysis of the alkene precursors 324 and 325 proceeded smoothly 
to give the corresponding aldehydes which were directly engaged in the next step. 
Surprisingly, the reduction of the aldehydes with NaBH4 in EtOH led to a 
chromatographically irresoluble mixture of two compounds. In order to isolate 
both products, we decided to acetylate the two hypothetical hydroxyl groups since 
acetylated compounds (even isomers) usually display distinct Rf. Hence, treatment 
of the mixture with acetic anhydride in pyridine served our purpose, conducting to 
the formation of two products with distinct Rf (Rf = 0.56 327, Rf = 0.63 328; Rf = 
0.46 329, Rf = 0.54 330, in cyclohexane/EtOAc 2:1). After careful analysis of the 
NMR and mass spectra it was concluded that the expected compounds 327 and 
329 (lower Rf) were formed, together with the secondary products corresponding 
to the monofluorinated analogues 328 and 330 (higher Rf) derived from HF 
elimination (Scheme 73). This result could be related with the acidity of the H-5 in 
the proximity of two adjacent fluorine atoms, as well as with the stereochemistry 
at C-4, since none mono-fluorinated analogues were obtained from the mannose 
and glucose counterparts. 
 
The structure of compounds 328 and 330 was identified by the presence of a 
single fluorine atom in 19F spectrum and by the absence of the distinctive H-5, 
which displays a very large JH,F, and for that reason is easily detectable. Further 
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studies concerning to the mono-fluorinated analogues will be discussed in section 
2.5.  
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Scheme 73. Synthesis of the targets gem-difluorocarbagalactose 331 and 333. 
 
Prior deacetylation of 327 and 329, followed by deprotective hydrogenolysis 
furnished the desired 5a-difluoro-5a-carba-α-D-galactopyranose[161] (331) and 5a-
difluoro-5a-carba-β-D-galactopyranose[161] (333), respectively (Scheme 73). For 
structural studies we were interested in the X-ray structure of the final products 
both from carbamannose and carbagalactose series. Nevertheless, we were only 
able to crystallize compound 331 which X-ray structure is presented in figure 19. 
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Figure 19. X-ray structure of 5a-difluoro-5a-carba-α-D-galactopyranose 331. 
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2.4 – Structural Studies 
 
The structure of the gem-difluorocarbamannose and -galactose was studied by 
means of X-ray crystallography and ab initio calculations, in collaboration with 
Prof. Jimenez-Barbero, to ascertain the possible steric and stereoelectronic factors 
associated with the presence of the difluoromethylene group. It is well known that 
the presence of the anomeric effect strongly modifies the structural properties of 
pyranose rings, especially in the vicinity of the anomeric centre. Two different 
levels of theory were employed for comparison purposes. The key structural data 
for the four compounds are given in Table 6. According to the interatomic 
distances, it can be observed that the six-membered ring does not suffer any 
noticeable distortion. All the C–C bonds range between 1.514–1.529 Å, 
independently of the configuration of the centres or the presence of the gem-
difluoro moiety, and of the theoretical or experimental method employed. A 
maximum difference of 0.04 Å is observed for C–C bonds between the X-ray 
experimental and predicted data. For the C–O distances, the maximum discrepancy 
amounts to 0.01 Å (MP2) or 0.10 Å (QCISD). According to the calculations, a small 
decrease of the C1–O1 distance is observed in the two β-OH galactose and 
mannose derivatives, with respect to the rest of the C–O bonds in the two 
molecules. Moreover, the distance becomes the usual one (1.42–1.43 Å), when the 
calculations are performed for the mono-fluoro analogues (both at axial or 
equatorial orientations, data not shown). Therefore, it seems that there is an 
influence of the gem-difluoro moiety on the C1–O1 distance for the equatorial 
derivatives. The existence of stereoelectronic effects is more evident at the gem-
difluoro centre, which obviously contains two strongly electronegative atoms 
attached to one carbon atom.[171] One of the C–F bonds is clearly shorter than the 
other one, resembling the anomeric centre in regular pyranoses. This fact is also 
clearly observed in the X-ray structure of 331 (Figure 19). Nevertheless, the 
differences are more evident when the QCISD and the MP2 protocols (0.026–0.027 
Å) are used than for the X-ray experimental technique (0.012 Å). The C–F distances 
are 0.003–0.004 Å shorter for the QCISD than for the MP2 method, approaching 
the experimental distances in the solid state. Regarding the difference between the 
equatorial and axial C-F bonds, the predicted difference is even more evident for 
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the galactose derivatives. Curiously, the Feq–CF distance is shorter than the Fax–CF 
one for the galactose derivatives, according to both theoretical and experimental 
data, while the opposite trend is calculated for the mannose analogues, for which 
the Fax-CF bond is predicted to be shorter. Previous X-ray analysis of other gem-
difluoro cyclohexanone-like compounds have shown similar distances for the 
pseudoaxial and pseudoequatorial C–F linkages (only 0.006 Å).[172] The 
corresponding distances for the monofluoro analogues are always noticeably 
larger (between 1.41–1.43 Å), thus indicating the existence of stereoelectronic 
effects at the gem-difluoro moiety. 
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2.5 – Synthesis of mono-fluorinated pseudo-carbasugars 
 
Due to the resemblance of the mono-fluorinated analogues 328 and 330 obtained 
in the aldehyde reduction step (Scheme 73), with the patented (+)-MK7607 13 
(Figure 5), we decided to keep on going with the synthesis of these analogues for 
further biological studies. But before moving on with deprotection studies and in 
order to improve selectivity towards di- or mono-fluorinated compounds, the 
aldehyde reduction step was firstly investigated. Therefore, reducing agents, 
temperature control, and non-nucleophilic bases were explored and the results are 
presented in table 7.  
 
Table 6. Experimental conditions tried for mono- and difluorinated selectivity improvement. 
 
Entry Reagent (Solvent) Temperature Time 
di-/mono-
fluorinated ratio 
1 NaBH4 (EtOH/CH2Cl2 4:1) rt 45 min 3:1 
2 NaBH4 (EtOH/CH2Cl2 4:1) -30 °C 1 h  No reaction 
3 LiAlH4 (Et2O/ CH2Cl2 1:1) rt 45 min 2:1 
4 LiAlH4 (Et2O/ CH2Cl2 1:1) -10 °C 1 h 5:3 
5 NaBH3CN (EtOH/CH2Cl2 4:1) rt 3 h 
3:1 (60% Starting 
material recovered) 
6 DBU (THF) -10 °C to rt 2 h Complex mixture 
7 DBU (DMSO) -10 °C to rt 2 h Complex mixture 
8 NaH (DMF) 0 °C 3 h Complex mixture 
 
 
According to table 7 no improvement on the selectivity towards the mono- or di-
fluorinated analogues was obtained with the conditions used. Both typical 
aldehyde and ketone reducing agents NaBH4 and LiAlH4 (Entries 1, 3, 4) led to a 
mixture of both compounds. NaBH3CN, which is an extremely non-aggressive 
reducing agent, also afforded both mono- and di-fluorinated analogues, with 60% 
of starting material recovered after 3 h reaction time. The expected α,β-elimination 
of HF from the transient aldehydes with DBU and NaH was investigated and led 
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only to complex mixtures, whose products were not isolated. In summary, NaBH4 
(Entry 1) proved to be the most effective reagent in the formation of the 
difluorinated analogue whereas the stronger reducing agent LiAlH4 was the one 
that permitted to obtain the major proportion of the mono-fluorinated analogue, 
despite giving mostly the difluorinated compound. 
 
As it was not possible to improve the mono-/di-fluorinated ratio we moved 
forward with the deprotection sequence. The strategy outlined for 
monofluorinated compound deprotection involved the cleavage of the benzyl 
groups, subsequent acetylation, for an easier purification and NMR spectroscopy 
analysis, and final deacetylation. Hence, hydrogenolysis of the mono-fluorinated 
analogue 328 and acetylation, surprisingly, led to the 6-deoxy derivative 334, 
putatively through a π-allyl intermediate accounting for the abstraction of the 
acetate group (Scheme 74). For biological studies purpose the derivative 334 was 
deacetylated to yield the 6-deoxy-5-Fluoro-(+)-MK7607[13] 335. 
 
To circumvent the problem of the acetyl abstraction we decided to reverse the 
reaction sequence. Nevertheless, prior deacetylation of 330 followed by 
hydrogenolysis of 336 and acetylation led to a complex mixture of products 
(Scheme 74). 
 
 
 
Scheme 74. Synthesis of the 6-deoxy-5-fluoro-(+)-MK7607 335. 
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Coming back to the outlined strategy, the cleavage of the benzyl protecting groups 
with the Lewis acid BCl3[173] was investigated. Thus, treatment of both mono-
fluorinated analogues 328 and 330 with BCl3 at –78 °C and subsequent acetylation 
of the free hydroxyl groups afforded the desired peracetylated derivatives 337 and 
339 (Scheme 75) in very good yields. The cleavage of the acetyl groups proceeded 
smoothly to give the 5-ﬂuoro-(+)-MK7607[13] 338 and its epimer 1-epi-5-fluoro-
(+)-MK7607[13] 340. 
 
 
 
Scheme 75. Synthesis of the 5-ﬂuoro-(+)-MK7607 338 and 1-epi-5-fluoro-(+)-MK7607 340. 
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2.6 – Biological Studies 
 
In order to evaluate the influence of the gem-difluoro moiety in the biological 
recognition process, all of the gem-difluorocarbamannose 290 and 291 and             
–galactose 331 and 333 products as well as the (+)-MK7607 mono-fluorinated 
derivatives 335, 338 and 340 were tested as glycosidase inhibitors in a 
collaboration with Prof. Pierre Vogel from Switzerland. The compounds were 
assessed as glycosidase inhibitors for bovine kidney α-L-fucosidase, coffee beans α-
galactosidase, Escherichia coli and Aspergillus oryzae β-galactosidase, rice and 
yeast α-glucosidase, Aspergillus niger amyloglucosidase, almonds β-glucosidase, 
jack beans α-mannosidase, snail β-mannosidase, A. niger β-xylosidase, bovine 
kidney and jack beans β-N-acetylglucosaminidase however no significant 
biological activity was detected. 
 
The absence of inhibition by the new synthetic scaffolds may be related to the fact 
that they are too small to be recognized by the enzymes, which substrates are 
known to have an oligomeric nature. For that reason we are very interested on the 
synthesis of gem-difluorocarbalactosides which will be attractive candidates for 
probing the role of endocyclic oxygen atoms in carbohydrate-enzymes 
interactions. It should be emphasized that the carbalactoside is no longer 
recognized by the enzyme β-galactosidase due to the absence the endocyclic 
oxygen and consequently no interactions involving this heteroatom and the active 
site of the enzyme are possible.  
 
Concerning the mono-fluorinated derivatives of the (+)-MK7607, their biological 
interest, as well as that of the natural product, may rely on the evaluation of the 
herbicidal activity, a goal that will be carried out in a near future. 
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2.7 – Carbadisaccharides synthesis  
 
2.7.1 – Anomeric O-alkylation approach  
 
As stated above, our interest in the synthesis of the gem-difluorocarbalactose and 
gem-difluorocarbalactosamide relies on the possibility to demystify the role of the 
endocyclic oxygen in the biological recognition processes involving carbohydrate-
galactosidase interactions. Having the galactose carbocyclic derivatives 320 and 
321 in hands, our approach consisted on the alkylation of these compounds with 
another molecule suitably protected carrying a triflate at C-4.  
 
1,6-Anhydrohexopyranose derivatives were chosen as alkylating agents to 
accomplish the synthesis of the target disaccharides. This decision is related with 
the susceptibility of the galactose derivatives, displaying an axial triflate group at 
C-4, to undergo elimination[174] under basic conditions due to the presence of two 
trans-diaxial hydrogen atoms (H-3 and H-5). In addition, Prof. Schmidt[175, 176] 
observed that the triflates of 1,6-anhydrohexopyranoses show higher reactivity 
and stability in this type of coupling reactions. Therefore, the triflates of 1,6-
anhydro-2,3-di-O-benzyl-β-D-galactopyranose[177] (341) and 1,6-anhydro-2-azido-
3-O-benzoyl-2-deoxy-β-D-galactopyranose[178] (343) (scheme 76) were selected, 
which should furnish via inversion of configuration at position 4, (1→4)-
connection to 1,6-anhydroglucose. 
 
 
 
Scheme 76. gem-Difluorocarbalactose and gem-difluorocarbalactosamide synthetic strategy.   
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The 1,6-anhydro bridges can be considered as protecting groups for both the 
anomeric centre and 6-hydroxyl group. These derivatives are formed by an 
internal displacement reaction, where the leaving group can be in either 1- or 6-
position. Base treatment of phenyl β-glycosides or 6-O-tosyl derivatives with a free 
hemiacetal group are the conventional ways to prepare such compounds. The 1,6-
anhydro bridges are stable to most reaction conditions, but very susceptible to 
mild acetolysis to give 1,6-diacetates. 
 
2.7.1.1 – Synthesis of the 1,6-anhydro-2,3-di-O-benzyl-4-O-
trifluoromethanesulfonyl-β-D-galactopyranoside (341) 
 
Studies on the anomeric protection of galactose derivative (see Scheme 61) have 
shown that introduction of the pMP group could be stereoselectively achieved by 
replacing the acetyl by benzoyl groups, which are better neighboring participation 
groups.[179] Hence, we took advantage of this product to explore the synthesis of 
the 1,6-anhydrogalactose. According to the methodology described in the 
literature,[180] treatment of the p-methoxyphenyl 2,3,4,6-tetra-O-benzoyl-β-D-
galactopyranoside (346) with a 2.5 M aqueous solution of NaOH under reflux, 
yielded the expected 1,6-anhydro-β-D-galactopyranoside (347)[181] (Scheme 77). 
 
 
 
Scheme 77. Synthesis of the 1,6-anhydro-β-D-galactopyranoside (347). 
 
It is important to note the conformation change from 4C1 to 1C4 that occurred by 
the formation of 1,6-anhydro derivatives. This modification of the ring 
conformation alters the relative reactivity of the hydroxyl groups. So, the 
unreactive axial OH-4 adopts an equatorial orientation and is, therefore 
significantly more reactive.[182] The 1H-NMR spectrum of 1,6-anhydrogalactose 
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347 reveals low values for J1,2 and J2,3 (ca. 1.3 Hz) indicating a 1C4 chair 
conformation. 
 
The two cis-diols were then protected with a 3,4-O-benzylidene group (Scheme 
78). However, special attention should be paid to this reaction, since the formation 
of the correct isomer in this step will be important later on for the selection of the 
desired product after benzylidene cleavage. The exo isomers give mainly 
derivatives containing equatorial O-benzyl groups, while the endo isomers yield 
derivatives having axial O-benzyl groups.[183] The desired endo-3,4-O-benzylidene 
derivative 348 was achieved solventless in 58% yield in the presence of 
benzaldehyde dimethyl acetal and 10-camphorsulfonic acid. The result was 
confirmed by NMR spectroscopy through comparison with the literature.[183] The 
benzylidene proton (H-7) in the exo isomer (δ 6.32 ppm) resonates at lower field 
than that of the corresponding endo isomer (δ 5.83 ppm). The signal at δ 5.74 
obtained for H-7 is in agreement with the endo isomer.  
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Scheme 78. Synthesis of the suitable triflate 341 for the coupling reaction. 
 
The remaining hydroxyl group was benzylated with benzyl bromide and sodium 
hydride in DMF to afford the fully protected 1,6-anhydro derivative 349 in 93% 
yield. Hidrogenolysis of the 1,6-anhydro-2-O-benzyl-(S)-3,4-O-benzylidene (349) 
with LiAlH4-AlCl3 in a 2:1 mixture of ether/CH2Cl2 provided the expected 1,6-
anhydro-2,3-di-O-benzyl-β-D-galactopyranose (350) in 82% yield. The suitable 
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substrate 341 for further coupling reaction was finally achieved after treatment of 
derivative 350 with triflic anhydride in anhydrous dichloromethane containing 
10% of pyridine. 
 
The base-promoted O-alkylation of anomeric hydroxyl groups with secondary alkyl 
triflates, including sugars, has already been described by Paulsen,[177, 184] for the 
synthesis of pseudo-carbadisaccharides, and by Schmidt[176] for the synthesis of 
disaccharides. They both reported that aprotic dipolar solvent mixtures and low 
temperatures (between 0 and –10 °C) are required for clean reactions and high 
product yields. 
 
Extrapolating to our case, the base promoted reaction of the gem-difluoro 
carbocyclic product 321 with the sugar triflate 341 in a 2:1 mixture of DMF/HMPT 
should provide the gem-difluorocarbalactoside derivative 342 (Scheme 76). 
Disappointingly no reaction occurred, even changing some experimental 
conditions such as temperature, base (NaH, BuLi) and solvent (THF/HMPT). This 
result could be related with the lower nucleophilicity (stability) of the alkoxide due 
to the electron withdrawing character of the neighboring CF2 group. 
 
Playing with the alleged electrophilicity of the anomeric centre it was envisaged 
that placing the triflate in the carbocyclic derivative this problem could be 
overcome. Accordingly, the triflate derivative 351 was obtained in quantitative 
yield by reaction of the gem-difluorocarbocyclic 320 with triflic anhydride and 
pyridine in anhydrous dichloromethane (Scheme 79). 
 
 
 
Scheme 79. Synthesis of the gem-difluorocarbagalactose triflate derivative 351. 
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The other suitable sugar derivative having a free hydroxyl group at C-4 for further 
coupling reaction was easily achieved in three steps from commercial methyl α-D-
glucopyranoside. Treatment with benzaldehyde dimethyl acetal and 10-
canphorsulphonic acid in CH3CN yielded the 4,6-O-benzylidene derivative 352. 
Benzylation of the secondary hydroxyl groups and selective cleavage of the 4,6-O-
benzylidene cycle with Et3SiH and TFA in dichloromethane provided the methyl 
2,3,6-tri-O-benzyl-α-D-glucopyranoside precursor (354) (Scheme 80). 
 
 
 
Scheme 80. Preparation of the methyl 2,3,6-tri-O-benzyl-α-D-glucopyranoside precursor (354). 
 
The base promoted reaction of the gem-difluorocarbocyclic triflate 351 with the 
sugar precursor 354 proved to be once again ineffective. Both starting materials 
were recovered from the reaction mixture after aqueous work-up.  
In order to assess the reactivity of the carbocyclic triflate 351 we decided to 
investigate the reaction with NaN3, which is a very common and highly efficient 
methodology in carbohydrate chemistry for azide introduction (Scheme 81). No 
reaction occurred and the starting material was always recovered even when 
experienced temperatures around 40 °C. For higher temperatures only 
decomposition of the starting material was observed. 
 
 
 
Scheme 81. Attempt to triflate displacement by sodium azide. 
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Due to this unexpected unreactivity of the gem-difluorocarbocyclic triflate 351, the 
reaction of the galactose triflate in 4C1 conformation with the carbocyclic product 
321 was investigated, even taking the risk of the eventual formation of the 
elimination side product.  
 
The galactose triflate derivative was obtained from the 2,3,6-tri-O-benzyl-α-D-
glucopyranoside (354) precursor after inversion of the configuration at C-4, which 
was achieved through Swern oxidation of the free hydroxyl group and subsequent 
reduction of the intermediate ketone with NaBH4 in EtOH.[185] Treatment of 356 
with triflic anhydride and pyridine in dichloromethane afforded the desired triflate 
357 which was used without further purification (Scheme 82). 
 
 
 
Scheme 82. Synthesis of the galactose triflate precursor 357. 
 
The anomeric O-alkylation of the carbocycle 321 with the triflate 357 did not 
furnish the desired disaccharide. The triflate 357 revealed to be fairly unstable, 
decomposing during the course of the reaction. Thereby, we decided to replace the 
triflyl by a mesyl group, which despite of being more stable should be reactive 
enough to allow the coupling reaction. The mesylated compound 358 was 
achieved in 76% yield from 356 using MsCl and Et3N in anhydrous 
dichloromethane (Scheme 83). 
 
 
 
Scheme 83. Synthesis of the galactose mesylated precursor 358. 
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However, the base promoted (NaH) reaction of the gem-difluorocarbocyclic 
product 321 with the mesylated sugar 358 in a 2:1 mixture of DMF/HMPT did not 
succeed and the starting materials could be recovered. Temperatures above 80 °C 
led to the decomposition of the mesylated compound and partial decomposition of 
the carbocyclic product. 
 
In order to evaluate the reliability of this coupling reaction we decided to 
investigate the O-alkylation using a triflate of a primary alcohol which is known to 
be more reactive than secondary ones. The primary triflate 360 was obtained in 
two steps from the bicyclic compound 353, after regioselective opening of the 
benzylidene ring with LiAlH4-AlCl3 and subsequent treatment of the primary 
alcohol 359 with triflic anhydride and Et3N in toluene, which gave a clean reaction 
when compared to that obtained with pyridine in dichloromethane (Scheme 84). 
 
 
 
Scheme 84. Preparation of the primary sugar triflate 360. 
 
Schmidt[176] described that reaction of primary alkyl triflates with various 
aldopyranosides in the presence of a base could be performed in both nonpolar 
and polar solvents. Nevertheless the coupling reaction of the gem-
difluorocarbocyclic products 320 and 321 with the primary triflate 360 (Scheme 
85) was unsuccessful in various solvents (toluene, DMF, THF, DMF/HMPT). The 
triflate 360 proved to be very unstable, decomposing under the reaction 
conditions used. Thus, the influence on the reactivity of the axial (in 320) or 
equatorial (in 321) orientation of the free alcohol could not be investigated. 
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Scheme 85. (1→6)-gem-difluorocarbadisaccharides synthesis attempt. 
 
The instability of the primary triflate prompted us to investigate the same reaction 
with a primary mesylated alcohol. Hence, this derivative was obtained in good 
yield by treatment of the primary alcohol 359 with MsCl in pyridine (Scheme 86). 
 
 
 
Scheme 86. Preparation of the primary mesylated compound 363. 
 
The O-alkylation of the gem-difluorocarbocyclic products 320 and 321 with 
compound 363 proved to be once again fruitless. All the starting materials were 
recovered from the reaction mixture. 
 
In summary, the O-alkylation of the anomeric hydroxyl group reported by Paulsen 
and Schmidt demonstrated to be ineffective in the case of gem-difluorocarbocyclic 
derivatives, probably due to the deactivation at the anomeric centre by the 
presence of the CF2 group at α-position.  
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2.7.2 – Cyclic Sulfates approach  
 
The epoxides play a unique role in organic synthesis, activing and protecting 
simultaneously adjacent functionalized carbon atoms for nucleophilic attack. In 
1988 Sharpless[186] reported that cyclic sulfates behave like epoxides with the 
remark that they are generally more reactive, and for that reason excellent 
substrates for nucleophilic substitution. Their synthesis is easily achieved through 
reaction of a diol with thionyl chloride (SOCl2) to afford the cyclic sulfite which is 
then oxidized to sulfate by sodium periodate (NaIO4) with a catalytic amount of 
ruthenium (III) chloride (Scheme 87). 
 
 
 
Scheme 87. Sharpless methodology for the preparation of cyclic sulphates. 
 
Taking advantage of our experience on the synthesis of 2-azido 1,6-anhydro 
derivatives (Scheme 76) for the preparation of gem-difluorocarbalactosamides, we 
decided to use a compound of this type as scaffold for the construction of the 3,4-
cyclic sulfate, where position 2 is already “protected” with an azido group. 
 
 
2.7.2.1 – Synthesis of 1,6-anhydro-2-azido-2-deoxy-3,4-sulfone-β-D-
galactopyranoside (373) 
 
Although 1,5-Anhydro-2-deoxy-D-lyxo-hex-1-enitol is commercially available 
(trivial name: D-galactal), its high price prompted us to prepare this compound 
starting from the galactose pentaacetate 293 (Scheme 88). Accordingly, the 
glycosyl bromide 364 was obtained from 293 by treatment with 33% HBr in acetic 
acid at room temperature for 3 h. The bromide 364 was subjected, in turn, to 
reductive elimination with zinc dust and 1-methylimidazole in EtOAc to give the 
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triacetate 365. Deacetylation of 373 was carefully achieved using K2CO3 (0.05 eq.) 
in MeOH to yield D-galactal 366. 
 
 
 
Scheme 88. Preparation of D-galactal 366 from galactose pentaacetate 293. 
 
The 2-azido 1,6-anhydrogalactose derivatives have been used for the preparation 
of D-galactosamine-containing oligosaccharides[175, 187, 188] and are commonly 
prepared from D-galactal. Activation of the hydroxyl groups of 366 by O-
tributylstannylation followed by reaction with iodine afforded the desired 1,6-
anhydro-2-deoxy-2-iodo-β-D-galactopyranose (367) along with the 1,4-anhydro-2-
deoxy-2-iodo-β-D-galactopyranose (368) (Scheme 89). The ratio between these 
two products was improved in favor of the 1,6-anhydro derivative by removal of 
acetonitrile after O-stannylation and addition of dry dichloromethane prior to the 
iodocyclization step. The two broad singlets for H-1 and H-2 in the 1H NMR 
spectrum of 367, indicating low values of J1,2 and J2,3, are representative of a 1C4 
chair conformation. On the other hand, J4,5 ~0 for a dihedral angle of ~90° and the 
long-range coupling J2,4 observed for 368 are in agreement with the strained 
bicyclic structure of this 1,4-anhydro derivative and also in accordance with the 
literature data.[189] 
 
When treated with sodium azide in DMF – H2O at 120 °C, the iodide 367 afforded a 
mixture of two products chromatographically irresoluble. In order to separate 
both compounds the mixture was subsequently acetylated to afford, after 
purification by flash column chromatography, 3,4-di-O-acetyl-1,6-anhydro-2-
azido-2-deoxy-β-D-galactopyranose (369) and 2,4-di-O-acetyl-1,6-anhydro-3-
azido-3-deoxy-β-D-idopyranose (370) in a 6:1 ratio (Scheme 89). The preferential 
formation of compound 369 is explained by the opening of the transient manno–
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epoxide in a trans-diaxial fashion by the azide anion. Identification of the 
compounds was performed by means of NMR spectroscopy. The large J2,3 and J3,4 
(> 9.1 Hz) indicating a trans-diaxial orientation of H-3 relatively to H-2 and H-4, 
and the deshielding of the H-2 in the compound 370, due to the presence of an 
acetyl group, led us to propose the 1,6-anhydro idopyranose configuration 
resulting from the epoxide opening at C-3. 
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Scheme 89. Preparation of the key cyclic sulphate precursor 373. 
 
Deacetylation of 369, carried out with sodium methoxide in methanol, proceeded 
smoothly to give 371 in quantitative yield. Further treatment of the intermediate 
371 with SOCl2 in dichloromethane afforded the cyclic sulfite 372. This 
transformation was accompanied by a significant deshielding of both H-3 and H-4 
indicating a 3,4-cyclic sulfite. The key sulfate precursor 373 was finally achieved 
after oxidation of 372 with sodium periodate catalyzed by ruthenium (III) chloride 
(Scheme 89). 
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The opening of cyclic sulfates with nucleophiles had already been used in Prof. 
Sinaÿ’s group[190] in a sugar alkylation for the total synthesis of the calditol. Indeed, 
the cyclic sulfates are easily opened by nucleophilic attack at the less hindered 
position. The application of the same experimental conditions previously 
developed[190] for the nucleophilic attack of the gem-difluorocarbocyclic alkoxide 
321 to the cyclic sulfate 373 (Scheme 90) did not conduct to the desired product. 
We observed a slight degradation of 373, and the carbocyclic compound 321 was 
recovered after aqueous treatment. Changing temperature and solvent did not lead 
to any progress for the preparation of the gem-difluorocarbadisaccharide. 
 
 
 
Scheme 90. Disaccharide synthesis attempt via nucleophilic attack to a cyclic sulfate.  
 
 
2.7.3 – Orthoesters approach  
 
The introduction and regioselective cleavage of the 4,6-benzylidene acetal in 
sugars to give O-6 or O-4 benzyl sugars has been used as a protecting group 
manipulation trick in carbohydrate chemistry. An ingenious extension of this idea 
was developed by Ikegami and co-workers who have exploited it for the regio- and 
stereoselective formation of β-(1→4) disaccharides.[191] The first step of their 
methodology is the preparation of the sugar orthoester, which is efficiently 
achieved by treating a sugar lactone and a diol with TMSOTf and TMSOMe[192] 
(Scheme 91). 
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Scheme 91. Ikegami’s methodology for the preparation of sugar orthoesters from sugar lactones 
and sugar diols. 
 
Although two stereoisomers are possible, only one isomer was always isolated in 
the orthoester formation between several sugar lactones and the glucose 
derivative 376. In order to determine their configuration, molecular modeling 
calculations were carried out. Accordingly, it was suggested that the (R)-isomer 
was more stable by 3.4 – 10 Kcal/mol than the (S)-isomer. In addition, the 
conformation of the dioxane ring in the favored isomer was assigned as having a 
chair form, while in the case of the disfavored isomer the conformation of dioxane 
ring was the skew boat form[193] (Figure 20). 
 
 
 
Figure 20. Proposed conformation for both isomers of methyl 2,3-di-O-benzyl-4,6-O-(2,3,4,6-tetra-
O-benzyl-D-mannopyrano-sylidene)-α-D-glucopyranoside calculated by Ikegami’s group. 
 
The subsequent reductive ring opening of the orthoester with LiAlH4-AlCl3 
proceeded regio- and stereospecifically to afford disaccharides in excellent 
yields[191] (Scheme 92). 
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Scheme 92. Reduction of sugar orthoester with LiAlH4-AlCl3. 
 
It is reasonable to think that the reaction between the gem-difluorocarbocyclic 
ketone 379 and the glucose derivative 376, which was obtained from the 
hydrolysis of the 4,6-O-benzylidene on 353, would constitute a promising 
approach for the preparation of the gem-difluorocarbalactose (Scheme 93). 
 
 
 
Scheme 93. Disaccharide approach by employing the methodology developed by Ikegami. 
 
The gem-difluorocarbocyclic ketone 379 could be directly obtained from the 
rearrangement of 317 induced by TiCl3(OiPr). Nevertheless, to avoid the formation 
of the ketohydrate 323 during the work-up for removal of the Lewis acid, we opted 
to oxidize the carbocyclic alcohols 320 or 321 by a Swern oxidation and proceed 
then directly with the acetal formation. Unfortunately all attempts to synthesize 
the disaccharide 380 proved to be ineffective. For the reactions carried out at 
room temperature compound 323 was preferentially obtained. Temperatures 
around 60 °C led to decomposition of the carbocyclic ketone 379. 
 
In order to validate and accurate this methodology we decided to reproduce the 
reaction depicted in Scheme 91. Therefore, treatment of lactone 375 and diol 376 
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with TMSOTf and TMSOMe at room temperature gave, as expected, the orthoester 
377 in a 74% yield. Further attempts to prepare the target disaccharide with this 
methodology revealed always fruitless. 
 
 
2.7.4 – Bromine activation approach  
 
In the search for an efficient coupling method, we took special attention to the 
work of Bonnet-Delpon’s group since they experienced similar problems in the 
direct etherification or acylation of an Artemisinin derivative containing a CF3 
moiety adjacent to a hydroxyl group (Scheme 94).[194] They suggested that the 
weak nucleophilicity of the corresponding alkoxide, due to the neighboring 
trifluoromethyl group, explains the inefficiency of the transformation. In addition 
they stated that the high electron-withdrawing effect of the CF3 group destabilizes 
the intermediary carbocation thus disfavoring an SN1 process in substitution 
reactions of the hydroxyl or the corresponding mesylate. 
 
Bonnet-Delpon et al. also verified that replacement of the hydroxyl group in 381 
by a bromine atom was easily achieved using thionyl bromide. Being the bromine 
more labile than a hydroxyl group, they investigated the substitution reaction on 
the substrate 383. After optimization of the reaction conditions they obtained 
good yields for the alkylation and acylation of the bromine precursor 383 using 
1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) as activator (Scheme 94).[194] 
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Scheme 94. Bonnet-Delpon’s methodology for the alkylation of an alcohol adjacent to a CF3 group. 
 
In this context we decided to transform the gem-difluorocarbocyclic alcohol 320 
into the corresponding bromine derivative and then explore the alkylation step. 
Accordingly, the bromine precursor 384 was obtained in a reasonable yield from 
compound 320 after treatment with thionyl bromide in dichloromethane at –30 °C 
(Scheme 95). 
 
 
 
Scheme 95. Preparation of the bromine derivative 384 for further alkylation. 
 
Further reaction of the bromide 384 with the glucose derivative 354 in 
dichloromethane using HFIP as activator (Scheme 96) did not cause any variation 
on the starting materials even at reflux. 
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Scheme 96. Attempt to alkylation of the bromine derivative 384. 
 
Replacement of HFIP by AgOTf as activator, also used by Bonnet-Delpon and co-
workers[194] but abandoned due to the poor stereoselectivity, once again did not 
afford the desired gem-difluorocarbadisaccharide. 
This disappointing result, in sharp contrast with that observed for the artemisinin 
fluorinated analogue 383, could be related to the impossibility of stabilizing the 
carbocation formed after the HFIP activation (Scheme 97), consequently increasing 
the energetic barrier in our case.  
 
 
 
Scheme 97. Activation pathway of substitution reaction of bromide 383. 
 
 
2.7.5 – Rearrangement approach  
 
As we have seen so far, the anomeric reactivity of the gem-difluorocarbocyclic 
products 320 and 321 is severely compromised by the presence of the CF2 group.  
Considering that all the attempts to achieve the preparation of the gem-
difluorocarbalactose by either nucleophilic or electrophilic reaction, involving the 
carbocyclic products, failed, we decided to take advantage of the rearrangement 
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procedure developed by Profs. Sinaÿ’s and Sollogoub, since in this methodology 
both the aglycon moiety and stereochemistry are retained.[139] Thus, applying a 
similar methodology to lactose 390 that those used in the preparation of the gem-
difluorocarbagalactose and -mannose, we should be able to obtain the target gem-
dilfuorocarbadisaccharide 387 (Scheme 98). 
 
 
 
Scheme 98. gem-Difluorocarbalactose retrosynthetic strategy based on the rearrangement induced 
by a Lewis acid. 
 
The reluctance on the use of this methodology was related with the necessity to 
optimize a new synthetic route. Although the same steps used in the galactose and 
mannose derivatives are involved in the construction of the gem-
difluorocarbadisaccharide, it is always required some level of optimization, 
whereas the synthesis of the gem-difluorocarbagalactose derivatives 320 and 321 
was already optimized. Neverthless, the major concern was related to the 
construction of the difluoroalkene unit 389 (Scheme 99). It is described in the 
literature that when cyclic keto acetals type 391 are subjected to nucleophylic 
conditions, what is usually observed is the opening of the ring and consequent 
rejection of the aglycon (Scheme 99).[195-198] 
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Scheme 99. Nucleophilic attack to cyclic keto acetals type 391. 
 
Therefore, in order to validate the gem-difluorocarbalactose proposed synthetic 
strategy, the introduction of the gem-difluoroalkene unit and the rearrangement in 
a small scaffold, that could be easily prepared, was investigated. Hence, we decided 
to transform the 5-eno-pyranoside 394, which could be easily obtained from the 
precursor 376, into the key gem-difluoroalkene 396 (Scheme 100). Selective 
iodination of the diol 376 under condition developed by Garegg[199] gave 393, 
which underwent slow but smooth benzylation of the secondary alcohol, and 
elimination with excess of NaH in DMF containing two equivalents of benzyl 
bromide to give 394 in 82% yield. After ozonolysis, the intermediate ketone 395 
was submitted to a Wittig-type reaction with the phosphorous ylide generated in 
situ from the combination of HMPT and CBr2F2. Hopefully, unlike described in 
literature, we obtained the desired gem-difluoroalkene precursor 396 (Scheme 
100). The non-opening of the cycle could be related with the mild conditions used, 
which did not require the employ of bases as used in the cited references.  
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Scheme 100. Preparation of the key gem-difluoroalkene precursor 396. 
 
Reaction of precursor 396 with excess of TIBAL at 50 °C resulted in the 
transposition of an oxygen of the ring with the exocyclic CF2 moiety as expected, to 
afford 397 in good yield (Scheme 101). The diastereoselectivity observed is in 
accordance to the hydride delivery from the less hindered face of the keto 
intermediate. Furthermore, it should be emphasized the complete retention of the 
anomeric information observed. 
 
 
 
Scheme 101. Synthesis of the gem-difluorocarbocyclic product 397 by TIBAL induced 
rearrangement of precursor 396. 
 
Applying now this methodology to lactose and lactosamide we should be able to 
obtain the target disaccharides for further structural studies. For lack of time it 
could not be synthesized during the course of this thesis but surely it will be 
accomplished in a near future. 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Conclusion
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The first synthesis of both the α and β anomers of gem-difluorocarbamannose and 
–galactose was accomplished in the present work starting from the corresponding 
natural sugars in 18 steps. The strategy was based on a Lewis acid induced 
rearrangement of a gem-difluoroalkene derivative containing an original cobalt 
cluster as electron donating group. The synthetic pathway outlined was divided in 
4 major steps. The first one consisted on the construction of the triple bond at C-6. 
Accordingly, the first reactions were directed to the orthogonal protection of the 
anomeric position with OpMP, followed by a sequence of protection/deprotection 
steps leading to a benzylated molecule with the primary alcohol free. After Swern 
oxidation, the triple bond was installed via Corey-Fuchs reaction and 
methylenation. 
The second step was directed to the introduction of the gem-difluoroalkene at the 
anomeric position. Thus, cleavage of the OpMP group and subsequent oxidation 
allowed the formation of the lactone, which was transformed into the gem-
difluoroalkene precursor by difluoromethylenation according to Motherwell’s 
procedure. Removal of the OpMP in the galactose derivative proved to be 
unexpectedly difficult, resulting in modest yields. An alternative approach 
replacing OpMP by SPh as anomeric protecting group was investigated, and 
revealed to be a good choice, which permitted to improve the synthesis of the 
lactol precursor. 
The third and key step was the rearrangement sequence performed through a two-
step one-pot procedure that involved first, the complexation of the alkyne by 
dicobalt octacarbonyl, followed by the reductive TIBAL-induced rearrangement. 
Decomplexation with CAN of the transient carbocyclic cobalt cluster afforded the 
desired rearranged products as a mixture of both equatorial and axial alcohols. 
Other Lewis acids were investigated in order to improve the stereoselectivity of 
the reaction; however, it was not possible to optimize these results. 
The fourth step of the outlined strategy consisted on the final deprotection of the 
molecule. The CH2OH function was rebuilt after controlled hydrogenation of the 
triple bond using Lindlar catalyst, and reductive ozonolysis. Final deprotective 
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hydrogenolysis yielded the target α and β gem-difluorocarbamannose and –
galactose. 
Reduction of the transient aldehyde obtained after ozonolysis, conducted, in the 
case of the galactose derivative, to the formation of monofluorinated analogues via 
HF elimination, which were only chromatographically separable from the 
difluorinated compounds after acetylation of the free hydroxyl groups. The 
resemblance of these compounds structure with the patented (+)-MK7607 
prompted us to investigate their synthesis for further biological assays. Selective 
synthesis of such analogues via α,β elimination on the transient aldehyde was 
investigated. Among the reagents tested, LiAlH4 slightly improved the yield of the 
target molecule, but the major compound was again the difluorinated one. The free 
monofluorinated compounds were then obtained by cleavage of the benzyl 
protecting groups with BCl3 and deacetylation. 
All deprotected carba- and pseudo-carbasugars were evaluated as glycosidase 
inhibitors. Nevertheless, no interesting activity was detected for any of the 
compounds tested. 
Our efforts were then focused on the synthesis of the gem-difluorocarbalactose 
and –lactosamide, which will be attractive candidates to prove the role of the 
endocyclic oxygen in sugar-enzyme interactions. Several approaches were 
investigated to achieve the direct coupling between the carbocyclic products, 
obtained after the rearrangement sequence, and another molecule suitably 
protected. However, all the strategies tried, namely anomeric O-alkylation, opening 
of cyclic sulfates, regioselective cleavage of orthoesthers and bromine activation, 
proved to be ineffective. For that reason we exploited the rearrangement 
procedure developed by Profs. Sinaÿ’ and Sollogoub in a small scaffold, in order to 
accurate the reliability of this strategy. Therefore, methyl 2,3-di-O-benzyl-α-D-
glucopyranoside was transformed in 5 steps into the methyl 2,3,4-tri-O-benzyl-6-
deoxy-6,6-difluoro-α-D-xylo-hex-5-enopyranoside. The TIBAL-induced 
rearrangement of this precursor proceeded smoothly to afford stereoselectively 
the target gem-difluorocarbocyclic alcohol with total retention of the anomeric 
group and configuration. The diastereoselectivity observed was in accordance to 
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the hydride delivery from the less hindered face of the keto intermediate. Applying 
now this methodology to lactose and lactosamide we should be able to obtain the 
target disaccharides for further structural studies. 
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4.1 General Methods.  
 
Solvents and reagents were purchased from Sigma-Aldrich, Acros or Fluka. 
Anhydrous solvents were freshly distilled under argon from Na/benzophenone 
(THF, Et2O and Toluene) or P2O5 (CH2Cl2). Other anhydrous solvents were dried 
over a bed of activated molecular sieves (acetone, DMF, ethanol and methanol), or 
KOH (pyridine). Dry DMSO was purchased from Sigma-Aldrich. Solvents for 
column chromatography (cyclohexane, EtOAc, CH2Cl2 and toluene) were distilled 
before use. 
 
All transfers (reagents in solution and solvents) were carried out with oven dried 
needle or cannula. 
 
Reactions were monitored by thin-layer chromatography (TLC) on a precoated 
plate of Silica Gel 60 F254 (layer thickness 0.2 mm; E. Merck, Darmstadt, Germany) 
and detection under UV light (254 nm) and by charring with a 10% ethanolic 
solution of H2SO4 or with 0.2% w/v cerium sulphate and 5% ammonium 
molybdate in 2 M H2SO4. 
 
Products were purified by flash column chromatography using silica gel 60 (230-
400 mesh, E. Merck). 
 
Melting points (m. p.) were recorded on a Büchi B-535 capillary apparatus and are 
uncorrected. 
 
Optical rotations ([α]D) were measured at 20±2 °C with a Perkin Elmer Model 241 
digital polarimeter, using a 10 cm, 1 mL cell. 
 
Mass spectra (MS) and high resolution mass spectra (HRMS) were recorded on a 
JMS-700 spectrometer, using chemical ionization (ammonia and methane) or FAB 
(ENS Paris) or using positive electrospray ionization (ESI) recorded on an Apex 
Ultra FTICR mass spectrometer equipped with an Apollo II Dual ESI/MALDI ion 
source, from Brüker Daltonics, and 7 T actively shielded magnet from Magnex 
Scientific (FCUL Lisbon). 
 
Elemental analyses were performed by the Service de Microanalyse du Centre 
Régional de Mesures Physiques de l’Ouest (Rennes). 
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X-ray crystallography was performed in the Institut Lavoisier-IREM at Université 
de Versailles Saint Quentin. 
 
1H NMR spectra were recorded at 250 MHz with a Brüker AC-250 or at 400 MHz 
with a Brüker Advance 400 for solutions in CDCl3, CD3OD, C6D6 or D2O at room 
temperature. Assignments were confirmed by COSY experiments. 13C NMR spectra 
were recorded at 63 MHz with a Brüker AC-250 or at 100.6 MHz with a Brüker 
Advance 400 spectrometer. Assignments were confirmed by J-mod technique and 
HMQC. 19F NMR spectra were recorded at 235 MHz with a Brüker AC-250 or at 376 
MHz with a Brüker Advance 400 spectrometer. All chemical shifts (δ) are given in 
ppm relative to the residual deuterated solvent signals. Coupling constants (J) are 
reported in Hertz. 
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1,2,3,4,6-Penta-O-acetyl-D-mannopyranose (258a,b) 
 
 
 
Commercial D-(+)-mannose (20.0 g, 0.11 mol) was dissolved in pyridine (250mL) 
and acetic anhydride (79.0 mL, 0.77 mmol) was added dropwise.  The reaction was 
stirred overnight at room temperature. The solvent was removed under reduced 
pressure in the presence of toluene, and the residue puriﬁed by flash column 
chromatography (Cyclohexane/EtOAc, 6:4) to yield compound 258a,b[200] (40.8 g, 
95%) as a 2:1 mixture of α and β anomers. 
 
extracted data for α anomer:  
 
1H NMR (CDCl3, 250 MHz): δ 6.07 (d, 1H, J1,2 = 1.9 Hz, H-1), 5.34 – 5.21 (m, 3H, H-2, 
H-3, H-4), 4.26 (dd, 1H, J5,6a = 5.0 Hz, J6a,6b = 12.3 Hz, H-6a), 4.10 (dd, 1H, J5,6b = 2.4 
Hz, J6a,6b = 12.3 Hz, H-6b), 4.04 – 4.08 (m, 1H, H-5), 2.16 (s, 3H, OAc), 2.14 (s, 3H, 
OAc), 2.08 (s, 3H, OAc), 2.03 (s, 3H, OAc), 2.00 (s, 3H, OAc). 
 
extracted data for β anomer: 
 
1H NMR (CDCl3, 250 MHz): δ 5.86 (d, 1H, J1,2 = 0.9 Hz, H-1), 5.47 (dd, 1H, J1,2 = 0.9 
Hz, J2,3 = 3.2 Hz, H-2), 5.29 (t, 1H, J3,4 = J4,5 = 9.9 Hz, H-4), 5.10 (dd, 1H, J2,3 = 3.2 Hz, 
J3,4 = 9.9 Hz, H-3), 4.32 (dd, 1H, J5,6a = 4.8 Hz, J6a,6b = 12.4 Hz, H-6a), 4.13 (dd, 1H, J5,6b 
= 1.7 Hz, J6a,6b = 12.4 Hz, H-6b), 3.78 – 3.83 (m, 1H, H-5), 2.23 (s, 3H, OAc), 2.10 (s, 
3H, OAc), 2.09 (s, 3H, OAc), 2.05 (s, 3H, OAc), 1.98 (s, 3H, OAc). 
 
 
4-Methoxyphenyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (259) 
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CF3SO3H (13.3 mL, 0.15 mmol) was added to a stirred mixture of 4-methoxyphenol 
(18.6 g, 0.15 mol) and the crude pentaacetate 258a,b (40.8 g, 0.10 mol) dissolved 
in anhydrous CH2Cl2 (500 mL) at 0 °C under argon. The reaction mixture was 
allowed to reach room temperature and stirred for 16 h, then quenched with a 
saturated solution of NaHCO3 (300 mL) and stirred for 15 min. The mixture was 
washed with a saturated solution of NaHCO3 (2 x 200 mL), and with a 1 M solution 
of HCl (150 mL). The organic extract was dried (MgSO4), filtered and the solvent 
evaporated under reduced pressure. Flash column chromatography 
(cyclohexane/EtOAc, 4:1) afforded the tetraacetate 259[201] (44.1 g, 97%) as a 
white solid.  
 
1H NMR (CDCl3, 250 MHz): δ 7.05 (d, 2H, J = 9.1 Hz, Harom. OpMP), 6.85 (d, 2H, J = 
9.1 Hz, Harom. OpMP), 5.58 (dd, 1H, J2,3 = 3.3 Hz, J3,4 = 10.0 Hz, H-3), 5.48 – 5.43 (m, 
2H, H-1, H-2), 5.38 (t, 1H, J3,4 = J4,5 = 10.0 Hz, H-4), 4.34 – 4.28 (m, 1H, H-5), 4.20 – 
4.09 (m, 2H, H-6a, H-6b), 3.80 (s, 3H, OCH3), 2.22 (s, 3H, OAc), 2.08 (s, 3H, OAc), 
2.07 (s, 3H, OAc), 2.06 (s, 3H, OAc). 
 
CIMS (M+NH4)+: m/z 472. 
 
 
4-Methoxyphenyl 2,3,4-tri-O-benzyl-α-D-mannopyranoside (263) 
 
 
 
To a solution of 260 (2.0 g, 7.00 mmol) in dry pyridine (11 mL), TBDMSCl (1.5 g, 
7.70 mmol) and N,N-dimethylaminopyridine (50.0 mg, 0.41 mmol) were added at  
0 °C under argon. After stirring for 2.5 h at room temperature, the mixture was 
diluted with EtOAc (10 mL), successively washed with saturated solutions of NH4Cl 
(10 ml) and NaHCO3 (10 mL). The organic layer was dried (MgSO4), filtered and 
concentrated under reduced pressure. The product obtained (white solid) was 
directly engaged in the next step. Rf 0.8 (EtOAc/iPrOH/H2O 3:3:1). 
NaH (0.9 g, 21.40 mmol) was added to a solution of the product of the previous 
step (1.9 g, 4.75 mmol) in DMF (40 mL) at 0 °C, and after 15 min BnBr (2.0 mL, 
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17.10 mmol) was added. After stirring for 16 h at room temperature, the reaction 
mixture was quenched with MeOH (10 mL) and concentrated under reduced 
pressure. The product obtained (yellow oil) was directly engaged in the next step. 
Rf 0.7 (cyclohexane/EtOAc 2:1). 
TBAF (3.0 g, 9.50 mmol) was added to a solution of the product of the previous 
step (2.6 g, 4.75 mmol) in THF (5 mL). After 2 h, EtOAc (20 mL) and water (30 mL) 
were added, and the aqueous layer was extracted with EtOAc (2 × 20 mL). The 
organic layers were dried (MgSO4) and concentrated in vacuo. Column 
chromatography (cyclohexane/EtOAc 4:1) of the residue gave 263 (1.8 g, 68 % 
over 3 steps) as a white solid. 
 
1H NMR (CDCl3, 400 MHz): δ  7.46 – 7.35 (m, 15H, Harom. Ph), 6.96 (d, 2H, J = 9.1 Hz, 
Harom. OpMP), 6.86 (d, 2H, J = 9.1 Hz, Harom. OpMP), 5.48 (d, 1H, J1,2 = 2.3 Hz, H-1), 
5.03 (d, 1H, J = 10.9 Hz, CHPh), 4.90 (d, 1H, J = 12.3 Hz, CHPh), 4.81 (d, 1H, J = 11.7 
Hz, CHPh), 4.80 (d, 1H, J = 12.3 Hz, CHPh), 4.77 (d, 1H, J = 11.7 Hz, CHPh), 4.76 (d, 
1H, J = 10.9 Hz, CHPh), 4.19 (dd, 1H, J2,3 = 2.3 Hz, J3,4 = 9.3 Hz, H-3), 4.15 (t, 1H, J3,4 = 
J4,5 = 9.3 Hz, H-4), 4.03 (t, 1H, J1,2 = J2,3 = 2.3 Hz, H-2), 3.85 – 3.82 (m, 3H, H-5, H-6a 
and H-6b), 3.81 (s, 3H, OCH3), 2.04 (s, 1H, OH). 
 
13C NMR (CDCl3, 100 MHz): δ 154.97, 149.94 (2 x Carom. quat. OpMP), 138.35, 
138.27, 138.04 (3 x Carom. quat. Ph), 128.40 – 127.62 (15 x CHarom. Ph), 117.65, 
114.58 (4 x CHarom. OpMP), 97.32 (C-1), 79.87 (C-3), 75.21 (CH2Ph), 74.71 (C-2), 
74.52 (C-4), 73.06 (CH2Ph), 72.81 (C-5), 72.41 (CH2Ph), 62.05 (C-6), 55.57 (OCH3). 
 
[α]D20 = +79.3 (c 0.10, CHCl3). 
 
m. p. 79 – 80°C (Cyclohexane/EtOAc). 
 
HRCIMS Calcd for C34H40O7N (M+NH4)+: 574.2805. Found: 574.2808. 
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4-Methoxyphenyl 2,3,4 tri-O-benzyl-7,7-dibromo-6,7-dideoxy-α-D-manno-hept-6-
enopyranoside (265) 
 
 
 
Anhydrous DMSO (1.1 mL, 15.90 mmol) was added dropwise to a solution of oxalyl 
chloride (1.2 mL, 13.80 mmol) in anhydrous CH2Cl2 (80 mL) at –60 °C under argon. 
After 15 minutes, a solution of 263 (5.9 g, 10.60 mmol) in anhydrous CH2Cl2 (60 
mL) was added dropwise. After 40 min, triethylamine (4.5 mL, 31.80 mmol) was 
added and the mixture was let warm up to room temperature. After 30 min, water 
(150 mL) was added and the aqueous layer was extracted with CH2Cl2 (3 × 50 mL). 
The organic layers were combined, dried over MgSO4, filtered and concentrated 
under reduced pressure. The product (yellow oil) was directly engaged in the next 
step: Rf 0.75 (cyclohexane/EtOAc 1:1). 
A solution of CBr4 (7.0 g, 21.11 mmol) in anhydrous CH2Cl2 (60 mL) was added 
dropwise to a solution of PPh3 (11.1 g, 41.93 mmol) in anhydrous CH2Cl2 (60 mL) 
at 0 °C under argon atmosphere. After 20 minutes, a solution of the product of the 
previous step (7.2 g, 10.60 mmol) in anhydrous CH2Cl2 (80 mL) was added 
dropwise and the mixture was let warm up to room temperature. After 1.5 h, water 
(150 mL) was added and the aqueous layer was extracted with CH2Cl2 (3 × 50 mL). 
The organic phase was dried (MgSO4) and concentrated in vacuo. Column 
chromatography (cyclohexane/EtOAc 6:1) of the residue gave 265 (5.1 g, 68% 
over 2 steps) as a white solid.  
 
1H NMR (CDCl3, 400 MHz): δ 7.34 – 7.21 (m, 15H, Harom. Ph), 6.84 (d, 2H, J = 9.1 Hz, 
Harom. OpMP), 6.42 (d, 2H, J = 9.1 Hz, Harom. OpMP), 6.37 (d, 1H, J5,6 = 8.7 Hz, H-6), 
5.24 (d, 1H, J1,2 = 1.8 Hz, H-1), 4.78 (d, 1H, J = 10.8 Hz, CHPh), 4.74 (d, 1H, J = 12.3 
Hz, CHPh), 4.67 (s, 2H, CH2Ph), 4.62 (d, 1H, J = 11.6 Hz, CHPh), 4.60 (d, 1H, J = 11.0 
Hz, CHPh), 4.41 (t, 1H, J4,5 = J5,6 = 9.1 Hz, H-5), 4.04 (dd, 1H, J2,3 = 3.0 Hz, J3,4 = 9.4 
Hz, H-3), 3.82 (t, 1H, J3,4 = J4,5 = 9.6 Hz, H-4), 3.86 (dd, 1H, J1,2 = 1.8 Hz, J2,3 = 3.2 Hz, 
H-2), 3.68 (s, 3H, OCH3). 
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13C NMR (CDCl3, 100 MHz): δ 155.12, 150.01 (2 x Carom. quat. OpMP), 138.33 (Carom. 
quat. Ph), 137.92 (2 x Carom. quat. Ph), 135.67 (C-6), 128.43 – 127.65 (15 x CHarom. 
Ph), 118.08, 114.53 (4 x CHarom. OpMP), 97.53 (C-1), 95.64 (=CBr2), 79.42 (C-3), 
77.50 (C-4), 75.32 (CH2Ph), 74.74 (C-2), 73.12 (CH2Ph), 72.81 (CH2Ph), 72.63 (C-5), 
55.57 (OCH3). 
 
[α]D20 = +66.0 (c 0.10, CHCl3). 
 
m. p. 82 – 83°C (cyclohexane/EtOAc); 
 
HRCIMS Calcd for C35H38O6NBr2 (M+NH4)+: 726.1066 (49.1%), 728.1049 
(100.0%), 730.1038 (55.2%). Found: 726.1050 (52.2%), 728.1039 (100.0%), 
730.1033 (58.5%). 
 
 
4-Methoxyphenyl 2,3,4-tri-O-benzyl-6,7,8-trideoxy-α-D-manno-oct-6-ynopyranoside 
(266) 
 
 
 
A 2.5 M solution of buthyl lithium in hexanes (3.4 mL, 8.48 mmol) was added 
dropwise to a solution of 265 (3.0 g, 4.22 mmol) in anhydrous THF (75 mL) at        
–70 °C under argon and the mixture was let warm up to 0 °C. After 1 h, 
iodomethane (5.3 mL, 84.50 mmol) and HMPA (2.9 mL, 16.90 mmol) were added 
dropwise at –70 °C and then the reaction mixture was allowed to reach room 
temperature. After 18 h, diethyl ether (50 mL) and water (100 mL) were added 
and the aqueous layer was extracted with diethyl ether (3 × 40 mL). The organic 
layers were combined and washed with a saturated solution of CuSO4 (2 x 80 mL). 
The organic phase was dried (MgSO4) and concentrated under reduced pressure. 
Column chromatography (cyclohexane/EtOAc 10:1) of the residue gave 266 (1.9 g, 
79%) as a white foam.  
 
1H NMR (CDCl3, 400 MHz): δ 7.37 – 7.46 (m, 15H, Harom. Ph), 6.98 (d, 2H, J = 9.2 Hz, 
Harom. OpMP), 6.86 (d, 2H, J = 9.2 Hz, Harom. OpMP), 5.45 (d, 1H, J1,2 = 2.0 Hz, H-1), 
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5.02 (d, 1H, J = 10.6 Hz, CHPh), 4.95 (d, 1H, J = 10.6 Hz, CHPh), 4.87 (d, 1H, J = 12.5 
Hz, CHPh), 4.83 (d, 1H, J = 11.7 Hz, CHPh), 4.82 (d, 1H, J = 12.4 Hz, CHPh), 4.74 (d, 
1H, J = 11.7 Hz, CHPh), 4.51 (dq, 1H, J5,8 = 2.0 Hz, J4,5 = 9.3 Hz, H-5), 4.11 (dd, 1H, J4,5 
= 9.3 Hz, J3,4 = 9.4 Hz, H-4), 4.05 (dd, 1H, J2,3 = 3.0 Hz, J3,4 = 9.4 Hz, H-3), 3.97 (dd, 
1H, J1,2 = 2.3 Hz, J2,3 = 2.8 Hz, H-2), 3.82 (s, 3H, OCH3), 1.93 (d, 3H, J5,8 = 2.2 Hz, H-8). 
 
13C RMN (CDCl3, 100 MHz): δ 154.98, 149.99 (2 x Carom. quat. OpMP), 138.47, 
138.42, 138.01 (3 x Carom. quat. Ph), 128.38 – 127.55 (15 x CHarom. Ph), 117.50, 
114.60 (4 x CHarom. OpMP), 97.00 (C-1), 81.74 (C alcyn.), 79.10 (C-4), 76.50 (C 
alcyn.), 78.80 (C-3), 75.50 (CH2Ph), 74.70 (C-2), 72.90 (CH2Ph), 72.80 (CH2Ph), 
63.90 (C-5), 55.60 (OCH3), 3.70 (C-8). 
 
[α]D20 = +66.8 (c 1.00, CHCl3). 
 
HRCIMS Calcd for C36H40O6N (M+NH4)+: 582.2856. Found: 582.2861. 
 
Elemental Analalysis Calcd for C36H36O6: C, 76.57; H, 6.43. Found: C, 76.13; H, 
6.38. 
 
 
2,3,4-Tri-O-benzyl-6,7,8-trideoxy-α-D-manno-oct-6-ynopyrano-1,5-lactone (268) 
 
 
 
To a solution of 266 (1.7 g, 3.08 mmol) in a mixture of H2O/Acetonitrile/Toluene 
(60 mL, 1:1:1), ammonium cerium (IV) nitrate (16.9 g, 30.80 mmol) was added at  
0 °C. After 45 minutes, the reaction mixture was quenched with a saturated 
solution of NaHCO3 (100 mL), and the aqueous layer was extracted with EtOAc (3 × 
40 mL). The organic layers were dried (MgSO4) and concentrated in vacuo. 
Filtration on silica gel (cyclohexane/EtOAc 10:1) of the residue gave the lactol as 
an orange oil (1.0 g, 70%). This product was directly engaged in the next step: Rf 
0.3 (cyclohexane/EtOAc 2:1). 
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The product of the previous step (1.0 g, 2.18 mmol) was dissolved in anhydrous 
CH2Cl2 (100 mL) and molecular sieves 4 Å (1.5 g) were added. After 30 minutes, 
PCC (1.4 g, 6.54 mmol) was added and the reaction mixture was stirred for 1 h. 
Diethyl ether (100mL) was added and the mixture was filtered through a silica gel 
column. Purification by flash column chromatography (cyclohexane/EtOAc 4:1) of 
the residue afforded the lactone 268 (0.8 g, 81%) as a white solid. 
 
1H NMR (CDCl3, 400 MHz): δ 7.44 – 7.26 (m, 15H, Harom. Ph), 5.08 (d, 1H, J = 11.9 
Hz, CHPh), 4.84 (d, 1H, J = 12.3 Hz, CHPh), 4.81 (dq, 1H, J5,8 = 2.2 Hz, J4,5 = 7.0 Hz, H-
5), 4.68 (d, 1H, J = 12.3 Hz, CHPh), 4.63 (d, 1H, J = 11.9 Hz, CHPh), 4.56 (d, 1H, J = 
11.7 Hz, CHPh), 4.51 (d, 1H, J = 11.7 Hz, CHPh), 4.34 (d, 1H, J2,3 = 2.8 Hz, H-2), 4.06 
(dd, 1H, J3,4 = 1.7 Hz, J2,3 = 2.4 Hz, H-3), 3.98 (dd, 1H, J3,4 = 1.2 Hz, J4,5 = 7.2 Hz, H-4), 
1.89 (d, 3H, J5,8 = 2.1 Hz, H-8). 
 
13C NMR (CDCl3, 100 MHz): δ 168.45 (C-1), 137.58, 137.11, 136.75 (3 x Carom. quat. 
Ph), 128.52 – 127.79 (15 x CHarom. Ph), 84.86 (C alcyn.), 80.57 (C-4), 77.15 (C-3), 
74.97 (C-2), 74.20 (C alcyn.), 72.87 (CH2Ph), 72.80 (CH2Ph), 72.50 (CH2Ph), 69.54 
(C-5), 3.67 (C-8). 
 
[α]D20 = +10.9 (c 1.00, CHCl3). 
 
m. p. 94 – 95°C (cyclohexane/EtOAc). 
 
HRCIMS Calcd for C29H32O5N (M+NH4)+: 474.2280. Found: 474.2283. 
 
Elemental Analysis Calcd for C29H28O5: C, 76.30; H, 6.18. Found: C, 76.02; H, 5.99. 
 
 
2,6-Anhydro-3,4,5-tri-O-benzyl-1,7,8,9-tetradeoxy-1,1-difluoro-D-manno-non-1-en-7-
ynitol (269) 
 
 
 
To a solution of 268 (107 mg, 0.24 mmol) in anhydrous THF (10 mL), cooled at      
–20 °C, was added CBr2F2 (110 μL, 1.19 mmol) using a cooled syringe. To the 
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vigorously stirred solution was added HMPT (213 μL, 1.19 mmol), and a dense 
white precipitate was formed immediately. The reaction mixture was stirred at    
10 °C for 30 min, and then HMPT (640 μL, 3.75 mmol) was added and the mixture 
allowed to reach room temperature. After 1 h diethyl ether (10 mL) was added and 
the mixture washed with a saturated solution of CuSO4 (3 × 10 mL). The organic 
phase was dried (MgSO4), filtered and concentrated under reduced pressure. 
Column chromatography (cyclohexane/EtOAc 6:1) of the residue gave 269 (103 
mg, 89%) as a white solid. 
 
1H NMR (CDCl3, 400 MHz): δ 7.45 – 7.30 (m, 15H, Harom. Ph), 4.97 (s, 2H, CH2Ph), 
4.79 (d, 1H, J = 12.6 Hz, CHPh), 4.63 (d, 1H, J = 11.9 Hz, CHPh), 4.59 (d, 1H, J = 11.9 
Hz, CHPh), 4.38 (d, 1H, J = 12.6 Hz, CHPh), 4.17 – 4.12 (m, 2H, H-4 and H-5), 4.35 
(dd, 1H, J2,3 = 3.0 Hz, H-2), 3.55 – 3.49 (dd, 1H, J2,3 = 3.0 Hz, J3,4 = 9.1 Hz, H-3), 1.96 
(br s, 3H, H-8). 
 
13C NMR (CDCl3, 100 MHz): δ 153.91 (dd, 1JC,F = 282.3 Hz, 1JC,F’ = 295.7 Hz, CF2), 
138.24, 137.80, 137.28 (3 x Carom. quat. Ph), 128.34 – 127.68 (15 x CHarom. Ph), 
111.75 (dd, 2JC,F = 13.7 Hz, 2JC,F’ = 41.3 Hz, C-1), 83.43 (C alcyn.), 80.17 (dd, 4JC,F = 1.4 
Hz, 4JC,F’ = 3.0 Hz, C-3), 78.26 (C-4), 75.91 (CH2Ph), 75.38 (C alcyn.), 72.49 (t, 4JC,F = 
2.2 Hz, C-5), 71.76 (CH2Ph), 69.87 (CH2Ph), 67.61 (t, 3JC,F = 2.9 Hz, C-2), 3.74 (C-8). 
 
19F NMR (CDCl3, 235 MHz): δ –111.76 (dd, 1F, J2,F = 2.4 Hz, JF,F’ = 61.2 Hz), –96.01 
(dd, J2,F = 2.4 Hz, JF,F’ = 61.2 Hz).  
 
[α]D20 = +27.2 (c 0.10, CHCl3). 
 
m. p. 133 – 134°C (cyclohexane/EtOAc). 
 
HRCIMS Calcd for C30H32F2O4N (M+NH4)+: 508.2299. Found: 508.2302. 
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Hexacarbonyldicobalt complex of 2,6-Anhydro-3,4,5-tri-O-benzyl-1,7,8,9-tetradeoxy-
1,1-difluoro-D-manno-non-1-en-7-ynitol (270) 
 
 
 
Co2(CO)8 (50.0 mg, 0.15 mmol) was added to a solution of difluoroalkene 269 
(50.0 mg, 0.10 mmol) in anhydrous CH2Cl2 (6 mL) under argon. After stirring at 
room temperature for 1 h, TLC (cyclohexane/EtOAc 4:1) indicated the complete 
complexation of the starting material. The reaction mixture was concentrated 
under reduced pressure. Flash column chromatography (cyclohexane/EtOAc 6:1) 
afforded 270 (77.6 mg, 100%) as a brown oil. 
 
1H NMR (CDCl3, 400 MHz): δ 7.44 – 7.29 (m, 15H, Harom. Ph), 5.33 (d, 1H, J = 11.3 
Hz, CHPh), 4.77 (d, 1H, J = 12.5 Hz, CHPh), 4.69 (d, 1H, J = 11.3 Hz, CHPh), 4.63 (d, 
1H, J = 11.5 Hz, CHPh), 4.57 (d, 1H, J4,5 = 9.1 Hz, H-5), 4.49 (d, 1H, J = 11.5 Hz, 
CHPh), 4.46 (d, 1H, J2,3 = 3.1 Hz, H-2), 4.40 (d, 1H, J = 12.5 Hz, CHPh), 4.01 (t, 1H, J3,4 
= J4,5 = 9.1 Hz, H-4), 3.84 (dd, 1H, J2,3 = 3.1 Hz, J3,4 = 9.1 Hz, H-3), 2.49 (s, 3H, H-8). 
 
13C NMR (CDCl3, 100 MHz): δ 199.97, 199.94, 199.89, 199.67, 199.60, 199.58 (6 x 
C=O, Co2(CO)6), 154.16 (dd, 1JC,F = 282.3 Hz, 1JC,F’ = 295.2 Hz, CF2), 138.67, 137.29, 
137.19 (3 x Carom. quat. Ph), 128.45 – 127.17 (15 x CHarom. Ph), 111.83 (dd, 2JC,F = 
12.5 Hz, 2JC,F’ = 40.9 Hz, C-1), 94.44 (C alcyn.), 92.25 (C alcyn.), 81.99 (dd, 4JC,F = 1.4 
Hz, 4JC,F’ = 3.3 Hz, C-3), 81.62 (t, 4JC,F = 2.0 Hz, C-5), 78.62 (C-4), 74.14 (CH2Ph), 
70.98 (CH2Ph), 69.58 (CH2Ph), 66.92 (t, 3JC,F = 3.1 Hz, C-2), 20.92 (C-8).  
 
19F NMR (CDCl3, 235 MHz): δ –113.27 (dd, 1F, J2,F  = 2.3 Hz, JF,F’ = 61.8 Hz), –98.18 
(dd, J2,F = 2.3 Hz, JF,F’ = 61.8 Hz). 
 
CIMS (M+NH4)+: m/z 912. 
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2,6-Anhydro-3,5-di-O-benzyl-1,7,8,9-tetradeoxy-1,1-difluoro-D-manno-non-1-en-7-
ynitol (275) 
 
 
 
A 1 M solution in toluene of TIBAL (1.3 mL, 1.30 mmol) was added dropwise to a 
solution of 270 (125 mg, 0.26 mmol) in anhydrous CH2Cl2 (10 mL) at –78 °C under 
argon. After 1 h, TIBAL (0.8 mL, 0.78 mmol) was added dropwise and the reaction 
mixture allowed to reach rt and then heated at 40 °C during 1 h. The reaction was 
quenched by addition of water (4 mL) and extracted with CH2Cl2 (2 x 10 mL). The 
organic layers were combined, dried over MgSO4, filtered and concentrated under 
reduced pressure. The product was directly engaged in the next step without 
further purification. To a solution of the product of the previous step in acetone 
(20 mL) was added Et3N (35.0 μL, 0.26 mmol) followed by CAN (700 mg, 1.30 
mmol). After 1h the TLC indicated no trace of the starting material. The reaction 
mixture was then concentrated and purified by flash column chromatography 
(cyclohexane/EtOAc 10:1) to yield 275 (17 mg, 16%) as a pale yellow oil. 
 
1H NMR (CDCl3, 400 MHz): δ 7.46 – 7.30 (m, 10H, Harom. Ph), 4.99 (d, 1H, J = 10.9 
Hz, CHPh), 4.92 (d, 1H, J = 10.9 Hz, CHPh), 4.72 (d, 1H, J = 11.6 Hz, CHPh), 4.39 (d, 
1H, J = 11.6 Hz, CHPh), 4.38 (dd, 1H, J2,3 = 3.2 Hz, J2,F = 6.9 Hz, H-2), 4.12 (dq, 1H, J5,8 
= 2.1 Hz, J4,5 = 9.3 Hz, H-5), 3.69 (dd, 1H, J2,3 = 3.2 Hz, J3.4 = 9.3 Hz, H-3), 3.85 (t, 1H, 
J3.4 = J4.5 = 9.3 Hz, H-4), 1.96 (d, 1H, J5,8 = 2.1 Hz, H-8). 
 
13C NMR (CDCl3, 100 MHz): δ 154.15 (dd, 1JC,F’ = 278.7 Hz, 1JC,F = 296.1 Hz, CF2) 
138.03, 136.88 (2 x Carom. quat. Ph), 128.55 – 127.86 (10 x CHarom. Ph), 111.68 (dd, 
2JC,F = 13.2 Hz, 2JC,F = 40.9 Hz, C-1), 83.91 (C alcyn.), 79.58 (C-4), 75.57 (CH2Ph), 
75.23 (C alcyn.), 73.10 (t, 4JC,F = 1.2 Hz, C-5), 72.27 (t, 3JC,F = 2.0 Hz, C-3), 70.83 (t, 
3JC,F = 3.1 Hz, C-2), 70.41 (CH2Ph), 3.71 (C-8). 
 
19F NMR (CDCl3, 235 MHz): δ –111.64 (dd, 1F, J2,F = 2.4 Hz, JF,F’ = 58.8 Hz), –95.22 
(dd, 1F, J2,F = 2.4 Hz, JF,F’ = 58.8 Hz). 
 
[α]D20 = –4.3 (c 0.35, CHCl3). 
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HRCIMS Calcd for C23H23O4F2 (M+CH4)+: 401.1564. Found: 401.1562. 
 
 
2,6-Anhydro-3,5-di-O-benzyl-4-O-(trichloroacetyl)carbamoyl-1,7,8,9-tetradeoxy-1,1-
difluoro-D-manno-non-1-en-7-ynitol (276) 
 
 
 
Trichloroacetyl isocianate (1 drop) was directly added to the NMR tube containing 
a solution of 275 in CDCl3. The tube was manually shaken during 1 minute and 
then another NMR was recorded. 
 
1H NMR (CDCl3, 400 MHz): δ 7.38 – 7.30 (m, 10H, Harom. Ph), 4.99 (d, 1H, J = 11.3 
Hz, CHPh), 4.87 (dd, 1H, J2,3 = 3.4 Hz, J3.4 = 9.6 Hz, H-3), 4.78 (d, 1H, J = 11.3 Hz, 
CHPh), 4.69 (d, 1H, J = 11.8 Hz, CHPh), 4.64 (dd, 1H, J2,3 = 3.4 Hz, J2,F = 6.4 Hz, H-2), 
4.31 (d, 1H, J = 11.8 Hz, CHPh), 4.26 (dq, 1H, J5,8 = 2.1 Hz, J4,5 = 9.6 Hz, H-5), 4.16 (t, 
1H, J3.4 = J4.5 = 9.3 Hz, H-4), 1.98 (d, 1H, J5,8 = 2.1 Hz, H-8). 
 
 
Rearrangement of 269 into 2,3,4-tri-O-benzyl-6,7,8-trideoxy-5a-difluoro-5a-carba-α-
D-manno-oct-6-ynopyranose (280) and 2,3,4-tri-O-benzyl-6,7,8-trideoxy-5a-difluoro-
5a-carba-β-D-manno-oct-6-ynopyranose (281) 
 
 
 
Co2(CO)8 (50.0 mg, 0.15 mmol) was added to a solution of difluoroalkene 269 
(50.0 mg, 0.10 mmol) in anhydrous CH2Cl2 (6 mL) under argon. After stirring at 
room temperature for 1 h, TLC (cyclohexane/EtOAc 4:1) indicated no trace of 
starting material. A 1 M solution in toluene of TIBAL (1.5 mL, 1.50 mmol) was 
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added dropwise over a period of 30 min. After 1 h the mixture was diluted with 
CH2Cl2 (15 mL) and washed with a saturated solution of NaHCO3 (10 mL) (an 
emulsion appeared). The organic phase was filtered through a pad of celite® and 
rewashed with a saturated solution of NaHCO3. The organic phase was dried 
(MgSO4), filtered and concentrated under reduced pressure. The crude product 
was dissolved in acetone (10 mL) and Et3N (14.0 μL, 0.10 mmol) and CAN (550.0 
mg, 1.0 mmol) were added. After stirring at room temperature for 1 h, TLC 
(cyclohexane/EtOAc 4:1) indicated completion of the reaction and the formation of 
2 products. The mixture was concentrated in vacuo and chromatographed 
(cyclohexane/EtOAc 8:1) to afford 280 (20.6 mg, 41%) and 281 (8.3 mg, 17%) as a 
colorless oils. 
 
2,3,4-Tri-O-benzyl-6,7,8-trideoxy-5a-difluoro-5a-carba-α-D-manno-oct-6-
ynopyranose (280) 
 
1H NMR (CDCl3, 400 MHz): δ 7.41 – 7.30 (m, 15H, Harom. Ph), 4.87 (d, 1H, J = 10.8 Hz, 
CHPh), 4.78 (d, 1H, J = 10.7 Hz, CHPh), 4.75 (d, 1H, J = 11.8 Hz, CHPh), 4.72 (d, 1H, J 
= 12.0 Hz, CHPh), 4.69 (d, 1H, J = 12.1 Hz, CHPh), 4.59 (d, 1H, J = 11.9 Hz, CHPh), 
4.26 – 4.21 (m, 1H, H-1), 4.08 (t, 1H, J3,4 = J4,5 = 8.0 Hz, H-4), 3.94 – 3.91 (m, 1H, H-
2), 3.85 (dd, 1H, J2,3 = 3.2 Hz, J3,4 = 7.9 Hz, H-3), 3.34 (ddq, 1H, J5,8 = 2.3 Hz, J4,5 = 8.8 
Hz, J5,Fax = 23.1Hz, H-5), 2.27 (t, 1H, J = 1.5 Hz, OH), 1.85 (d, 3H, J5,8 = 2.4 Hz, H-8). 
 
13C NMR (CDCl3, 100 MHz): δ 138.30, 138.17, 137.95 (3 x Carom. quat. Ph), 128.51 – 
127.59 (15 x CHarom. Ph), 120.42 (t, 1JC,F = 250.6 Hz, CF2), 80.16 (C alcyn.), 78.34, 
77.26, 75.91 (C-2, C-3, C-4), 74.84 (C alcyn.), 72.93 (2 x CH2Ph), 72.86 (CH2Ph), 
68.77 (t, 2JC,F = 24.4 Hz, C-1), 38.96 (t, 2JC,F = 21.8 Hz, C-5), 3.65 (C-8). 
 
19F NMR (CDCl3, 235 MHz): δ –108.35 (d, 1F, JF,F’ = 255.1 Hz), –105.60 (d, 1F, JF,F’ = 
259.6 Hz). 
 
[α]D20 = +15.2 (c 0.50, CHCl3). 
 
HRCIMS Calcd for C30H34F2O4N (M+NH4)+: 510.2456. Found: 510.2449. 
 
 
 
 
 
Experimental Part 
139 
2,3,4-Tri-O-benzyl-6,7,8-trideoxy-5a-difluoro-5a-carba-β-D-manno-oct-6-
ynopyranose (281) 
 
1H NMR (CDCl3, 400 MHz): δ 7.41 – 7.29 (m, 15H, Harom.), 5.12 (d, 1H, J = 11.7 Hz, 
CHPh), 4.93 (d, 1H, J = 10.4 Hz, CHPh), 4.85 (d, 1H, J = 11.9 Hz, CHPh), 4.84 (d, 1H, J 
= 10.3 Hz, CHPh), 4.75 (d, 1H, J = 11.8 Hz, CHPh), 4.64 (d, 1H, J = 11.7 Hz, CHPh), 
4.08 (t, 1H, J3,4 = J4,5 = 9.4 Hz, H-4), 4.02 (br d, 1H, J = 3.0 Hz, H-2), 3.74 – 3.66 (m, 
1H, H-1), 3.54 (dd, 1H, J2,3 = 2.5, J3,4 = 9.1 Hz, H-3), 2.95 – 2.86 (m, 2H, H-5 and OH), 
1.88 (d, 3H, J5,8 = 2.3 Hz, H-8). 
 
13C NMR (CDCl3, 100 MHz): δ 138.56, 138.54, 138.45 (3 x Carom. quat.), 128.94 – 
127.92 (15 CHarom. Ph), 81.79 (C-3), 81.09 (C alcyn.), 78.34, 77.95 (C-2, C-4), 76.12 
(C alcyn.), 75.42 (CH2Ph), 74.13 (2 CH2Ph), 70.65 (br s, C-1), 4.13 (C-8). 
 
19F NMR (CDCl3, 235 MHz): δ –116.21 (br s, 1F), –102.13 (d, 1F, JF,F’ = 248.4 Hz). 
 
[α]D20 = +18.5 (c 0.40, CHCl3). 
 
HRCIMS Calcd for C30H31F2O4 (M+H)+: 493.2190. Found: 493.2181. 
 
 
2,3,4-Tri-O-benzyl-5a-difluoro-5a-carba-α-D-mannopyranose (287) 
 
 
 
Lindlar’s catalyst (2 mg) was added to a solution of 280 (8.0 mg, 0.02 mmol) in 
EtOAc (1 mL). Three purges of vacuum/argon were performed, followed by 5 
purges of vacuum/H2. After stirring for 2 h at room temperature under hydrogen 
(ca. 2 atm), the mixture was filtered through a Rotilabo® Nylon 0.45 μm filter, the 
solvent evaporated and the product was directly engaged in the next step. Ozone 
gas was bubbled through a solution of the product of the previous step (8.0 mg, 
0.02 mmol) in CH2Cl2 (15 mL) at –78 °C until the solution obtained a blue/violet 
colouration. Oxygen was then bubbled through the solution for 1 min and then 
DMS (3 drops) was added. The solution was allowed to warm to room temperature 
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over a period of 30 min and the solvent was removed in vacuo. The product 
obtained was dissolved in a mixture of ethanol/CH2Cl2 (3.5 mL, 5:1) and NaBH4 
(2.0 mg, 0.05 mmol) was added carefully. After stirring for 45 min at room 
temperature, TLC (cyclohexane/EtOAc 2:1) showed no trace of starting material. 
Methanol (10 mL) was added, the solvent removed, the residue co-evaporated with 
methanol (3 x 10 mL), and then purified by flash column chromatography 
(cyclohexane/EtOAc 3:1) to yield 287 (3.0 mg, 38%) as a colorless oil. 
  
1H NMR (CDCl3, 400 MHz): δ 7.37 – 7.29 (m, 15H, Harom. Ph), 4.84 (d, 1H, J = 11.2 
Hz, CHPh), 4.73 – 4.64 (m, 5H, 5 x CHPh), 4.16 – 4.12 (m, 1H, H-1), 4.10 (t, 1H, J3,4 = 
J4,5 = 8.1 Hz, H-4), 3.97 – 3.94 (m, 4H, H-2, H-3, H-6a and H-6b), 2.56 – 2.45 (m, 2H, 
H-5 and OH), 2.31 (br s, 1H, OH). 
 
13C NMR (CDCl3, 100 MHz): δ 138.32, 138.27, 138.25 (3 x Carom. quat. Ph), 128.96 – 
128.18 (15 x CHarom. Ph), 123.30 (dd, 1JC,F = 245.3 Hz, 1JC,F’ = 248.7 Hz, CF2), 79.50 
(C-3), 76.94 (dd, 3JC,F = 1.9 Hz, 3JC,F’ = 6.3 Hz, C-4), 76.36 (br s, C-2), 74.75 (CH2Ph), 
73.60 (CH2Ph), 73.54 (CH2Ph), 69.94 (dd, 2JC,F = 22.0 Hz, 2JC,F’ = 26.8 Hz, C-1), 59.80 
(t, 3JC,F = 4.5 Hz, C-6), 46.98 (t, 2JC,F = 20.1 Hz, C-5). 
 
19F NMR (CDCl3, 235 MHz): δ –109.84 (d, 1F, JFax,Feq = 258.2 Hz), –103.28 (d, 1F, 
JFax,Feq = 258.2 Hz). 
 
[α]D20 = +8.3 (c 0.23, CHCl3). 
 
HRCIMS Calcd for C28H34O5NF2 (M+NH4)+: 502.2405. Found: 502.2426. 
 
 
2,3,4-Tri-O-benzyl-5a-difluoro-5a-carba-β-D-mannopyranose (289) 
 
 
 
Lindlar’s catalyst (2.0 mg) was added to a solution of 281 (9.5 mg, 0.02 mmol) in 
EtOAc (3 mL). Three purges of vacuum/argon were performed, followed by 5 
purges of vacuum/H2. After stirring for 2 h at room temperature under hydrogen 
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(2 atm), the mixture was filtered through a Rotilabo® Nylon 0.45 μm filter, the 
solvent evaporated and the product was directly engaged in the next step. Ozone 
gas was bubbled through a solution of the product of the previous step (9.9 mg, 
0.02 mmol) in CH2Cl2 (15 mL) at –78 °C until the solution obtained a blue/violet 
coloration. Oxygen was then bubbled through the solution for 1 min and then DMS 
(2 drops, until the blue colour disappear) was added. The solution was allowed to 
warm to room temperature over a period of 30 min and the solvent was removed 
under reduced pressure. The product obtained was dissolved in a mixture of 
ethanol/CH2Cl2 (5.0 mL, 4:1) and NaBH4 (5.0 mg, 0.05 mmol) was added carefully. 
After stirring for 30 min at room temperature, TLC (cyclohexane/EtOAc 2:1) 
showed no trace of starting material. Methanol (10 mL) was added, the solvent 
removed, the residue co-evaporated with methanol (3 x 10 mL), and then purified 
by flash column chromatography (cyclohexane/EtOAc 5:1) to yield 289 (6.0 mg, 
62%) as a colorless oil. 
 
1H NMR (CDCl3, 400 MHz): δ 7.40 – 7.29 (m, 15H, Harom. Ph), 5.14 (d, 1H, J = 11.7 
Hz, CHPh), 5.01 (d, 1H, J = 10.7 Hz, CHPh), 4.83 (d, 1H, J = 11.7 Hz, CHPh), 4.79 (d, 
1H, J = 11.7 Hz, CHPh), 4.77 (d, 1H, J = 10.7 Hz, CHPh), 4.65 (d, 1H, J = 11.7 Hz, 
CHPh), 4.22 (t, 1H, J3,4 = J4,5 = 10.1 Hz, H-4), 4.08 (br d, 1H, J1,2 = J2,3 = 3.3 Hz, H-2) 
4.05 – 4.02 (m, 2H, H-6a, H-6b), 3.75 – 3.64 (m, 1H, H-1), 3.64 (dd, 1H, J2,3 = 2.5 Hz, 
J3,4 = 9.4 Hz, H-3), 2.81 (d, 1H, J1,OH = 11.2 Hz, OH), 2.23 (br s, 1H, OH), 1.99 (ddt, 1H, 
J = 4.5 Hz, J4,5 = 10.1 Hz, J5,Fax = 28.2 Hz, H-5). 
 
13C NMR (CDCl3, 100 MHz): δ 138.50, 138.12, 138.02 (3 x Carom. quat. Ph), 129.05 – 
127.93 (15 x CHarom. Ph), 122.07 (t, 1JC,F = 247.4 Hz, CF2), 83.22 (d, 4JC,F = 1.5 Hz, C-
3), 76.89 (d, 3JC,F = 9.2 Hz, C-2), 76.47 (d, 3JC,F = 8.7 Hz, C-4), 76.02 (CH2Ph), 75.61 
(CH2Ph), 73.79 (CH2Ph), 70.77 (dd, 2JC,F = 19.4 Hz, 2JC,F’ = 23.5 Hz, C-1), 58.73 (dd, 
3JC,F = 3.6 Hz, 3JC,F = 4.8 Hz, C-6), 48.42 (t, 2JC,F = 20.4 Hz, C-5). 
 
19F NMR (CDCl3, 235 MHz): δ –120.13 (d, 1F, JFeq,Fax = 251.3 Hz), –103.76 (d, 1F, 
JFeq,Fax = 251.9 Hz). 
 
[α]D20 = +12.6 (c 0.31, CHCl3). 
 
HRFABMS Calcd for C28H30O5F2Na (M+Na)+: 507.1959. Found: 507.1960. 
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5a-Difluoro-5a-carba-α-D-mannopyranose (290) 
 
 
 
10% Pd/C (2.0 mg) was added to a solution of 287 (3.0 mg, 4 μmol) in MeOH (1 
mL). Three purges of vacuum/argon were performed, followed by 5 purges of 
vacuum/H2. After stirring for 2 h at room temperature under hydrogen (ca. 2 atm), 
the mixture was filtered through a Rotilabo® Nylon 0.45 μm filter and the solvent 
evaporated to afford the gem-difluorocarba-α-D-mannopyranose 290 (0.8 mg, 
100%). 
 
1H NMR (CD3OD, 400 MHz): δ 4.01 – 3.96 (m, 3H, H-2, H-6a, H-6b), 3.91 – 3.84 (m, 
2H, H-1 and H-4), 3.78 (dd, 1H, J2,3 = 3.5 Hz, J3,4 = 8.7 Hz, H-3), 2.27 (dddt, 1H, J5,6a = 
J5,6b = 5.0 Hz, J5,Feq = 6.3 Hz, J4,5 = 9.7 Hz, J5,Fax = 25.8 Hz, H-5). 
 
13C NMR (CD3OD, 100 MHz): δ 123.25 (t, 1JC,F = 247.0 Hz, CF2), 72.47 (C-3), 71.97 
(d, 3JC,F = 5.9 Hz, C-2), 71.36 (dd, 2JC,F = 21.9 Hz, 2JC,F’ 28.2 Hz, C-1), 69.47 (d, 3JC,F = 
7.8 Hz, C-4), 58.19 (dd, 3JC,F = 3.5 Hz, 3JC,F’ = 4.7 Hz, C-6), 47.05 (t, 2JC,F = 19.7 Hz, C-
5). 
 
19F NMR (CD3OD, 235 MHz): δ –111.80 (ddd, 1F, J = 6.0 Hz, J5,Fax = 25.8 Hz, JFeq,Fax = 
260.1 Hz, Fax), –106.35 (dd, 1F, J5,Feq = 5.9 Hz, JFeq,Fax = 260.9 Hz, Feq). 
 
[α]D20 = –4.4 (c 0.27, MeOH). 
 
HRCIMS Calcd for C7H16O5NF2 (M+NH4)+: 232.0997. Found: 232.0991. 
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5a-Difluoro-5a-carba-β-D-mannopyranose (291) 
 
 
 
10% Pd/C (3.0 mg) was added to a solution of 289 (6.0 mg, 12.00 μmol) in MeOH 
(3 mL). Three purges of vacuum/argon were performed, followed by 5 purges of 
vacuum/H2. After stirring for 6 h at room temperature under hydrogen (2 atm), 
the mixture was filtered through a Rotilabo® Nylon 0.45 μm filter and the solvent 
evaporated to afford the gem-difluorocarba-α-D-mannopyranose 291 (2.7 mg, 
100%). 
 
1H NMR (D2O, 400 MHz): δ 4.09 – 4.06 (m, 1H, H-2) 3.99 – 3.84 (m, 3H, H-1, H-6a, 
H-6b), 3.68 (t, 1H, J3,4 = J4,5 = 10.4 Hz, H-4), 3.54 (dd, 1H, J2,3 = 3.2 Hz, J3,4 = 9.9 Hz, H-
3), 1.91 (br d, 1H, J5,Fax = 28.4 Hz, H-5). 
 
13C NMR (D2O, 100 MHz): δ 122.82 (t, 1JC,F = 249.7 Hz, CF2), 73.08 (d, 4JC,F = 1.8 Hz, 
C-3), 71.25 (d, 3JC,F = 9.1 Hz, C-2), 69.81 (dd, 2JC,F = 18.0 Hz, 2JC,F’ = 21.3 Hz, C-1), 
67.46 (d, 3JC,F = 9.7 Hz, C-4), 56.43 (dd, 3JC,F = 1.8 Hz, 3JC,F’ = 4.8 Hz, C-6), 47.50 (t, 2JC,F 
= 19.9 Hz, C-5). 
 
19F NMR (D2O, 235 MHz): δ –120.86 (ddd, 1F, J1,Fax = 23.1 Hz, J5,Fax = 28.8 Hz, JFeq,Fax 
= 247.6 Hz, Fax), –104.37 (dq, 1F, J5,Feq = J1, Feq = 5.5 Hz, JFeq,Fax = 247.6 Hz, Feq). 
 
[α]D20 = –9.1 (c 0.22, MeOH). 
 
HRCIMS Calcd for C7H13O5F2 (M+H)+: 215.0731. Found: 215.0728. 
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1,2,3,4,6-Penta-O-acetyl-D-galactopyranose (293a,b) 
 
 
 
Commercial D-(+)-galactose (20.0 g, 0.11 mol) was dissolved in pyridine (250mL) 
and acetic anhydride (79.0 mL, 0.77 mmol) was added dropwise.  The reaction was 
stirred overnight at room temperature. The solvent was removed under reduced 
pressure in the presence of toluene, and the residue puriﬁed by flash column 
chromatography (cyclohexane/EtOAc, 3:2) to yield compound 293a,b[202] in a 
quantitative yield, as a 5:2 mixture of α- and β-anomer.  
 
extracted data for α anomer: 
 
1H NMR (CDCl3, 250 MHz): δ 6.35 (d, 1H, J1,2 = 2.2 Hz, H-1), 5.44 (dd, 1H, J4,5 = 1.0 
Hz, J3,4 = 3.5 Hz, H-4), 5.37 – 5.31 (m, 2H, H-2, H-3), 4.37 – 4.32 (m, 1H, H-5), 4.14 – 
4.08 (m, 2H, H-6a, H-6b), 2.16 (s, 6H, 2 x OAc), 2.10 (s, 3H, OAc), 2.07 (s, 6H, 2 x 
OAc). 
 
extracted data for β anomer:  
 
1H NMR (CDCl3, 250 MHz): δ 5.70 (d, 1H, J1,2 = 8.4 Hz, H-1), 5.42 (app d, 1H, J3,4 = 
3.2 Hz, H-4), 5.35 (t, 1H, J1,2 = J2,3 = 8.4 Hz, H-2), 5.08 (dd, 1H, J3,4 = 3.2 Hz, J2,3 = 8.4 
Hz, H-3), 4.18 – 4.04 (m, 3H, H-5, H-6a, H-6b), 2.16 (s, 3H, OAc), 2.12 (s, 3H, OAc), 
2.04 (s, 6H, 2 x OAc), 1.99 (s, 3H, OAc). 
 
 
4-Methoxyphenyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (294a) and                
4-methoxyphenyl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside (294b) 
 
 
 
BF3.Et2O (8.0 mL, 63.4 mmol) was added to a stirred mixture of p-methoxyphenol 
(7.9 g, 63.4 mmol) and pentaacetate 293a,b (16.5 g, 42.3 mmol) dissolved in 
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anhydrous CH2Cl2 (250 mL) at 0 °C under argon. The reaction mixture was allowed 
to reach room temperature and stirred for 6 h, then quenched with a saturated 
solution of NaHCO3 (100 mL) and stirred for 15 min. The mixture was washed with 
a saturated solution of NaHCO3 (2 x 100 mL) and with a 1 M solution of HCl (100 
mL). The organic phase was dried (MgSO4), filtered and the solvent evaporated in 
vacuo. Flash column chromatography (cyclohexane/EtOAc, 5:1) afforded the 
tetraacetates 294a and 294b[203] (21.9 g, 76%) as a 2:1 mixture of anomers in 
favor of β.  
 
extracted data for α anomer: 
 
1H NMR (CDCl3, 250 MHz): δ 6.99 (d, 2H, J = 9.1 Hz, Harom. OpMP), 6.83 (d, 2H, J = 
9.1 Hz, Harom. OpMP), 5.66 (d, 1H, J1,2 = 3.5 Hz, H-1), 5.58 – 5.53 (m, 2H, H-3 and H-
4), 5.27 (dd, 1H, J1,2 = 3.5 Hz, J2,3 = 10.6 Hz, H-2), 4.40 (t, 1H, J5,6a = J5,6b = 6.5 Hz, H-
5), 4.15 – 4.09 (m, 2H, H-6a, H-6b), 3.77 (s, 3H, OCH3), 2.17 (s, 3H, OAc), 2.09 (s, 3H, 
OAc), 2.03 (s, 3H, OAc), 1.98 (s, 3H, OAc). 
 
extracted data for β anomer: 
 
1H NMR (CDCl3, 250 MHz): δ 6.97 (d, 2H, J = 9.1 Hz, Harom. OpMP), 6.84 (d, 2H, J = 
9.1 Hz, Harom. OpMP), 5.53 (dd, 1H, J1,2 = 7.8 Hz, J2,3 = 10.2 Hz, H-2), 5.47 (dd, 1H, J4,5 
= 1.0 Hz, J3,4 = 3.3 Hz, H-4), 5.06 (dd, 1H, J3,4 = 3.3 Hz, J2,3 = 10.2 Hz, H-3), 4.92 (d, 
1H, J1,2 = 7.8 Hz, H-1), 4.20 (dd, 1H, J5,6a = 6.9 Hz, J6a,6b = 11.5 Hz, H-6a), 4.12 (dd, 1H, 
J5,6b = 6.3 Hz, J6a,6b = 11.5 Hz, H-6b), 4.03 – 4.01 (m, 1H, H-5), 3.79 (s, 3H, OCH3), 
2.20 (s, 3H, OAc), 2.10 (s, 3H, OAc), 2.06 (s, 3H, OAc), 1.99 (s, 3H, OAc). 
 
CIMS (M+NH4)+: m/z 472. 
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4-Methoxyphenyl 2,3,4-tri-O-benzyl-α-D-galactopyranoside (298) and 4-
methoxyphenyl 2,3,4-tri-O-benzyl-β-D-galactopyranoside (299) 
 
 
 
To a solution of 4-methoxyphenyl 2,3,4,6-tetra-O-acetyl-D-galactopyranoside 
(294a,b) (10.0 g, 22.0 mmol) in methanol (300 mL), was added a 1 M solution of 
NaOMe previously prepared until the pH of the reaction mixture reached the value 
of 10. After 5 h the mixture was neutralized with acid resin Amberlite® IR 120 (H+), 
filtered and concentrated under reduced. The product obtained was directly 
engaged in the step.  
To a solution of 4-methoxyphenyl D-galactopyranoside in dry pyridine (150 mL) 
was added chlorotriphenylmethane (9.2 g, 33.0 mmol) and the resulting mixture 
stirred for 21 h at 50 °C. The reaction mixture was concentrated in vacuo 
(azeotroped with toluene) and the yellow residue obtained was dissolved in CH2Cl2 
(200 mL) and washed with a saturated solution of NH4Cl (3 x 50 mL). The organic 
phase was dried over MgSO4, filtered and concentrated. The product obtained was 
used without further purification. 
NaH (5.3 g, 132.0 mmol, 60% w/w) was added to a solution of the product of the 
previous step (11.6 g, 22.0 mmol) in DMF (150 mL) at 0 °C, and after 15 min BnBr 
(15.7 mL, 132.0 mmol) was added. After stirring for overnight at room 
temperature, the reaction mixture was quenched with MeOH (50 mL) and 
concentrated under reduced pressure. The crude product was dissolved in diethilic 
ether (300 mL) and washed with water (150 mL). The aqueous phase was 
extracted with ether (3 x 200 mL). The organic layers were combined, dried 
(MgSO4), filtered and concentrated in vacuo. The product obtained (yellow oil) was 
directly engaged in the next step.  
p-Toluenosulfonic acid (2.0 g, 11.0 mmol) was added to a solution of the product of 
the previous step in a 1:1 mixture of CH2Cl2/MeOH (300 mL). After 4 h, the 
reaction mixture was neutralized by dropwise addition of Et3N and concentrated 
under reduced pressure. Flash column chromatography (cyclohexane/EtOAc 3:1) 
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of the residue gave 298 (5.0 g, 41 % over 4 steps) as a white solid and 299 (4.4 g, 
36 % over 4 steps) as a white solid. 
 
4-Methoxyphenyl 2,3,4-tri-O-benzyl-α-D-galactopyranoside (298) 
 
1H NMR (CDCl3, 400 MHz): δ 7.48 – 7.30 (m, 15H, Harom. Ph), 7.03 (d, 2H, J = 9.1 Hz, 
Harom. OpMP), 6.85 (d, 2H, J = 9.1 Hz, Harom. OpMP), 5.46 (d, 1H, J1,2 = 3.5 Hz, H-1), 
5.06 (d, 1H, J = 11.6 Hz, CHPh), 5.00 (d, 1H, J = 11.7 Hz, CHPh), 4.91 (d, 1H, J = 11.9 
Hz, CHPh), 4.87 (d, 1H, J = 11.7 Hz, CHPh), 4.78 (d, 1H, J = 11.9 Hz, CHPh), 4.72 (d, 
1H, J = 10.6 Hz, CHPh), 4.25 (dd, 1H, J1,2 = 3.5 Hz, J2,3 = 10.0 Hz, H-2), 4.20 (dd, 1H, 
J3,4 = 2.6 Hz, J2,3 = 10.0 Hz, H-3), 4.03 (app. dd, 1H, J4,5 = 0.9 Hz, J3,4 = 2.6 Hz, H-4), 
4.00 – 3.97 (m, 1H, H-5), 3.81 (s, 3H, OCH3), 3.73 (dd, 1H, J5,6a = 5.4 Hz, J6a,6b = 11.3 
Hz, H-6a), 3.53 (dd, 1H, J5,6a = 6.3 Hz, J6a,6b = 11.3 Hz, H-6b), 1.77 (s, 1H, OH).  
 
13C NMR (CDCl3, 100 MHz): δ 155.07, 150.89 (2 x Carom. quat. OpMP), 138.65, 
138.30, 138.06 (3 x Carom. quat. Ph), 128.57 – 127.54 (15 x CHarom. Ph), 118.52, 
114.51 (4 x CHarom. OpMP), 97.43 (C-1), 78.97 (C-3), 76.31 (C-2), 74.87 (C-4), 74.52 
(CH2Ph), 73.59 (CH2Ph), 73.43 (CH2Ph), 71.08 (C-5), 62.24 (C-6), 55.58 (OCH3). 
 
[α]D20 = +69.8 (c 1.00, CHCl3).  
 
HRCIMS Calcd for C34H40O7N (M+NH4)+: 574.2805. Found: 574.2808. 
 
4-Methoxyphenyl 2,3,4-tri-O-benzyl-β-D-galactopyranoside (299) 
 
1H NMR (CDCl3, 400 MHz): δ 7.43 – 7.30 (m, 15H, Harom. Ph), 7.05 (d, 2H, J = 9.1 Hz, 
Harom. OpMP), 6.86 (d, 2H, J = 9.1 Hz, Harom. OpMP), 5.07 (d, 1H, J = 10.9 Hz, CHPh), 
5.04 (d, 1H, J = 11.8 Hz, CHPh), 4.94 (d, 1H, J1,2 = 7.6 Hz, H-1), 4.92 (d, 1H, J = 10.9 
Hz, CHPh), 4.89 (d, 1H, J = 11.8 Hz, CHPh), 4.82 (d, 1H, J = 11.8 Hz, CHPh), 4.74 (d, 
1H, J = 11.8 Hz, CHPh), 4.15 (dd, 1H, J1,2 = 7.6 Hz, J2,3 = 9.7 Hz, H-2), 3.87 (app. d, 1H, 
J3,4 = 2.9 Hz, H-4), 3.85 (dd, 1H, J5,6a = 5.9 Hz, J6a,6b = 10.2 Hz, H-6a), 3.81 (s, 3H, 
OCH3), 3.66 (dd, 1H, J3,4 = 2.9 Hz, J2,3 = 9.7 Hz, H-3), 3.58 – 3.51 (m, 2H, H-5, H-6b). 
 
13C NMR (CDCl3, 100 MHz): δ 155.14, 151.40 (2 x Carom. quat. OpMP), 138.44, 
138.26, 138.12 (3 x Carom. quat. Ph), 128.57 – 127.61 (15 x CHarom. Ph), 118.23, 
114.49 (4 x CHarom. OpMP), 102.88 (C-1), 82.15 (C-3), 79.30 (C-2), 75.37 (CH2Ph), 
74.90 (C-5), 74.18 (CH2Ph), 73.38 (CH2Ph), 72.68 (C-4), 61.90 (C-6), 55.60 (OCH3). 
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[α]D20 = –30.6 (c 1.00, CHCl3). 
 
HRCIMS Calcd for C34H40O7N (M+NH4)+: 574.2805. Found: 574.2807. 
 
Elemental Analysis Calcd for C34H36O7: C, 73.36; H, 6.52. Found: C, 73.50; H, 6.55. 
 
 
4-Methoxyphenyl 2,3,4-tri-O-benzyl-7,7-dibromo-6,7-dideoxy-α-D-galacto-hept-6-
enopyranoside (301) 
 
 
 
To a solution of oxalyl chloride (0.9 mL, 10.6 mmol) in anhydrous CH2Cl2 (30 mL), 
was added dropwise DMSO (1.5 mL, 21.2 mmol) at –78 °C under argon. After 15 
min a solution of 4-methoxyphenyl 2,3,4-tri-O-benzyl-α-D-galactopyronoside 
(298) (3.0 g, 5.3 mmol) in anhydrous CH2Cl2 (50 mL) was added dropwise. After 1 
h, triethylamine (3.7 mL, 26.5 mmol) was added and the reaction mixture was 
allowed to reach room temperature. After 45 min, water was added (30 mL) and 
the aqueous layer was extracted with CH2Cl2 (3 x 50 mL). The organic layers were 
combined, dried (MgSO4), filtered and concentrated under reduced pressure. The 
crude aldehyde was azeotroped with toluene and used without further 
purification.  
A solution of tetrabromomethane (3.5 g, 10.6 mmol) in anhydrous CH2Cl2 (10 mL) 
was added to a solution of triphenylphosphane (5.6 g, 21.2 mmol) in anhydrous 
CH2Cl2 (30 mL) at 0 °C under argon. The mixture was stirred at room temperature 
for 15 min. The resulting bright orange slurry was cooled to 0 °C, the solution of 
the aldehyde (2.9 g, 5.3 mmol) in anhydrous CH2Cl2 (30 mL) was added and the 
resulting mixture was stirred for 2 h at room temperature. Water (80 mL) and 
CH2Cl2 (100 mL) were added. The organic layer was dried (MgSO4), filtered and 
concentrated. The residue was chromatographed (cyclohexane/EtOAc, 15:1) to 
afford 301 (2.9 g, 77% over two steps) as an orange oil. 
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1H NMR (CDCl3, 400 MHz): δ 7.56 – 7.40 (m, 15H, Harom. Ph), 7.15 (d, 2H, J = 9.1 Hz, 
Harom. OpMP), 6.94 (d, 2H, J = 9.1 Hz, Harom. OpMP), 6.73 (d, 1H, J5,6 = 7.6 Hz, H-6), 
5.51 (d, 1H, J1,2 = 2.8 Hz, H-1), 5.11 (d, 1H, J = 11.5 Hz, CHPh), 5.07 (d, 1H, J = 11.7 
Hz, CHPh), 4.98 (d, 1H, J = 11.9 Hz, CHPh), 4.93 (d, 1H, J = 11.7 Hz, CHPh), 4.84 (d, 
1H, J = 11.9 Hz, CHPh), 4.79 (d, 1H, J = 11.5 Hz, CHPh), 4.72 (dd, 1H, J4,5 = 1.0 Hz, J5,6 
= 7.6 Hz, H-5), 4.33 (dd, 1H, J1,2 = 2.8 Hz, J2,3 = 10.1 Hz, H-2), 4.30 (dd, 1H, J3,4 = 2.2 
Hz, J2,3 = 10.1 Hz, H-3), 4.14 – 4.12 (m, 1H, H-4), 3.86 (s, 3H, OCH3). 
 
13C NMR (CDCl3, 100 MHz): δ 155.11, 151.01 (2 x Carom. quat. OpMP), 138.48, 
138.20, 137.77 (3 x Carom. quat. Ph), 135.26 (C-6), 128.34 – 127.40 (15 x CHarom. Ph), 
118.63, 114.38 (4 x CHarom. OpMP), 97.81 (C-1), 92.19 (=CBr2), 78.32 (C-3), 75.86 
(C-2), 75.63 (C-4), 74.91 (CH2Ph), 73.44 (CH2Ph), 73.27 (CH2Ph), 72.18 (C-5), 55.44 
(OCH3). 
 
[α]D20 = +51.1 (c 1.20, CHCl3). 
 
HRCIMS Calcd for C35H38O6NBr2 (M+NH4)+: 726.1066 (49.1%), 728.1049 
(100.0%), 730.1038 (55.2%). Found: 726.1049 (50.8%), 728.1028 (100.0%), 
730.1053 (54.7%). 
 
 
4-Methoxyphenyl 2,3,4-tri-O-benzyl-6,7,8-trideoxy-α-D-galacto-oct-6-ynopyranoside 
(302) 
 
 
 
A 2.5 M solution of butyl lithium in hexanes (1.7 mL, 4.13 mmol) was added 
dropwise to a solution of 301 (1.4 g, 1.97 mmol) in anhydrous THF (30 mL) at        
–78 °C under argon. The solution was stirred for 2 h at –40 °C and then cooled to    
–78 °C. MeI (1.2 mL, 19.70 mmol) was added dropwise followed by the HMPA (3.3 
mL, 19.70 mmol). The mixture was allowed to reach room temperature, and 
stirred for 72 h. The reaction mixture was concentrated under reduced pressure, 
the crude dissolved in diethilic ether (150 mL), washed with water (75 mL) and 
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then with a saturated solution of CuSO4 (2 x 75 mL). The organic phase was dried 
(MgSO4), filtered and concentrated under reduced pressure. The residue was 
purified by column chromatography (cyclohexane/EtOAc, 9:1) to give 302 (0.9 g, 
80 %) as a syrup. 
 
1H NMR (CDCl3, 400 MHz): δ 7.58 – 7.37 (m, 15H, Harom. Ph), 7.17 (d, 2H, J = 9.0 Hz, 
Harom. OpMP), 6.94 (d, 2H, J = 9.0 Hz, OpMP), 5.52 (d, 1H, J1,2 = 3.7 Hz, H-1), 5.13 (d, 
1H, J = 11.7 Hz, CHPh), 5.04 (d, 1H, J = 11.7 Hz, CHPh), 4.97 (d, 1H, J = 11.9 Hz, 
CHPh), 4.94 (d, 1H, J = 11.9 Hz, CHPh), 4.84 (d, 1H, J = 11.9 Hz, CHPh), 4.81 (d, 1H, J 
= 11.9 Hz, CHPh), 4.78 – 4.73 (m, 1H, H-5), 4.32 (dd, 1H, J1,2 = 3.7 Hz, J2,3 = 10.0 Hz, 
H-2), 4.20 (dd, 1H, J3,4 = 2.9 Hz, J2,3 = 10.0 Hz, H-3), 4.08 (app. dd, 1H, J4,5 = 1.1 Hz, 
J3,4 = 2.9 Hz, H-4), 3.85 (s, 3H, OCH3), 1.92 (d, 3H, J5,8 = 2,1 Hz, H-8). 
 
13C NMR (CDCl3, 100 MHz): δ 154.90, 150.99 (2 x Carom. quat. OpMP), 138.51, 
138.36, 138.16 (3 x Carom. quat. Ph), 128.18 – 127.28 (15 x CHarom. Ph), 118.20, 
114.36 (4 x CHarom. OpMP), 97.42 (C-1), 82.20 (C alcyn.), 77.68 (C-3), 77.26 (C-4), 
75.53 (C-2), 75.04 (C alcyn.), 74.89 (CH2Ph), 73.22 (CH2Ph), 72.85 (CH2Ph), 62.90 
(C-5), 55.36 (OCH3), 3.45 (C-8). 
 
[α]D20 = +81.7 (c 1.10, CHCl3). 
 
HRCIMS Calcd for C36H40O6N (M+NH4)+: 582.2856. Found: 582.2853. 
 
 
4-Methoxyphenyl 2,3,4-tri-O-benzyl-7,7-dibromo-6,7-dideoxy-β-D-galacto-hept-6-
enopyranoside (304) 
 
 
 
To a solution of oxalyl chloride (0.6 mL, 7.22 mmol) in anhydrous CH2Cl2 (30 mL), 
DMSO (1.0 mL, 14.44 mmol) was added dropwise at –78 °C under argon. After 15 
min a solution of 4-methoxyphenyl 2,3,4-tri-O-benzyl-β-D-galactopyronoside (299) 
(2.0 g, 3.61 mmol) in anhydrous CH2Cl2 (15 mL) was added. After 1 h, 
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triethylamine (2.8 mL, 19.86 mmol) was added and the reaction mixture was 
allowed to reach room temperature. After 45 min, water was added (80 mL) and 
the aqueous layer was extracted with CH2Cl2 (3 x 50 mL). The organic layers were 
combined, dried (MgSO4), filtered and concentrated under reduced pressure. The 
crude aldehyde was azeotroped with toluene and used without further 
purification.  
A solution of tetrabromomethane (2.4 g, 7.22 mmol) in dry CH2Cl2 (15 mL) was 
added to a solution of triphenylphosphine (3.8 g, 14.44 mmol) in dry CH2Cl2 (30 
mL) at 0 °C under argon. The mixture was stirred at room temperature for 15 min. 
The resulting bright orange slurry was cooled to 0 °C, the solution of the aldehyde 
(2.0 g, 3.61 mmol) in anhydrous CH2Cl2 (15 mL) was added and the resulting 
mixture was stirred for 2 h at room temperature. Water (80 mL) and CH2Cl2 (100 
mL) were added. The organic layer was separated, dried (MgSO4), filtered and 
concentrated. The residue was chromatographed (cyclohexane/EtOAc 15:1) to 
afford 304 (1.8 g, 71% over two steps) as an orange oil. 
 
1H NMR (CDCl3, 400 MHz): δ 7.43 – 7.36 (m, 15H, Harom. Ph), 7.08 (d, 2H, J = 9.1 Hz, 
Harom. OpMP), 6.88 (d, 2H, J = 9.0 Hz, Harom. OpMP), 6.71 (d, 1H, J5,6 = 7.1 Hz, H-6), 
5.08 (d, 1H, J = 10.9 Hz, CHPh), 5.03 (d, 1H, J = 11.8 Hz, CHPh), 4.93 (d, 1H, J1,2 = 7.5 
Hz, H-1), 4.92 (d, 1H, J = 11.3 Hz, CHPh), 4.88 (d, 1H, J = 11.8 Hz, CHPh), 4.80 (d, 1H, 
J = 11.8 Hz, CHPh), 4.76 (d, 1H, J = 11.8 Hz, CHPh), 4.14 (dd, 1H, J1,2 = 7.7 Hz, J2,3 = 
9.7 Hz, H-2), 4.11 (dd, 1H, J4,5 = 0.9 Hz, J5,6 = 7.2 Hz, H-5), 3.94 (dd, 1H, J4,5 = 0.8 Hz, 
J3,4 = 2.8 Hz, H-4), 3.82 (s, 3H, OCH3), 3.67 (dd, 1H, J3,4 = 2.9 Hz, J2,3 = 9.7 Hz, H-3). 
 
13C NMR (CDCl3, 100 MHz): δ 155.29, 151.41 (2 x Carom. quat. OpMP), 138.45, 
138.15, 137.77 (3 x Carom. quat. Ph), 135.57 (C-6), 128.46 – 127.60 (15 x CHarom. Ph), 
118.55, 114.61 (4 x CHarom. OpMP), 102.88 (C-1), 91.89 (=CBr2), 81.59 (C-3), 78.80 
(C-2), 75.42 (C-5), 75.35 (CH2Ph), 74.58 (CH2Ph), 74.00 (C-4), 73.39 (CH2Ph), 55.59 
(OCH3). 
 
[α]D20 = –43.4 (c 1.40, CHCl3). 
 
HRCIMS Calcd for C35H38O6NBr2 (M+NH4)+: 726.1066 (49.1%), 728.1049 
(100.0%), 730.1038 (55.2%). Found: 726.1079 (53.9%), 728.1056 (100.0%), 
730.1069 (54.9%). 
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Elemental Analysis Calcd for C35H34O6Br2: C, 59.17; H, 4.82. Found: C, 58.91; H, 
4.85. 
 
 
4-Methoxyphenyl 2,3,4-tri-O-benzyl-6,7,8-trideoxy-β-D-galacto-oct-6-ynopyranoside 
(305) 
 
 
 
A 2.5 M solution of butyl lithium in hexanes (2.1 mL, 5.31 mmol) was added 
dropwise to a solution of 304 (1.8 g, 2.53 mmol) in anhydrous THF (50 mL) at         
–78 °C under argon. The solution was stirred for 2 h at –40 °C and then cooled to    
–78 °C. MeI (1.6 mL, 25.30 mmol) was added dropwise followed by the HMPA (4.4 
mL, 25.30 mmol). The mixture was allowed to reach room temperature, and 
stirred for 72 h. The reaction mixture was concentrated under reduced pressure, 
the crude dissolved in ether (200 mL) washed with water (100 mL) and then with 
a saturated solution of CuSO4 (2 x 75 mL). The organic phase was dried (MgSO4), 
filtered and concentrated under reduced pressure. The residue was purified by 
flash column chromatography (cyclohexane/EtOAc 10:1) to give 305 (1.1 g, 78%) 
as a syrup. 
 
1H NMR (CDCl3, 400 MHz): δ 7.56 – 7.34 (m, 15H, Harom. Ph), 7.12 (d, 2H, J = 9.0 Hz, 
Harom. OpMP), 6.87 (d, 2H, J = 9.0 Hz, OpMP), 5.09 (d, 1H, J = 11.7 Hz, CHPh), 5.07 (d, 
1H, J = 10.3 Hz, CHPh), 5.03 (d, 1H, J = 12.0 Hz, CHPh), 4.92 (d, 1H, J = 10.8 Hz, 
CHPh), 4.87 (d, 1H, J1,2 = 7.7 Hz, H-1), 4.76 (d, 1H, J = 12.0 Hz, CHPh), 4.71 (d, 1H, J = 
11.9 Hz, CHPh), 4.21 (dd, 1H, J4,5 = 0.8 Hz, J5,8 = 2.0 Hz, H-5), 4.13 (dd, 1H, J1,2 = 7.8 
Hz, J2,3 = 9.7 Hz, H-2), 3.93 (dd, 1H, J4,5 = 0.8 Hz, J3,4 = 3.0 Hz, H-4), 3.82 (s, 3H, 
OCH3), 3.58 (dd, 1H, J3,4 = 3.0 Hz, J2,3 = 9.7 Hz, H-3), 1.90 (d, 3H, J5,8 = 2,2 Hz, H-8). 
 
13C NMR (CDCl3, 100 MHz) δ 155.20, 151.62 (2 x Carom. quat. OpMP), 138.52, 
138.38, 138.21 (3 x Carom. quat. Ph), 128.39 – 127.46 (15 x CHarom. Ph), 118.70, 
114.38 (4 x CHarom. OpMP), 102.97 (C-1), 82.61 (C alcyn.), 80.96 (C-3), 78.72 (C-2), 
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75.75 (C-4), 75.33 (CH2Ph), 74.81 (C alcyn.), 74.55 (CH2Ph), 72.74 (CH2Ph), 65.97 
(C-5), 55.56 (OCH3), 3.67 (C-8). 
 
[α]D20 = –29.7 (c 1.00, CHCl3). 
 
HRCIMS Calcd for C36H40O6N (M+NH4)+: 582.2856. Found: 582.2858. 
 
Elemental Analalysis Calcd for C36H36O6: C, 76.57; H, 6.43. Found: C, 76.64; H, 
6.45. 
 
 
Phenyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-galactopyranoside (308) 
 
 
 
To a well stirred solution of the crude pentaacetate 293 (21.7 g, 55.59 mmol) and 
thiophenol (11.3 mL, 111.18 mmol) in anhydrous CH2Cl2 (300 mL) was added 
dropwise BF3.Et2O (21.0 mL, 166.77 mmol) at 0 °C under argon. The reaction 
mixture was allowed to reach room temperature and stirred overnight, then 
quenched with a saturated solution of NaHCO3 (200 mL). The mixture was washed 
with a saturated solution of NaHCO3 (2 x 150 mL), and with a 1 M solution of HCl 
(100 mL). The organic extract was dried (MgSO4), filtered and the solvent 
evaporated under reduced pressure. Flash column chromatography 
(cyclohexane/EtOAc, 1:2) afforded the tetraacetate 308[204] (20.1 g, 82%) as a 
white solid.  
 
1H NMR (CDCl3, 250 MHz): δ 7.53 – 7.49 (m, 2H, Harom. Ph), 7.32 – 7.29 (m, 3H, 
Harom. Ph), 5.41 (br d, 1H, J3,4 = 3.3 Hz, H-4), 5.23 (t, 1H, J1,2 = J2,3= 9.9 Hz, Hz, H-2), 
5.04 (dd, 1H, J3,4 = 3.3 Hz, J2,3 = 9.9 Hz, H-3), 4.72 (d, 1H, J1,2 = 9.9 Hz, H-1), 4.19 (dd, 
1H, J5,6a = 7.1 Hz, J6a,6b = 11.3 Hz, H-6a), 4.10 (dd, 1H, J5,6b = 6.1 Hz, J6a,6b = 11.3 Hz, 
H-6b), 3.93 (br t, 1H, J5,6a = J5,6b = 6.6 Hz, H-5), 2.11 (s, 3H, OAc), 2.09 (s, 3H, OAc), 
2.04 (s, 3H, OAc), 1.97 (s, 3H, OAc). 
 
CIMS (M+NH4)+: m/z 485. 
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Phenyl 2,3,4-tri-O-benzyl-1-thio-β-D-galactopyronoside (312) 
 
 
 
To a solution of phenyl-2,3,4,6-tetra-O-acetyl-1-thio-β-D-galactopyranoside (308) 
(8.3 g, 18.75 mmol) in methanol (150 mL), was added a 1 M solution of NaOMe 
previously prepared until the pH of the reaction mixture reached the value of 10. 
After 7 h the mixture was neutralized with acid resin Amberlite® IR 120 (H+), 
filtered and concentrated under reduced pressure. The product obtained was 
directly engaged in the step.  
To a solution of phenyl 1-thio-β-D-galactopyranoside in dry pyridine (100 mL) was 
added chlorotriphenylmethane (6.3 g, 22.50 mmol) and the resulting mixture 
stirred for 21 h at 50 °C. The reaction mixture was concentrated in vacuo 
(azeotroped with toluene) and the yellow residue obtained was dissolved in CH2Cl2 
(100 mL) and washed with a saturated solution of NH4Cl (3 x 50 mL). The organic 
phase was dried over MgSO4, filtered and concentrated. The product obtained was 
used without further purification. 
NaH (4.5 g, 112.50 mmol, 60% w/w) was added to a solution of the product of the 
previous step (9.7 g, 18.75 mmol) in DMF (200 mL) at 0 °C, and after 15 minutes 
BnBr (13.4 mL, 112.50 mmol) was added. After stirred overnight at room 
temperature, the reaction mixture was quenched with MeOH (30 mL) and 
concentrated under reduced pressure. The crude product was dissolved in ether 
(200 mL) and washed with water (75 mL). The aqueous phase was extracted with 
ether (3 x 100 mL). The organic layers were combined, dried (MgSO4), filtered and 
concentrated in vacuo. The product obtained (yellow oil) was directly engaged in 
the next step.  
p-Toluenosulfonic acid (0.7 g, 3.75 mmol) was added to a solution of 311 in a 1:1 
mixture of CH2Cl2/MeOH (200 mL). After 4 h, the reaction mixture was neutralized 
by dropwise addition of Et3N and concentrated under reduced pressure. Flash 
column chromatography (cyclohexane/EtOAc 3:1) of the residue gave 312[205] (6.9 
g, 68 % over 4 steps) as a white solid. 
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1H NMR (CDCl3, 400 MHz): δ 7.58 – 7.25 (m, 20H, Harom.), 5.02 (d, 1H, J = 10.9 Hz, 
CHPh), 5.03 (d, 1H, J = 11.7 Hz, CHPh), 4.86 (d, 1H, J = 10.2 Hz, CHPh), 4.83 – 4.79 
(m, 3H, 3 x CHPh), 4.69 (d, 1H, J1,2 = 9.5 Hz, H-1), 4.67 (d, 1H, J = 11.7 Hz, CHPh), 
3.99 (t, 1H, J1,2 = J2,3 = 9.5 Hz, H-2), 3.90 – 3.86 (m, 2H, H-4, H-6a), 3.65 (dd, 1H, J3,4 = 
2.7 Hz, J2,3 = 9.5 Hz, H-3), 3.56 (dd, 1H, J5,6b = 5.0 Hz, J6a,6b = 11.3 Hz, H-6b), 3.50 – 
3.47 (m, 1H, H-5), 1.83 (br s, 1H, OH). 
 
13C NMR (CDCl3, 100 MHz): δ 138.72, 138.63, 138.54 (3 x Carom. quat. Ph), 134.34 
(Carom. quat. SPh), 131.96 – 127.65 (20 x CHarom), 88.12 (C-1), 84.67 (C-3), 79.22 (C-
5), 77.92 (C-2), 76.15 (CH2Ph), 74.61 (CH2Ph), 73.63 (C-4), 73.49 (CH2Ph), 62.69 
(C-6). 
 
[α]D20 = –17.0 (c 1.00, CDCl3). 
 
CIMS (M+NH4)+: m/z 560. 
 
 
Phenyl 2,3,4-tri-O-benzyl-7,7-dibromo-6,7-dideoxy-1-thio-β-D-galacto-hept-6-
enopyranoside (314) 
 
 
 
To a solution of oxalyl chloride (1.4 mL, 16.16 mmol) in anhydrous CH2Cl2 (60 mL) 
at –78 °C under argon, was added dropwise DMSO (2.4 mL, 32.32 mmol). After 15 
min a solution of thiophenol 2,3,4-tri-O-benzyl-β-D-galactopyronoside 312 (4.5 g, 
8.08 mmol) in anhydrous CH2Cl2 (40 mL) was added and the reaction mixture 
stirred for 1 h. Triethylamine (5.8 mL, 44.44 mmol) was added and the reaction 
mixture was allowed to reach room temperature. After 45 min, water was added 
(80 mL) and the aqueous layer was extracted with CH2Cl2 (3 x 50 mL). The organic 
layers were combined, dried (MgSO4), filtered and concentrated under reduced 
pressure. The crude aldehyde was azeotroped with toluene and used without 
further purification.  
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To a solution of PPh3 (8.7 g, 32.32 mmol) in anhydrous CH2Cl2 (50 mL) at 0 °C 
under argon was added dropwise a solution of CBr4 (5.5 g, 16.16 mmol) in 
anhydrous CH2Cl2 (20 mL). The mixture was stirred at room temperature for 15 
min. The resulting bright orange slurry was cooled to 0 °C, the solution of the 
aldehyde 313 (4.5 g, 8.08 mmol) in anhydrous CH2Cl2 (30 mL) was added and the 
resulting mixture was stirred for 2 h at room temperature. The reaction mixture 
was diluted with CH2Cl2 (75 mL) and washed with a brine solution. The organic 
layer was dried (MgSO4), filtered and concentrated. The residue was 
chromatographed (cyclohexane/EtOAc, 15:1) to afford 314 (4.9 g, 84% over two 
steps) as a pale yellow oil. 
 
1H NMR (CDCl3, 400 MHz): δ 7.48 – 7.31 (m, 20H, Harom.), 6.79 (d, 1H, J5,6 = 7.4 Hz, 
H-6), 5.05 (d, 1H, J = 11.7 Hz, CHPh), 4.93 (d, 1H, J = 10.3 Hz, CHPh), 4.87 – 4.82 (m, 
3H, 3 x CHPh),  4.75 (d, 1H, J = 11.9 Hz, CHPh), 4.74 (d, 1H, J1,2 = 9.5 Hz, H-1), 4.12 
(dd, 1H, J4,5 = 1.0 Hz, J5,6 = 7.3 Hz, H-5), 4.04 (t, 1H, J1,2 = J2,3 = 9.5 Hz, H-2), 3.98 (app 
dd, 1H, J4,5 = 1.1 Hz, J3,4 = 2.7 Hz H-4), 3.71 (dd, 1H, J3,4 = 2.7 Hz, J2,3 = 9.3 Hz, H-3). 
 
13C NMR (CDCl3, 100 MHz): δ 138.78, 138.51, 138.50 (3 x Carom. quat. Ph), 136.19 
(C-6), 134.35 (Carom. quat. SPh), 132.22 – 127.80 (20 x CHarom.), 92.57 (=CBr2), 88.37 
(C-1), 84.10 (C-3), 79.50 (C-5), 77.39 (C-2), 76.12 (CH2Ph), 75.08 (CH2Ph), 75.00 
(C-4), 73.59 (CH2Ph). 
 
[α]D20 = –43.4 (c 1.40, CHCl3). 
 
HRCIMS Calcd for C34H36Br2NO4S (M+NH4)+: 716.0691 (48.6%), 714.0711 
(100.0%), 712.0732 (51.4%). Found: 716.0689 (48.9%), 714.0726 (100.0%), 
712.0751 (52.3%). 
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Phenyl 2,3,4-tri-O-benzyl-6,7,8-trideoxy-1-thio-β-D-galacto-oct-6-ynopyranoside 
(315) 
 
 
 
A 2.5 M solution of butyl lithium in hexanes (5.7 mL, 14.20 mmol) was added 
dropwise to a solution of 314 (4.8 g, 6.76 mmol) in anhydrous THF (150 mL) at      
–90 °C under argon. The solution was stirred for 2 h at –40 °C and then cooled to    
–78 °C. MeI (4.3 mL, 67.60 mmol) was added dropwise followed by the HMPA (12 
mL, 67.60 mmol). The mixture was allowed to reach room temperature, and 
stirred for 72 h. The reaction mixture was concentrated under reduced pressure, 
the crude dissolved in ether (100 mL) washed with water (50 mL) and then with a 
saturated solution of CuSO4 (2 x 50 mL). The organic phase was dried over MgSO4, 
filtered and concentrated under reduced pressure. The residue was purified by 
column chromatography (cyclohexane/EtOAc, 15:1) to give 315 (3.0 g, 79%) as a 
colorless oil. 
 
1H NMR (CDCl3, 400 MHz): δ 7.48 – 7.21 (m, 20H, Harom.), 5.00 (s, 2H, 2 x CHPh), 
4.80 (d, 1H, J = 10.2 Hz, CHPh), 4.75 (d, 1H, J = 10.2 Hz, CHPh), 4.67 (s, 2H, 2 x 
CHPh), 4.60 (d, 1H, J1,2 = 9.7 Hz, H-1), 4.14 (app d, 1H, J5,8 = 2.1 Hz, H-5), 3.93 (t, 1H, 
J1,2 = J2,3 = 9.5 Hz, H-2), 3.92 (app d, 1H, J3,4 = 3.2 Hz, H-4), 3.54 (dd, 1H, J3,4 = 3.0 Hz, 
J2,3 = 9.5 Hz, H-3), 1.87 (d, 3H, J5,8 = 2,2 Hz, H-8). 
 
13C NMR (CDCl3, 100 MHz): δ 139.00, 138.74, 138.52 (3 x Carom. quat. Ph), 134.55 
(Carom. quat. SPh), 132.05 – 127.53 (20 x CHarom.), 88.32 (C-1), 83.38 (C-3), 83.23 (C 
alcyn.), 77.13 (C-2), 76.46 (C-4), 76.04 (CH2Ph), 75.64 (C alcyn.) 74.99 (CH2Ph), 
72.90 (CH2Ph), 69.90 (C-5), 4.20 (C-8). 
 
[α]D20 = –27.3 (c 1.00, CHCl3). 
 
HRCIMS Calcd for C35H38NO4S (M+NH4)+: 568.2522. Found: 568.2530. 
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2,3,4-Tri-O-benzyl-6,7,8-trideoxy-α-β-D-galacto-oct-6-ynopyranose (307a,b) 
 
 
 
Method A: Cleavage of the OpMP 
To a solution of 302 (45.0 mg, 0.08 mmol) in a mixture of acetone/H2O (4 mL 3:1) 
was added ammonium cerium (IV) nitrate (310.0 mg, 0.56 mmol). The resulting 
clear orange solution was stirred at room temperature for 5 min. The mixture was 
partially concentrated under reduced pressure, diluted with dichloromethane (10 
mL) and washed with water (5 mL). The organic layer was dried (MgSO4) filtered 
and concentrated. The residue was purified by flash column chromatography 
(cyclohexane/EtOAc 4:1) to give 307a,b (26.1 mg, 71%) as an orange oil and as a 
3:1 mixture of α and β anomers. 
 
Method B: Cleavage of the SPh 
To a ice-cooled solution of phenyl 2,3,4-tri-O-benzyl-6,7,8-trideoxy-1-thio-β-D-
galacto-oct-6-ynopyranoside (315) (2.4 g, 4.36 mmol) in acetone/H2O (50 mL, 9:1) 
was added NBS (1.9 g, 10.90 mmol). After stirring for 2 h at room temperature, the 
reaction mixture was quenched with a saturated aqueous solution of NaHCO3 (25 
mL), diluted with EtOAc (50 mL) and washed with brine (25 mL). The organic 
layer was dried (MgSO4) and the solvents were removed under reduced pressure. 
The residue was purified by flash column chromatography (cyclohexane/EtOAc 
3:1) to afford 307a,b (1.7 g, 86%) as a colorless oil and as a 5:3 mixture of α and β 
anomers. 
 
extracted data for α anomer: 
 
1H NMR (CDCl3, 400 MHz): δ 7.49 – 7.30 (m, 15H, Harom. Ph), 5.33 (d, 1H, J1,2 = 3.5 
Hz, H-1), 4.99 (d, 1H, J = 11.9 Hz, CHPh), 4.93 (d, 1H, J = 11.9 Hz, CHPh), 4.85 (d, 1H, 
J = 11.7 Hz, CHPh), 4.75 – 4.70 (m, 4H, 3 x CHPh, H-5), 4.44 (dd, 1H, J1,2 = 3.5 Hz, J2,3 
= 9.5 Hz, H-2), 3.94 (dd, 1H, J4,5 = 1.6 Hz, J3,4 = 2.9 Hz, H-4), 3.89 (dd, 1H, J3,4 = 2.9 
Hz, J2,3 = 9.6 Hz, H-3), 3.03 (br s, 1H, OH), 1.87 (d, 3H, J5,8 = 2,2 Hz, H-8). 
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13C NMR (CDCl3, 100 MHz): δ 138.43, 138.38, 138.02 (3 x Carom. quat. Ph), 128.40 – 
127.49 (15 x CHarom. Ph), 91.87 (C-1), 82.42 (C alcyn.), 77.41 (C-3), 76.63 (C-4), 
75.93 (C-2), 75.27 (C alcyn.), 74.63 (CH2Ph), 73.60 (CH2Ph), 72.74 (CH2Ph), 62.60 
(C-5), 3.64 (C-8). 
 
extracted data for β anomer: 
 
1H NMR (CDCl3, 400 MHz): δ 7.49 – 7.30 (m, 15H, Harom. Ph), 5.01 – 4.90 (m, 3H, 3 x 
CHPh), 4.81 (d, 1H, J = 11.1 Hz, CHPh), 4.77 (d, 1H, J = 11.9 Hz, CHPh), 4.75 – 4.70 
(m, 2H, CHPh, H-1), 4.27 (quintet, 1H, J4,5 = J5,8 = 2.0 Hz, H-5), 3.90 – 3.87 (m, 1H, H-
4), 3.80 (dd, 1H, J1,2 = 6.8 Hz, J2,3 = 9.0 Hz, H-2), 3.58 (dd, 1H, J3,4 = 2.9 Hz, J2,3 = 9.0 
Hz, H-3) 3.53 (br s, 1H, OH), 1.87 (d, 3H, J5,8 = 2,2 Hz, H-8). 
 
13C NMR (CDCl3, 100 MHz) δ 138.43 – 138.02 (3 x Carom. quat. Ph), 128.40 – 127.49 
(15 x CHarom. Ph), 97.21 (C-1), 82.42 (C alcyn.), 80.36 (C-3), 79.87 (C-2), 75.50 (C-4), 
75.27 (C alcyn.), 74.74 (CH2Ph), 74.35 (CH2Ph), 72.86 (CH2Ph), 65.61 (C-5), 3.60 (C-
8). 
 
HRCIMS Calcd for C29H34O5N (M+NH4)+: 476.2437. Found: 476.2442. 
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2,6-Anhydro-3,4,5-tri-O-benzyl-1,7,8,9-tetradeoxy-1,1-difluoro-D-galacto-non-1-en-7-
ynitol (317) 
 
 
 
To a solution of oxalyl chloride (0.7 mL, 7.60 mmol) in anhydrous CH2Cl2 (20 mL), 
DMSO (1.1 mL, 15.20 mmol) was added dropwise at –70 °C under argon. After 15 
min a solution of 307a,b (1.8 g, 3.80 mmol) in anhydrous CH2Cl2 (15 mL) was 
added dropwise. After 1 h, triethylamine (2.9 mL, 20.90 mmol) was added and the 
reaction mixture was allowed to reach room temperature. After 45 min, the 
reaction mixture was quenched with water (50 mL) and extracted with CH2Cl2 (3 x 
70 mL). The organic layers were combined, dried (MgSO4), filtered and 
concentrated under reduced pressure. The crude lactone was azeotroped with 
toluene and used without further purification. To a solution of lactone (1.7 g, 3.80 
mmol) in anhydrous THF (100 mL) under argon, cooled at –10 °C, was added 
CBr2F2 (3.5 mL, 38.00 mmol) using a cooled syringe. To the vigorously stirred 
solution was added dropwise HMPT (6.9 mL, 38.00 mmol), and a dense white 
precipitate appeared. The reaction mixture was stirred at room temperature 
during 1 h and then HMPT (13.8 mL, 76.00 mmol) was added and the mixture 
stirred for 2 h at room temperature. The reaction mixture was concentrated under 
reduced pressure, diluted with ether (100 mL) and washed with water (50 mL). 
The organic layer was separated, washed with a saturated solution of CuSO4 (2 x 
30 mL), dried (MgSO4), filtered and the solvent removed in vacuo. The residue was 
purified by flash column chromatography (cyclohexane/EtOAc 25:1) to afford 317 
(1.3 g, 69%) as a colorless oil. 
 
1H NMR (400 MHz, CDCl3): δ 7.41 – 7.30 (m, 15H, Harom. Ph), 4.93 – 4.91 (m, 1H, H-
5), 4.89 (d, 1H, J = 12.3 Hz, CHPh), 4.74 (d, 1H, J = 12.1 Hz, CHPh), 4.70 (d, 1H, J = 
10.5 Hz, CHPh), 4.67 (d, 1H, J = 12.2 Hz, CHPh), 4.61 (d, 1H, J = 11.8 Hz, CHPh), 4.35 
(d, 1H, J = 11.8 Hz, CHPh), 4.31 (dd, 1H, 4J2,F = 3.4 Hz, J2,3 = 5.7 Hz, H-2), 4.09 (dd, 
1H, J4,5 = 2.8 Hz, J3,4 = 5.5 Hz, H-4), 4.00 – 3.98 (m, 1H, H-3), 1.85 (d, 3H, J5,8 = 2,2 Hz, 
H-8). 
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13C NMR (CDCl3, 100 MHz): δ 156.20 (dd, 1JC,F = 280.2 Hz, 1JC,F’ = 293.5 Hz, CF2) 
139.11, 138.28, 137.85 (3 x Carom. quat. Ph), 128.83 – 127.60 (15 x CHarom. Ph), 
84.73 (C alcyn.), 75.57 (d, 4JC,F = 1.6 Hz, C-3), 75.00 (C alcyn.), 73.89 (C-4), 73.10 
(CH2Ph), 72.43 (CH2Ph), 71.57 (t, 3JC,F = 3.3 Hz, C-2), 70.70 (CH2Ph), 68.45 (t, 4JC,F = 
1.6 Hz, C-5), 4.45 (C-8). 
 
19F NMR (CDCl3, 235 MHz) δ –111.64 (dd, 1F, J2,F = 2.4 Hz, JF,F’ = 61.1 Hz), –97.22 (d, 
1F, JF,F’ = 67.5 Hz). 
 
[α]D20 = +36.8 (c 0.60, CHCl3). 
 
HRFABMS Calcd for C30H28O4F2Na (M+Na)+: 513.1853. Found: 513.1849. 
 
 
Rearrangement of 317 into 2,3,4-tri-O-benzyl-6,7,8-trideoxy-5a-difluoro-5a-carba-α-
D-galacto-oct-6-ynopyranose (320) and 2,3,4-tri-O-benzyl-6,7,8-trideoxy-5a-difluoro-
5a-carba-β-D-galacto-oct-6-ynopyranose (321) 
 
 
 
Method A: TIBAL 
Co2(CO)8 (150.0 mg, 0.45 mmol) was added to a solution of difluoroalkene 317 
(150.0 g, 0.30 mmol) in CH2Cl2 (15 mL) under argon. After stirring at room 
temperature for 1 h, TLC (cyclohexane/EtOAc 4:1) indicated completely 
complexation of the starting material. The reaction mixture was cooled to –78 °C 
and a 1 M solution in toluene of TIBAL (3.00 mL, 3.00 mmol) was added dropwise 
over a period of 15 min. The mixture was allowed to reach room temperature and 
stirred for 1 h. The mixture was diluted with CH2Cl2 (20 mL) and washed with a 
saturated solution of NaHCO3 (15 mL) (an emulsion appeared). The organic phase 
was filtered through a pad of celite® and rewashed with a saturated solution of 
NaHCO3. The organic phase was dried (MgSO4), filtered and concentrated under 
reduced pressure. The crude product was dissolved in acetone (10 mL) and Et3N 
(30.0 μL, 0.30 mmol) and CAN (820.0 mg, 1.50 mmol) were added. After stirring at 
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room temperature for 30 min, TLC (cyclohexane/EtOAc 4:1) indicated completion 
of the reaction and the formation of 2 products. The mixture was concentrated 
under reduced pressure and chromatographed (cyclohexane/EtOAc 8:1) to afford 
320 (52.1 mg, 35%) as a colorless oil and 321 (42.2 mg, 29%) also as a colorless 
oil. 
 
Method B: TiCl3(OiPr) 
Co2(CO)8 (50 mg, 0.10 mmol) was added to a solution of difluoroalkene 317 (52 
mg, 0.15 mmol) in CH2Cl2 (10 mL) under argon. After stirring at room temperature 
for 1 h, TLC (cyclohexane/EtOAc 4:1) indicated completely complexation of the 
starting material. The reaction mixture was cooled to –78 °C and a 0.5 M solution 
in CH2Cl2 of TiCl3(OiPr) (300 μL, 0.15 mmol) was added dropwise. The reaction 
mixture was allowed to reach –20 °C and stirred for 30 min. THF (1 mL) was added 
and the mixture stirred for more 15 min. Then a 1 M solution of Et3BHLi (150 μL, 
0.15 mmol) was added dropwise at –78 °C. After 20 min a 35% solution of H2O2 (1 
mL) and 1 M soln of NaOH (0.3 mL) were carefully added and the reaction stirred 
during 30 min. The reaction mixture was diluted with CH2Cl2 (10 mL) and washed 
with water. The aqueous layer was extracted with CH2Cl2 (2 x 10 mL), and the 
organic layers were combined, dried (MgSO4), filtered and concentrated under 
reduced pressure. The crude product was dissolved in acetone (10 mL) and Et3N 
(20 μL, 0.10 mmol) and CAN (270 mg, 0.50 mmol) were added. After stirring at 
room temperature for 30 min, TLC (cyclohexane/EtOAc 4:1) indicated completion 
of the reaction. The mixture was concentrated under reduced pressure and 
chromatographed (cyclohexane/EtOAc 6:1) to afford 320 (8.1 mg, 16%) as a 
colorless oil and 321 (24.0 mg, 48%) as a colorless oil. 
 
2,3,4-Tri-O-benzyl-6,7,8-trideoxy-5a-difluoro-5a-carba-α-D-galacto-oct-6-
ynopyranose (320) 
 
1H NMR (CDCl3, 250 MHz): δ 7.37 – 7.20 (m, 15H, Harom. Ph), 4.89 (s, 2H, 2 x CHPh), 
4.79 (d, 1H, J = 11.2 Hz, CHPh), 4.75 (s, 2H, 2 x CHPh), 4.67 (d, 1H, J = 11.2 Hz, 
CHPh), 4.13 (dt, 1H, J1,2 = J1,Feq = 3.0 Hz, J1,Fax = 7.1 Hz, H-1), 4.01 (dd, 1H, J1,2 = 3.2 
Hz, J2,3 = 8.9 Hz, H-2), 3.93 (app t, 1H, J3,4 = J4,5 = 2.8 Hz, H-4), 3.74 (dd, 1H, J3,4 = 3.0 
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Hz, J2,3 = 8.9 Hz, H-3), 3.16 (br d, 1H, J5,Fax = 28.5 Hz, H-5), 2.51 (br s, 1H, OH), 1.83 
(d, 3H, J5,8 = 2.2 Hz, H-8). 
 
13C NMR (C6D6, 63 MHz): δ 139.42, 139.26, 138.54 (3 x Carom. quat. Ph), 128.62 – 
127.66 (15 x CHarom. Ph), 120.32 (t, 1JC,F = 251.5 Hz, CF2), 80.59 (C alcyn.), 78.29 (C-
3), 77.50 (br s, C-2), 76.35 (d, 3JC,F = 6.5 Hz, C-4), 75.66 (CH2Ph), 73.35 (2 x CH2Ph), 
72.78 (C alcyn.), 70.36 (br s, C-1), 36.94 (t, 2JC,F = 20.8 Hz, C-5), 3.41 (C-8). 
 
19F NMR (C6D6, 235 MHz) δ –107.53 (d, 1F JFeq,Fax = 248.9 Hz), –102.44 (d, 1F, JFeq,Fax 
= 247.8 Hz). 
 
[α]D20 = +33.5 (c 1.00, CHCl3). 
 
HRCIMS Calcd for C30H34O4NF2 (M+NH4)+: 510.2456. Found: 510.2441.  
 
2,3,4-Tri-O-benzyl-6,7,8-trideoxy-5a-difluoro-5a-carba-β-D-galacto-oct-6-
ynopyranose (321) 
 
1H NMR (CDCl3, 400 MHz): δ 7.37 – 7.29 (m, 15H, Harom. Ph), 4.92 (br d, 3H, J = 10.3 
Hz, 3 x CHPh), 4.79 (d, 1H, J = 11.1 Hz, CHPh), 4.75 (d, 3H, J = 12.0 Hz, CHPh), 4.71 
(d, 1H, J = 11.9 Hz, CHPh), 4.07 – 4.02 (m, 2H, H-2, H-4) 3.74 (ddd, 1H, J1,Feq = 6.8 
Hz, J1,2 = 8.7 Hz, J1,Fax = 15.3 Hz, H-1), 3.53 (dd, 1H, J3,4 = 2.0 Hz, J2,3 = 8.7 Hz, H-3), 
2.90 (br d, 1H, J5,Fax = 23.6 Hz, H-5), 1.84 (d, 3H, J5,8 = 2.4 Hz, H-8). 
 
13C NMR (CDCl3, 100 MHz): δ 138.83, 138.56, 138.32 (3 x Carom. quat. Ph), 128.92 – 
127.89 (15 x CHarom. Ph), 119.50 (dd, 1JC,F = 245.1 Hz, 1JC,F’ = 255.4 Hz, CF2), 81.50 (C 
alcyn.), 81.17 (C-3), 79.36 (d, 3JC,F = 6.3 Hz, C-2 or C-4), 75.87 (d, 3JC,F = 6.8 Hz, C-2 
or C-4), 75.81 (CH2Ph), 75.09 (CH2Ph), 74.22 (br s, C-1), 73.41 (CH2Ph), 71.48 (C 
alcyn.), 38.72 (t, 2JC,F = 21.0 Hz, C-5), 4.15 (C-8). 
 
19F NMR (CDCl3, 235 MHz): δ –117.05 (br s, 1F), –102.08 (d, 1F, JFeq,Fax = 247.0 Hz),  
 
[α]D20 = –15.1 (c 0.84, CHCl3). 
 
HRCIMS Calcd for C30H34O4NF2 (M+NH4)+: 510.2456. Found: 510.2463. 
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2,3,4-Tri-O-benzyl-6,7,8-trideoxy-5a-difluoro-5a-carba-D-galacto-oct-6-ynopyran-1-
ulose.hydrate (323) 
 
 
 
Co2(CO)8 (70 mg, 0.14 mmol) was added to a solution of difluoroalkene 317 (73 
mg, 0.21 mmol) in CH2Cl2 (10 mL) under argon. After stirring at room temperature 
for 1 h, TLC (cyclohexane/EtOAc 4:1) indicated completely complexation of the 
starting material. The reaction mixture was cooled to –20 °C and a 0.5 M solution 
in CH2Cl2 of TiCl3(OiPr) (420 μL, 0.21 mmol) was added dropwise. After 5 min the 
reaction mixture was quenched with cooled water and diluted with CH2Cl2 (10 
mL). The aqueous layer was extracted with CH2Cl2 (2 x 10 mL). The organic layers 
were combined, dried (MgSO4), filtered and concentrated under reduced pressure. 
The crude product was dissolved in acetone (10 mL) and Et3N (20 μL, 0.14 mmol) 
and CAN (380 mg, 0.70 mmol) were added. After stirring at room temperature for 
40 min, TLC (cyclohexane/EtOAc 2:1) indicated completion of the reaction. The 
mixture was concentrated under reduced pressure and chromatographed 
(cyclohexane/EtOAc 6:1) to afford 323 (61.4 mg, 76%) as a colorless oil. 
 
1H NMR (CDCl3, 400 MHz): δ 7.48 – 7.29 (m, 15H, Harom. Ph), 4.98 (d, 1H, J = 11.6 
Hz, CHPh), 4.95 (d, 1H, J = 11.6 Hz, CHPh), 4.92 (s, 2H, 2 x CHPh), 4.74 (d, 1H, J = 
11.8 Hz, CHPh), 4.65 (d, 1H, J = 11.8 Hz, CHPh), 4.15 (d, 1H, J2,3 = 9.4 Hz, H-2), 4.04 
(t, 1H, J3,4 = J4,5 = 3.0 Hz, H-4), 3.74 (br s, 1H, OH), 3.58 (dd, 1H, J3,4 = 3.0 Hz, J2,3 = 9.4 
Hz, H-3), 3.14 (br d, 1H, J5,Fax = 28.1 Hz, H-5), 1.84 (d, 3H, J5,8 = 2.4 Hz, H-8), 1.98 (br 
s, 1H, OH), 
 
19F NMR (C6D6, 235 MHz) δ –119.77 (d, 1F JFeq,Fax = 251.0 Hz, Feq), –113.4.7 (dd, 1F, 
J5,Fax = 28.1 Hz, JFeq,Fax = 251.0 Hz, Fax). 
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2,3,4-Tri-O-benzyl-6,7,8-trideoxy-5a-difluoro-5a-carba-β-D-galacto-oct-6-
enopyranose (325) and 2,3,4-tri-O-benzyl-6,7,8-trideoxy-5a-difluoro-5a-carba-β-D-
galacto-octopyranose (326) 
 
 
 
Lindlar’s catalyst (5.0 mg) was added to a solution of 321 (75.0 mg, 0.15 mmol) in 
EtOAc (5 mL). Three purges of vacuum/argon were performed, followed by 5 
purges of vacuum/H2. After stirring for 14 h at room temperature under hydrogen 
(ca. 2 atm), the mixture was filtered through a Rotilabo® Nylon 0.45 μm filter, and 
the solvent evaporated. Flash column chromatography (cyclohexane/EtOAc 8:1) 
gave 325 (52.0 mg, 70%) as a colorless oil and 326 (16.4 mg, 22%) also as a 
colorless oil. 
Reaction times around 5 h afforded exclusively the alkene 325.  
 
2,3,4-Tri-O-benzyl-6,7,8-trideoxy-5a-difluoro-5a-carba-β-D-galacto-oct-6-
enopyranose (325) 
 
1H NMR (CDCl3, 400 MHz): δ 7.40 – 7.28 (m, 15H, Harom. Ph), 5.82 – 5.74 (m, 2H, H-
7, H-8), 4.99 (d, 1H, J = 11.2 Hz, CHPh), 4.98 (d, 1H, J = 11.7 Hz, CHPh), 4.84 (d, 1H, J 
= 11.2 Hz, CHPh), 4.81 (d, 1H, J = 12.3 Hz, CHPh), 4.76 (d, 1H, J = 11.8 Hz, CHPh), 
4.63 (d, 1H, J = 11.7 Hz, CHPh), 4.10 (t, 1H, J1,2 = J2,3 = 9.6 Hz, H-2), 3.85 – 3.74 (m, 
2H, H-1, H-4), 3.59 (dd, 1H, J3,4 = 2.7 Hz, J2,3 = 9.6 Hz, H-3), 2.79 (br d, 1H, J5,F = 27.2 
Hz, H-5), 2.40 (d, 1H, J1,OH = 4,5 Hz), 1.64 (d, 3H, J7,8 = 5.1 Hz, H-8). 
 
13C NMR (CDCl3, 100 MHz): δ 139.03, 138.75, 138.46 (3 x Carom. quat. Ph), 129.93 
(C-7), 128.95 – 127.58 (15 x CHarom. Ph), 121.84 (d, 3JC,F = 4.9 Hz, C-6), 121.21 (dd, 
1JC,F = 247.2 Hz, 1JC,F’ = 254.6 Hz, CF2), 82.88 (d, 4JC,F = 1.8 Hz, C-3), 79.96 (d, 3JC,F = 
8.4 Hz, C-2), 77.11 (d, 3JC,F = 10.1 Hz, C-4), 76.20 (CH2Ph), 75.64 (CH2Ph), 75.28 (t, 
JC,F = 21.5 Hz, C-1), 73.58 (CH2Ph), 42.28 (t, 2JC,F = 21.2 Hz, C-5), 13.86 (C-8). 
 
19F NMR (CDCl3, 235 MHz): δ –119.18 (d, 1F, JFeq,Fax = 247.0 Hz), –104.01 (d, 1F, 
JFeq,Fax = 247.0 Hz). 
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[α]D20 = –43.5 (c 0.84, CHCl3). 
 
HRCIMS Calcd for C30H36O4NF2 (M+NH4)+: 512.2612. Found: 512.2618 
 
2,3,4-Tri-O-benzyl-6,7,8-trideoxy-5a-difluoro-5a-carba-β-D-galacto-octopyranose 
(326) 
 
1H NMR (CDCl3, 250 MHz): δ 7.32 – 7.19 (m, 15H, Harom. Ph), 5.00 (d, 1H, J = 11.8 
Hz, CHPh), 4.89 (d, 1H, J = 11.0 Hz, CHPh), 4.76 (d, 1H, J = 11.7 Hz, CHPh), 4.74 (d, 
1H, J = 11.0 Hz, CHPh), 4.70 (d, 1H, J = 11.7 Hz, CHPh), 4.52 (d, 1H, J = 11.7 Hz, 
CHPh), 3.96 (t, 1H, J1,2 = J2,3 = 9.7 Hz, H-2), 3.84 – 3.80 (m, 1H, H-4), 3.63 (ddd, 1H, 
J1,Feq = 6.6 Hz, J1,2 = 9.7 Hz, J1,Fax = 18.6 Hz, H-1), 3.43 (dd, 1H, J3,4 = 2.5 Hz, J2,3 = 9.7 
Hz, H-3), 1.67 – 1.53 (m, 3H, H-5, H-6a, H-6b), 1.20 – 1.03 (m, 2H, H-7a, H-7b), 0.77 
(t, 3H, J7,8 = 7.2 Hz, H-8). 
 
13C NMR (CDCl3, 100 MHz): δ 139.17, 138.77, 138.54 (3 x Carom. quat. Ph), 128.91 – 
127.79 (15 x CHarom. Ph), 121.79 (dd, 1JC,F = 242.9 Hz, 1JC,F’ = 252.1 Hz, CF2), 83.79 
(d, 4JC,F = 1.8 Hz, C-3), 79.99 (d, 3JC,F = 8.9 Hz, C-2), 76.23 (CH2Ph), 75.52 (t, JC,F = 
21.2 Hz, C-1), 75.36 (CH2Ph), 74.18 (d, 3JC,F = 10.3 Hz, C-4), 73.78 (CH2Ph), 44.31 (t, 
2JC,F = 21.0 Hz, C-5), 24.53 (d, 3JC,F = 2.1 Hz, C-6), 20.61 (C-7), 14.48 (C-8). 
 
19F NMR (CDCl3, 235 MHz): δ –122.19 (ddd, 1F, J1,Fax = 18.8 Hz, J5,Fax = 29.5 Hz, 
JFeq,Fax = 245.2 Hz, Fax), –105.97 (d, 1F, JFeq,Fax = 245.2 Hz, Feq).  
 
[α]D20 = –5.0 (c 0.98, CHCl3). 
 
FABMS (M+Na)+: m/z 519.3. 
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1,6-Di-O-acetyl-2,3,4-tri-O-benzyl-5a-difluoro-5a-carba-α-D-galactopyranose (327) 
and 1,6-di-O-acetyl-2,3,4-tri-O-benzyl-5a-fluoro-5a-carba-β-L-arabino-hex-5-
enopyranose (328) 
 
 
 
 
Lindlar’s catalyst (3.0 mg) was added to a solution of 320 (51.0 mg, 0.10 mmol) in 
EtOAc (4 mL). Three purges of vacuum/argon were performed, followed by 5 
purges of vacuum/H2. After stirring for 4 h at room temperature under hydrogen 
(ca. 2 atm), the mixture was filtered through a Rotilabo® Nylon 0.45 μm filter, the 
solvent evaporated and the product was directly engaged in the next step. Ozone 
gas was bubbled through a solution of the product of the previous step (51.0 mg, 
0.10 mmol) in CH2Cl2 (40 mL) at –78 °C until the solution obtained a blue/violet 
colouration (typically 2 minutes). Oxygen was then bubbled through the solution 
for 1 min and then DMS (5 drops, until the blue color disappear) was added. The 
solution was allowed to warm to room temperature over a period of 30 min and 
the solvent evaporated. The product obtained was dissolved in a mixture of 
ethanol/CH2Cl2 (5.0 mL, 4:1) and NaBH4 (26.0 mg, 0.70 mmol) was added carefully. 
After stirring for 45 min at room temperature, TLC (cyclohexane/EtOAc 2:1) 
indicated complete consumption of starting material (Rf 0.33) and methanol (10 
mL) was added. After stirring for 10 min the solvent was removed under reduced 
pressure, and the residue co-evaporated with methanol (3 x 10 mL). Acetic 
anhydride (0.5 mL) was added dropwise to a solution of the crude product in 
pyridine (1 mL), and the mixture was stirred overnight at room temperature. The 
reaction mixture was concentrated under reduced pressure (azeotroped with 
toluene) and purified by flash column chromatography (cyclohexane/EtOAc 8:1) to 
yield 327 (32.4 mg, 57%), as a colorless oil and 328 (13.0 mg, 23%) also as a 
colorless oil. 
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1,6-Di-O-acetyl-2,3,4-tri-O-benzyl-5a-difluoro-5a-carba-α-D-galactopyranose (327) 
 
1H NMR (CDCl3, 400 MHz): δ 7.39 – 7.29 (m, 15H, Harom. Ph), 5.68 (dt, 1H, J1,2 = J1,Feq 
= 3.2 Hz, J1,Fax = 6.9 Hz, H-1), 5.01 (br d, 1H, J = 10.8 Hz, CHPh), 4.91 (d, 1H, J = 11.7 
Hz, CHPh), 4.76 (d, 1H, J = 11.7 Hz, CHPh), 4.74 (d, 1H, J = 11.1 Hz, CHPh), 4.61 (d, 
1H, J = 11.6 Hz, CHPh), 4.60 (d, 1H J = 11.0 Hz, CHPh), 4.45 (dd, 1H, J5,6a = 4.8 Hz, 
J6a,6b = 11.2 Hz, H-6a), 4.31 – 4.22 (m, 2H, H-2 and H-6b), 4.07 (ddd, 1H, J = 2.6 Hz, J 
= 3.0 Hz, 4J4,F = 5.7 Hz, H-4), 3.84 (dd, 1H, J3,4 = 2.8 Hz, J2,3 = 9.9 Hz, H-3), 2.52 (br d, 
1H, J5,Fax = 27.0 Hz, H-5), 2.16 (s, 3H, OAc), 2.00 (s, 3H, OAc). 
 
13C NMR (CDCl3, 100 MHz): δ 171.01, 169.58 (2 x C quat. OAc), 138.90, 138.75, 
138.08 (3 x Carom. quat. Ph), 128.81 – 127.90 (15 x CHarom. Ph), 120.16 (dd, 1JC,F = 
249.0 Hz, 1JC,F’ = 251.2 Hz, CF2), 79.49 (C-3), 75.72 (d, 3JC,F = 5.7 Hz, C-2), 75.46 
(CH2Ph), 74.37 (CH2Ph), 73.12 (CH2Ph), 73.11 (d, 3JC,F = 9.5 Hz, C-4), 69.53 (dd, 2JC,F 
= 20.6 Hz, 2JC,F’ = 36.5 Hz, C-1), 58.92 (C-6), 42.50 (br s, C-5), 21.26 (CH3, OAc), 
21.24 (CH3, OAc). 
 
19F NMR (CDCl3, 235 MHz) δ –109.21 (d, 1F, JFeq,Fax = 260.9 Hz), –105.11 (d, 1F, 
JFeq,Fax = 260.9 Hz). 
 
[α]D20 = +39.4 (c 0.75, CHCl3). 
 
HRCIMS Calcd for C32H38O7NF2 (M+NH4)+: 586.2616. Found: 586.2610. 
 
1,6-Di-O-acetyl-2,3,4-tri-O-benzyl-5a-fluoro-5a-carba-β-L-arabino-hex-5-
enopyranose (328) 
 
1H NMR (CDCl3, 400 MHz): δ 7.36 – 7.29 (m, 15H, Harom. Ph), 5.95 (dd, 1H, J1,2 = 4.6 
Hz, J1,F = 8.7 Hz, H-1), 5.01 (d, 1H, J = 11.0 Hz, CHPh), 4.97 (d, 1H, J = 11.9 Hz, 
CHPh), 4,78 (d, 1H, J6a,6b = 12.2 Hz, H-6a), 4.75 (d, 2H, J = 11.5 Hz, 2 x CHPh), 4.64 
(d, 1H, J = 11.4 Hz, CHPh), 4.62 (d, 1H, J = 11.9 Hz, CHPh), 4.51 (dd, 1H, 4J6b,F = 3.4 
Hz, J6a,6b = 12.4 Hz, H-6b), 4.32 (dd, 1H, J3,4 = 3.5 Hz, 4J4,F = 5.9 Hz, H-4), 4.26 (dd, 1H, 
J1,2 = 4.6 Hz, J2,3 = 10.2 Hz, H-2), 3.91 (dd, 1H, J3,4 = 3.5 Hz, J2,3 = 10.2 Hz, H-3), 2.15 
(s, 3H, OAc), 2.01 (s, 3H, OAc). 
 
13C NMR (CDCl3, 100 MHz): δ 170.97, 170.56 (2 x C quat. OAc), 154.28 (d, 1JC,F = 
269.7 Hz, CF), 138.93, 138.51, 138.25 (3 x Carom. quat. Ph), 128.85 – 127.99 (15 x 
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CHarom. Ph), 115.60 (d, 2JC,F = 8.3 Hz, C-5), 77.48 (C-3), 75.49 (CH2Ph), 74.61 (d, 3JC,F 
= 9.1 Hz, C-2), 74.45 (CH2Ph), 73.52 (CH2Ph), 72.43 (d, 3JC,F = 9.5 Hz, C-4), 66.44 (d, 
2JC,F = 24.5 Hz, C-1), 57.65 (d, 3JC,F = 6.3 Hz, C-6), 21.32 (CH3, OAc), 21.21 (CH3, OAc).  
 
19F NMR (CDCl3, 235 MHz): δ –112.35 (s, 1F). 
 
[α]D20 = +147.7 (c 0.60, CHCl3). 
 
HRCIMS Calcd for C32H37FNO7 (M+NH4)+: 566.2554. Found: 566.2553. 
 
 
1,6-Di-O-acetyl-2,3,4-tri-O-benzyl-5a-difluoro-5a-carba-β-D-galactopyranose (329) 
and 1,6-di-O-acetyl-2,3,4-tri-O-benzyl-5a-fluoro-5a-carba-α-L-arabino-hex-5-
enopyranose (330) 
 
 
 
Ozone gas was bubbled through a solution of 325 (50.0 mg, 0.10 mmol) in CH2Cl2 
(40 mL) at –78 °C until the solution obtained a blue coloration (typically 2 
minutes). Oxygen was then bubbled through the solution for 1 min and then DMS 
(4 drops, until the blue color disappear) was added. The solution was allowed to 
warm to room temperature over a period of 30 min and the solvent removed 
under reduced pressure. The product obtained was dissolved in a mixture of 
ethanol/CH2Cl2 (5.0 mL, 4:1) and NaBH4 (26.0 mg, 0.70 mmol) was added carefully. 
After stirring for 30 min at room temperature, TLC (cyclohexane/EtOAc 2:1) 
indicated complete consumption of starting material (Rf 0.40) and methanol (10 
mL) was added. After 10 min the solvent was removed under reduced pressure 
and the residue co-evaporated with methanol (3 x 10 mL). Acetic anhydride (0.5 
mL) was added dropwise to a solution of the crude product in pyridine (1 mL), and 
the mixture was stirred overnight at room temperature. The reaction mixture was 
concentrated under reduced pressure (azeotroped with toluene) and purified by 
flash column chromatography (cyclohexane/EtOAc 8:1) to yield 329 (35.8 mg, 
63%), as a colorless oil and 330 (11.5 mg, 21%) as a colorless oil. 
Experimental Part 
170 
 
1,6-Di-O-acetyl-2,3,4-tri-O-benzyl-5a-difluoro-5a-carba-β-D-galactopyranose (329) 
 
1H NMR (CDCl3, 400 MHz): δ 7.39 – 7.29 (m, 15H, Harom. Ph), 5.68 (ddd, 1H, J1,Feq = 
5.7 Hz, J1,2 = 10.0 Hz, J1,Fax = 20.0 Hz, H-1), 5.06 (d, 1H, J = 11.6 Hz, CHPh), 4.91 (d, 
1H, J = 11.4 Hz, CHPh), 4.86 (d, 1H, J = 11.6 Hz, CHPh), 4.79 (d, 1H, J = 11.6 Hz, 
CHPh), 4.70 (d, 1H, J = 11.4 Hz, CHPh), 4.63 (d, 1H J = 11.6 Hz, CHPh), 4.47 (dd, 1H, 
J5,6a = 4.7 Hz, J6a,6b = 11.2 Hz, H-6a), 4.29 (dd, 1H, J5,6b = 8.8 Hz, J6a,6b = 11.2 Hz, H-6a), 
4.20 (t, 1H, J1,2 = J2,3 = 10.0 Hz, H-2), 4.03 (app dd, 1H, J3,4 = 2.7 Hz, 4J4,F = 6.5 Hz, H-
4), 3.63 (dd, 1H, J3,4 = 2.7 Hz, J2,3 = 10.0 Hz, H-3), 2.24 (ddt, 1H, J5,6a = 4.2 Hz, J5,6b = 
J5,Feq = 8.8 Hz, J5,Fax = 27.6 Hz, H-5), 2.07 (s, 3H, OAc), 1.99 (s, 3H, OAc). 
 
13C NMR (CDCl3, 100 MHz): δ 170.90, 170.16 (2 x C quat. OAc), 138.64, 138.57, 
138.32 (3 x Carom. quat. Ph), 128.93 – 128.01 (15 x CHarom. Ph), 120.05 (dd, 1JC,F = 
247.2 Hz, 1JC,F’ = 253.9 Hz, CF2), 83.37 (d, 4JC,F = 1.5 Hz, C-3), 77.93 (d, 3JC,F = 6.4 Hz, 
C-2), 76.20 (CH2Ph), 75.41 (CH2Ph), 74.22 (CH2Ph), 73.24 (dd, 2JC,F = 18.8 Hz, 2JC,F’ = 
21.7 Hz, C-1), 72.88 (d, 3JC,F = 9.6 Hz, C-4), 58.71 (dd, 3JC,F = 1.2 Hz, 3JC,F’ = 4.9 Hz, C-
6), 43.80 (t, 2JC,F = 19.3 Hz, C-5), 21.16 (CH3, OAc), 21.00 (CH3, OAc). 
 
19F NMR (CDCl3, 235 MHz): δ –121.26 (ddd, 1F, J1,Fax = 20.0 Hz, J5,Fax = 27.6 Hz, 
JFeq,Fax = 249.4 Hz, Fax), –110.24 (ddd, 1F, J1,Feq = 5.7 Hz, J5,Feq = 8.8 Hz, JFeq,Fax = 249.4 
Hz, Feq). 
 
[α]D20 = –26.3 (c 0.96, CHCl3). 
 
HRCIMS Calcd for C32H38O7NF2 (M+NH4)+: 586.2616. Found: 586.2614. 
 
1,6-Di-O-acetyl-2,3,4-tri-O-benzyl-5a-fluoro-5a-carba-α-L-arabino-hex-5-
enopyranose (330) 
 
1H NMR (CDCl3, 400 MHz): δ 7.40 – 7.29 (m, 15H, Harom. Ph), 5.71 (d, 1H, J1,2 = 7.0 
Hz, H-1), 4.99 (d, 1H, J = 11.3 Hz, CHPh), 4.90 (d, 1H, J = 11.8 Hz, CHPh), 4.89 (d, 1H, 
J = 11.7 Hz, CHPh), 4.80 – 4.71 (m, 3H, 2 x CHPh, H-6a), 4.67 (d, 1H, J = 11.4 Hz, 
CHPh), 4.48 (dd, 1H, 4J6b,F = 3.6 Hz, J6a,6b = 12.3 Hz, H-6b), 4.28 (dd, 1H, J3,4 = 3.2 Hz, 
4J4,F = 6.0 Hz, H-4), 4.24 (dd, 1H, J1,2 = 7.0 Hz, J2,3 = 9.9 Hz, H-2), 3.69 (dd, 1H, J3,4 = 
3.2 Hz, J2,3 = 9.9 Hz, H-3), 1.99 (s, 3H, OAc), 1.97 (s, 3H, OAc). 
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13C NMR (CDCl3, 100 MHz): δ 170.92, 170.45 (2 x C quat. OAc), 154.39 (d, 1JC,F = 
270.3 Hz, CF), 138.66, 138.53, 138.49 (3 x Carom. quat. Ph), 128.91 – 128.14 (15 x 
CHarom. Ph), 113,67 (d, 2JC,F = 8.1 Hz, C-5), 79.76 (C-3), 78.05 (d, 3JC,F = 7.9 Hz, C-2), 
75.04 (CH2Ph), 74.86 (CH2Ph), 74.06 (CH2Ph), 72.45 (d, 3JC,F = 8.7 Hz, C-4), 70.34 (d, 
2JC,F = 21.1 Hz, C-1), 57.77 (d, 3JC,F = 6.4 Hz, C-6), 21.12 (CH3, OAc), 21.07 (CH3, OAc). 
 
19F NMR (CDCl3, 235 MHz) δ –117.22 (s, 1F). 
 
[α]D20 = –22.1 (c 0.90, CHCl3). 
 
HRCIMS Calcd for C32H37FNO7 (M+NH4)+: 566.2554. Found: 566.2555. 
 
 
5a-Difluoro-5a-carba-α-D-galactopyranose (331) 
 
 
 
To a solution of 327 (25.1 mg, 0.04 mmol) in MeOH, was added dropwise a 1 M 
solution of NaOMe (1 mL) and the mixture stirred for 6 h at room temperature. 
The reaction mixture was neutralized with acid resin Amberlite® IR 120 (H+), 
filtered and concentrated under reduced pressure. The product was directly 
engaged in the next step. 10% Pd/C (2.0 mg) was added to a solution of the diol in 
MeOH (1.5 mL). Three purges of vacuum/argon were performed, followed by 5 
purges of vacuum/H2. After stirring for 3 h at room temperature under hydrogen 
(ca. 2 atm), the mixture was filtered through a Rotilabo® Nylon 0.45 μm filter and 
the solvent evaporated to afford 5a-difluoro-5a-carba-α-D-galactopyranose (331) 
(9.3 mg, 100%) as a white crystalline solid. 
 
1H NMR (CD3OD, 400 MHz): δ 4.18 (ddd, 1H, J = 3.0 Hz, J3,4 = 3.2 Hz, J = 6.0 Hz, H-4) 
4.00 – 3.85 (m, 4H, H-1, H-2, H-6a, H-6b), 3.78 (dd, 1H, J3,4 = 3.3 Hz, J2,3 = 9.8 Hz, H-
3), 2.36 (ddq, 1H, J = 4.4 Hz, J = 8.1 Hz, J5,Fax = 31.4 Hz, H-5). 
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13C NMR (CD3OD, 100 MHz): δ 123.07 (dd, 1JC,F = 246.1 Hz, 1JC,F’ = 258.5 Hz, CF2), 
72.53 (dd, 2JC,F = 20.4 Hz, 2JC,F’ = 33.1 Hz, C-1), 70.64 (C-3), 68.78 (d, 3JC,F = 7.3 Hz, C-
2), 67.35 (d, 3JC,F = 10.1 Hz, C-4) 55.72 (dd, 3JC,F = 2.2 Hz, 3JC,F’ = 3.5 Hz, C-6), 43.70 (t, 
2JC,F = 19.7 Hz, C-5). 
 
19F NMR (CD3OD, 235 MHz): δ –111.19 (dd, 1F, J5,Fax = 31.0 Hz, JFeq,Fax = 255.7 Hz, 
Fax), –107.23 (dd, 1F, J5,Feq = 5.0 Hz, JFeq,Fax = 256.3 Hz, Feq). 
 
[α]D20 = +1.8 (c 0.80, MeOH). 
 
m. p. 232°C (MeOH). 
 
HRCIMS Calcd for C7H16O5NF2 (M+NH4)+: 232.0997. Found: 232.1002. 
 
 
2,3,4-Tri-O-benzyl-5a-difluoro-5a-carba-β-D-galactopyranose (332) 
 
 
 
To a solution of 329 (35.8 mg, 0.06 mmol) in MeOH (5 mL) was added dropwise a 
1 M solution of NaOMe until the pH of the solution reached the value of 10. After 5 
h the reaction mixture was neutralized with acid resin Amberlite® IR 120 (H+), 
filtered and concentrated under reduced pressure. Purification by flash 
chromatography (Cyclohexane/EtOAc 2:1) yielded 332 (28.7 mg, 94%) as a pale 
yellow oil. 
 
1H NMR (CDCl3, 400 MHz): δ 7.41 – 7.28 (m, 15H, Harom. Ph), 5.02 (d, 1H, J = 11.9 
Hz, CHPh), 4.96 (d, 1H, J = 11.1 Hz, CHPh), 4.82 (d, 3H, J = 11.3 Hz, 3 x CHPh), 4.68 
(d, 1H, J = 11.9 Hz, CHPh), 4.17 (d, 1H, J3,4 = 3.0 Hz, H-4) 4.06 (t, 1H, J1,2 = J2,3 = 9.0 
Hz, H-2), 3.99 (dd, 1H, J5,6a = 4.3 Hz, J6a,6b = 10.9 Hz, H-6a), 3.87 (t, 1H, J5,6b = J6a,6b = 
10.5 Hz, H-6b), 3.76 (dt, 1H, J1,2 = J1,Feq = 8.5 Hz, J1,Fax = 16.7 Hz, H-1), 3.58 (dd, 1H, 
J3,4 = 2.6 Hz, J2,3 = 9.1 Hz, H-3), 2.70 (br s, 1H, OH), 2.04 (br d, 1H, J5,Fax = 24.5 Hz, H-
5), 1.64 (br s, 1H, OH). 
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13C NMR (CDCl3, 100 MHz): δ 138.87, 138.61, 138.24 (3 x Carom. quat. Ph), 128.98 – 
127.09 (15 x CHarom. Ph), 121.55 (dd, 1JC,F = 244.0 Hz, 1JC,F’ = 252.7 Hz, CF2), 82.53 
(C-3), 79.67 (d, 3JC,F = 7.9 Hz, C-2), 75.97 (CH2Ph), 74.83 (CH2Ph), 74.63 (br s, C-1), 
73.73 (CH2Ph), 72.12 (d, 3JC,F = 9.0 Hz, C-4), 56.73 (dd, 3JC,F = 2.6 Hz, 3JC,F’ = 4.3 Hz, C-
6), 46.47 (t, 2JC,F = 19.8 Hz, C-5). 
 
19F NMR (CDCl3, 235 MHz): δ –119.52 (br d, 1F, JFeq,Fax = 256.7 Hz), –104.79 (br d, 
1F, JFeq,Fax = 251.0 Hz). 
 
[α]D20 = –19.1 (c 1.00, CHCl3). 
 
HRCIMS Calcd for C28H31O5F2 (M+H)+: 485.2140. Found: 485.2143. 
 
 
5a-Difluoro-5a-carba-β-D-galactopyranose (333) 
 
 
 
10% Pd/C (2 mg) was added to a solution of 332 (18.0 mg, 0.04 mmol) in MeOH (3 
mL). Three purges of vacuum/argon were performed, followed by 5 purges of 
vacuum/H2. After stirring for 2 h at room temperature under hydrogen (ca. 2 atm), 
the mixture was filtered through a Rotilabo® Nylon 0.45 μm filter and the solvent 
evaporated to afford gem-difluorocarba-β-D-galactopyranose 333 (7.2 mg, 91%) as 
a colorless oil. 
 
1H NMR (CD3OD, 400 MHz): δ 4.17 (ddd, 1H, J = 2.6 Hz, J3,4 = 3.0 Hz, J = 5.3 Hz, H-4) 
4.01 – 3.95 (m, 2H, H-6a, H-6b), 3.76 (dt, 1H, J2,F = 1.2 Hz, J1,2 = J2,3 9.8 Hz, H-2), 3.55 
(ddd, 1H, J1,Feq = 6.4 Hz, J1,2 = 9.8 Hz, J1,Fax = 20.1 Hz, H-1), 3.44 (dd, 1H, J3,4 = 3.2 Hz, 
J2,3 = 9.7 Hz, H-3), 2.06 (br d, 1H, J5,Fax = 27.4 Hz, H-5). 
 
13C NMR (CD3OD, 100 MHz): δ 122.17 (dd, 1JC,F = 243.2 Hz, 1JC,F’ = 250,0 Hz, CF2), 
74.64 (t, 2JC,F = 20.4 Hz, C-1), 73.89 (d, 4JC,F = 1.8 Hz, C-3), 71.29 (d, 3JC,F = 9.0 Hz, C-
2), 67.68 (d, 3JC,F = 9.8 Hz, C-4) 55.49 (dd, 3JC,F = 2.4 Hz, 3JC,F’ = 4.7 Hz, C-6), 46.18 (t, 
2JC,F = 19.4 Hz, C-5). 
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19F NMR (CD3OD, 235 MHz): δ –123.80 (ddd, 1F, J1,Fax = 20.1 Hz, J5,Fax = 29.8 Hz, 
JFeq,Fax = 247.0 Hz, Fax), –108.52 (ddd, 1F, J1,Feq = 5.2 Hz, J5,Feq = 10.5 Hz, JFeq,Fax = 
247.0 Hz, Feq). 
 
[α]D20 = –16.2 (c 0.50, MeOH). 
 
HRCIMS Calcd for C7H16O5NF2 (M+NH4)+: 232.0997. Found: 232.0988. 
 
 
1,2,3,4-Tetra-O-acetyl-6-deoxy-5a-fluoro-5a-carba-β-L-arabino-hex-5-enopyranose 
(334) 
 
 
 
10% Pd/C (3 mg) was added to a solution of 328 (14.0 mg, 0.03 mmol) in 
EtOAc/MeOH (4 mL, 3:1). Three purges of vacuum/argon were performed, 
followed by 5 purges of vacuum/H2. After stirring for 1.5 h at room temperature 
under hydrogen atmosphere, the mixture was filtered through a Rotilabo® Nylon 
0.45 μm filter and the solvent evaporated. The crude was dissolved in anhydrous 
pyridine (1 mL) and acetic anhydride (0.5 mL) was added dropwise. The reaction 
mixture was stirred for 3 h at room temperature and then concentrated under 
reduced pressure (azeotroped with toluene). Purification by flash chromatography 
(Cyclohexane/EtOAc 4:1) afforded 334 (9.8 mg, 94%), as a pale yellow oil. 
 
1H NMR (CDCl3, 400 MHz): δ 5.89 (dd, 1H, J1,2 = 4.2 Hz, J1,F = 9.3 Hz, H-1), 5.72 (dd, 
1H, J3,4 = 4.0 Hz, 4J4,F = 5.8 Hz, H-4), 5.47 (dd, 1H, J1,2 = 4.2 Hz, J2,3 = 11.4 Hz, H-2), 
5.39 (dd, 1H, J3,4 = 4.0 Hz, J2,3 = 11.4 Hz, H-3), 2.15 (s, 3H, OAc), 2.14 (s, 3H, OAc), 
2.02 (s, 6H, 2 x OAc), 1.73 (d, 3H, 4JCH3,F = 2.8 Hz, CH3). 
 
13C NMR (CDCl3, 100 MHz): δ 171.01, 170.52, 170.35, 170.15 (4 x Cquat. OAc), 
152.29 (d, 1JC,F = 261.2 Hz, CF), 114,70 (d, 2JC,F = 14.9 Hz, C-5), 68.49 (d, 3JC,F = 11.2 
Hz, C-4), 66.46 (d, 4JC,F = 1.6 Hz, C-3), 66.16 (d, 2JC,F = 25.5 Hz, C-1), 66.07 (d, 3JC,F = 
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13.6 Hz, C-2), 21.07 (CH3, OAc), 21.02 (CH3, OAc), 20.99 (CH3, OAc), 20.94 (CH3, 
OAc), 12.53 (d, 3JC,F = 4.0 Hz, C-6). 
 
19F NMR (CDCl3, 235 MHz): δ –113.79 (s, 1F). 
 
[α]D20 = +109.7 (c 0.35, CHCl3). 
 
HRCIMS Calcd for C15H23FNO8 (M+NH4)+: 364.1408. Found: 364.1408. 
 
 
6-Deoxy-5a-fluoro-5a-carba-β-L-arabino-hex-5-enopyranose (335) 
 
 
 
To a solution of 334 (9.8 mg, 0.03 mmol) in MeOH (2 mL) was added dropwise a    
1 M solution of NaOMe freshly prepared, until the pH of the solution reached the 
value of 10. After 2 h the reaction mixture was neutralized with acid resin 
Amberlite® IR 120 (H+), filtered and concentrated under reduced pressure to 
afford 335 (5.1 mg, 100%) as a colourless oil. 
 
1H NMR (D2O, 400 MHz): δ 4.28 (ddd, 1H, J = 0.9 Hz, J1,2 = 4.6 Hz, J1,F = 9.7 Hz, H-1), 
4.08 (dd, 1H, J3,4 = 4.1 Hz, 4J4,F = 6.5 Hz, H-4), 3.81 (ddd, 1H, J = 1.0 Hz, J1,2 = 4.6 Hz, 
J2,3 = 10.9 Hz, H-2), 3.71 (dd, 1H, J3,4 = 4.1 Hz, J2,3 = 10.9 Hz, H-3), 1.65 (d, 3H, 4JCH3,F 
= 2.8 Hz, CH3). 
 
13C NMR (CDCl3, 100 MHz): δ 153.97 (d, 1JC,F = 256.8 Hz, CF), 114,86 (d, 2JC,F = 12.1 
Hz, C-5), 69.70 (d, 3JC,F = 11.0 Hz, C-4), 68.29 (d, 4JC,F = 1.8 Hz, C-3), 67.94 (d, 3JC,F = 
11.0 Hz, C-2), 66.90 (d, 2JC,F = 25.7 Hz, C-1), 11.73 (d, 3JC,F = 5.0 Hz, C-6). 
 
19F NMR (CDCl3, 235 MHz): δ –118.15 (s, 1F). 
 
[α]D20 = +88.5 (c 0.13, MeOH). 
 
HRCIMS Calcd for C7H15FNO4 (M+NH4)+: 196.0985. Found: 196.0988. 
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2,3,4-Tri-O-benzyl-5a-fluoro-5a-carba-α-L-arabino-hex-5-enopyranose (336) 
 
 
 
To a solution of 330 (10.0 mg, 0.02 mmol) in MeOH (3 mL) was added dropwise a 
1 M solution of NaOMe until the pH of the solution reached the value of 10. After 4 
h the reaction mixture was neutralized with acid resin Amberlite® IR 120 (H+), 
filtered and concentrated under reduced pressure. Purification by flash 
chromatography (Cyclohexane/EtOAc 2:1) yielded 336 (8.3 mg, 89%) as a pale 
yellow oil. 
 
1H NMR (CDCl3, 400 MHz): δ 7.40 – 7.28 (m, 15H, Harom. Ph), 4.81 (d, 1H, J = 11.4 
Hz, CHPh), 4.80 (d, 1H, J = 11.8 Hz, CHPh), 4.75 (d, 1H, J = 11.6 Hz, CHPh), 4.73 (d, 
1H, J = 10.9 Hz, CHPh), 4.70 (d, 1H, J = 11.8 Hz, CHPh), 4.61 (d, 1H, J = 11.5 Hz, 
CHPh), 4.52 (dd, 1H, J3,4 = 3.3 Hz, 4J4,F = 6.0 Hz, H-4), 4.31 – 4.24 (m, 2H, H-6a, H-
6b), 4.19 (app d, 1H, J1,2 = 7.0 Hz, H-1), 4.03 (m, 1H, H-2), 3.81 (dd, 1H, J3,4 = 3.3 Hz, 
J2,3 = 7.0 Hz, H-3), 3.67 (m, 1H, OH-6), 2.80 (br s, 1H, OH-1). 
 
13C NMR (CDCl3, 100 MHz): δ 155.06 (d, 1JC,F = 264.9 Hz, CF), 138.27, 138.26, 
138.06 (3 x Carom. quat. Ph), 129.05 – 128.30 (15 x CHarom. Ph), 115,35 (d, 2JC,F = 9.8 
Hz, C-5), 78.93 (d, 3JC,F = 9.1 Hz, C-2), 76.19 (C-3), 74.70 (d, 3JC,F = 8.0 Hz, C-4), 74.04 
(CH2Ph), 73.97 (CH2Ph), 73.86 (CH2Ph), 69.41 (d, 2JC,F = 24.1 Hz, C-1), 56.50 (d, 3JC,F 
= 6.9 Hz, C-6). 
 
19F NMR (CDCl3, 235 MHz): δ –119.28 (s, 1F). 
 
[α]D20 = +24.6 (c 1.20, CHCl3). 
 
HRCIMS Calcd for C28H33FNO5 (M+NH4)+: 482.2343. Found: 482.2330. 
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1,2,3,4,6-Penta-O-acetyl-5a-fluoro-5a-carba-β-L-arabino-hex-5-enopyranose (337) 
 
 
 
A 1 M solution of boron trichloride in CH2Cl2 (0.31 mL, 310.0 μmol) was added 
dropwise to a stirred solution of 328 (19.0 mg, 34.0 μmol) in anhydrous CH2Cl2 (2 
mL) at –78 °C under argon. After 2 h, the reaction mixture was quenched with a 
solution of CH2Cl2/MeOH (10 mL, 1:1) and concentrated under reduced pressure. 
The crude product was dissolved in dry pyridine (1 mL) and acetic anhydride (0.5 
mL) was added dropwise. The reaction mixture was stirred overnight, and then 
concentrated under reduced pressure (azeotroped with toluene). Purification by 
flash chromatography (cyclohexane-EtOAc 2:1) afforded 337 (10.7 mg, 78%) as a 
colourless oil. 
 
1H NMR (CDCl3, 400 MHz): δ 5.86 – 5.82 (m, 2H, H-1, H-4), 5.41 (ddd, 1H, J = 0.8 Hz, 
J1,2 = 4.3 Hz, J2,3 = 11.4 Hz, H-2), 5.32 (dd, 1H, J3,4 = 3.9 Hz, J2,3 = 11.4 Hz, H-3), 4.70 
(dd, 1H, 4J6a,F = 2.0 Hz, J6a,6b = 13.0 Hz, H-6a), 4.55 (ddd, 1H, J = 0.9 Hz, 4J6b,F = 3.2 Hz, 
J6a,6b = 13.0 Hz, H-6b), 2.08 (s, 3H, OAc), 2.03 (s, 3H, OAc), 2.00 (s, 3H, OAc), 1.94 (s, 
6H, 2 x OAc). 
 
13C NMR (CDCl3, 100 MHz): δ 170.35, 170.08, 169.85, 169.64 (4 x Cquat. OAc), 
157.21 (d, 1JC,F = 280.3 Hz, CF), 113,66 (d, 2JC,F = 11.2 Hz, C-5), 65.88 (d, 4JC,F = 1.3 
Hz, C-3), 65.43 (d, 3JC,F = 10.3 Hz, C-2), 65.34 (d, 2JC,F = 27.6 Hz, C-1), 64.32 (d, 3JC,F = 
10.1 Hz, C-4), 56.72 (d, 3JC,F = 5.6 Hz, C-6), 20.64 (CH3, 2 x OAc), 20.56 (CH3, OAc), 
20.54 (CH3, OAc), 20.50 (CH3, OAc). 
 
19F NMR (CDCl3, 235 MHz): δ –108.79 (s, 1F). 
 
[α]D20 = +78.6 (c 0.23, CHCl3). 
 
HRCIMS Calcd for C17H25FNO10 (M+NH4)+: 422.1462. Found: 422.1467. 
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5a-Fluoro-5a-carba-β-L-arabino-hex-5-enopyranose (338) 
 
 
 
To a solution of 337 (10.7 mg, 0.03 mmol) in MeOH (3 mL) was added dropwise a 
1 M solution of NaOMe freshly prepared, until the pH of the solution reached the 
value of 10. After 4 h the TLC showed no trace of starting material. The mixture 
was neutralized with acid resin Amberlite® IR 120 (H+), filtered and concentrated 
under reduced pressure to afford 338 (5.0 mg, 100%) as a colourless oil. 
 
1H NMR (D2O, 400 MHz): δ 4.31 – 4.25 (m, 3H, H-1, H-4, H-6a), 3.93 (ddd, 1H, J = 
1.1 Hz, 4J6b,F = 3.4 Hz, J6a,6b = 12.7 Hz, H-6b), 3.80 (ddd, 1H, J = 0.7 Hz, J1,2 = 4.6 Hz, 
J2,3 = 10.7 Hz, H-2), 3.67 (dd, 1H, J3,4 = 4.1 Hz, J2,3 = 10.7 Hz, H-3). 
 
13C NMR (CDCl3, 100 MHz): δ 155.79 (d, 1JC,F = 266.7 Hz, CF), 116.61 (d, 2JC,F = 9.5 
Hz, C-5), 68.00 (d, 4JC,F = 1.6 Hz, C-3), 67.28 (d, 3JC,F = 10.9 Hz, C-2), 66.38 (d, 2JC,F = 
25.2 Hz, C-1), 65.45 (d, 3JC,F = 10.2 Hz, C-4), 54.40 (d, 3JC,F = 6.2 Hz, C-6). 
 
19F NMR (CDCl3, 235 MHz): δ –115.80 (s, 1F). 
 
[α]D20 = +41.3 (c 0.14, MeOH). 
 
HRCIMS Calcd for C7H15FNO5 (M+NH4)+: 212.0934. Found: 212.0935. 
 
 
1,2,3,4,6-Penta-O-acetyl-5a-fluoro-5a-carba-α-L-arabino-hex-5-enopyranose (339) 
 
 
 
A 1 M solution of boron trichloride in CH2Cl2 (0.40 mL, 0.40 mmol) was added 
dropwise to a solution of 330 (24.4 mg, 0.044 mmol) in anhydrous CH2Cl2 (4 mL) 
at –78 °C under argon. After stirred for 3.5 h, the reaction mixture was quenched 
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with a solution of CH2Cl2/MeOH (12 mL, 1:1) and concentrated under reduced 
pressure. The crude was dissolved in dry pyridine (1 mL) and acetic anhydride 
(0.5 mL) was added dropwise. The reaction mixture was stirred overnight, and 
then concentrated under reduced pressure (azeotroped with toluene). Purification 
by flash chromatography (cyclohexane-EtOAc 2:1) afforded 339 (13.3 mg, 75%) as 
a colourless oil 
 
1H NMR (CDCl3, 400 MHz): δ 5.88 (dd, 1H, J3,4 = 3.8 Hz, 4J4,F = 5.7 Hz, H-4), 5.72 (app 
d, 1H, J1,2 = 7.1 Hz, H-1), 5.52 (dd, 1H, J1,2 = 7.1 Hz, J2,3 = 11.1 Hz, H-2), 5.08 (dd, 1H, 
J3,4 = 3.8 Hz, J2,3 = 11.1 Hz, H-3), 4.70 (app dt, 1H, 4J6a,F =1.4 Hz, J6a,6b = 12.9 Hz, H-
6a), 4.54 (ddd, 1H, J = 1.10 Hz, 4J6b,F =3.5 Hz, J6a,6b = 12.9 Hz, H-6b), 2.06 (s, 3H, 
OAc), 2.05 (s, 3H, OAc), 1.99 (s, 3H, OAc), 1.98 (s, 3H, OAc), 1.94 (s, 3H, OAc). 
 
13C NMR (CDCl3, 100 MHz): δ 168.92, 168.62, 168.37, 168.18 (5 x Cquat. OAc), 
153.31 (d, 1JC,F = 272.8 Hz, CF), 110.34 (d, 2JC,F = 11.2 Hz, C-5), 67.77 (d, 3JC,F = 8.1 
Hz, C-2), 67.10 (d, 2JC,F = 22.9 Hz, C-1), 66.38 (d, 4JC,F = 1.9 Hz, C-3), 63.29 (d, 3JC,F = 
9.5 Hz, C-4), 55.46 (d, 3JC,F = 6.0 Hz, C-6), 19.28 (CH3, OAc), 19.20 (CH3, 2 x OAc), 
19.10 (CH3, OAc), 19.03 (CH3, OAc). 
 
19F NMR (CDCl3, 235 MHz): δ –113.98 (s, 1F). 
 
[α]D20 = +38.7 (c 0.34, CHCl3). 
 
HRCIMS Calcd for C17H25FNO10 (M+NH4)+: 422.1462. Found: 422.1461. 
 
 
5a-Fluoro-5a-carba-α-L-arabino-hex-5-enopyranose (340) 
 
 
 
To a solution of 339 (13.3 mg, 0.033 mmol) in MeOH (3 mL) was added dropwise a 
1 M solution of NaOMe freshly prepared, until the pH of the solution reached the 
value of 10. After 5 h the mixture was neutralized with acid resin Amberlite® IR 
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120 (H+), filtered and concentrated under reduced pressure to afford 340 (6.3 mg, 
100%) as a colourless oil. 
 
1H NMR (D2O, 400 MHz): δ 4.44 – 4.31 (m, 2H, H-4, H-6a), 4.19 (d, 1H, J1,2 = 7.6 Hz, 
H-1), 4.03 (ddd, 1H, J = 0.6 Hz, 4J6b,F = 3.8 Hz, J6a,6b = 12.5 Hz, H-6b), 3.73 (dd, 1H, J1,2 
= 7.6 Hz, J2,3 = 10.8 Hz, H-2), 3.53 (dd, 1H, J3,4 = 4.0 Hz, J2,3 = 10.8 Hz, H-3). 
 
13C NMR (D2O, 100 MHz): δ 155.67 (d, 1JC,F = 266.6 Hz, CF), 115.16 (d, 2JC,F = 9.6 Hz, 
C-5), 71.85 (d, 3JC,F = 8.2 Hz, C-2), 70.04 (d, 2JC,F = 21.6 Hz, C-1), 70.03 (d, 4JC,F = 2.6 
Hz, C-3), 66.04 (d, 3JC,F = 9.9 Hz, C-4), 54.60 (d, 3JC,F = 6.4 Hz, C-6). 
 
19F NMR (D2O, 235 MHz): δ –122.06 (s, 1F). 
 
[α]D20 = +17.5 (c 0.20, MeOH). 
 
HRCIMS Calcd for C7H15FNO5 (M+NH4)+: 212.0934. Found: 212.0933. 
 
 
4-Methoxyphenyl 2,3,4,6-tetra-O-benzoyl-β-D-galactopyranoside (346) 
 
 
 
BF3.Et2O (1.4 mL, 10.58 mmol) was added to a stirred solution of 4-methoxyphenol 
(1.3 g, 10.58 mmol) and 1,2,3,4,6-penta-O-benzoyl-D-galactopyranoside (345) (5.0 
g, 7.05 mmol) in anhydrous CH2Cl2 (150 mL) at 0 °C under argon. The reaction 
mixture was allowed to reach room temperature and stirred for 18 h, then 
quenched with a saturated solution of NaHCO3 (75 mL) and stirred for more 15 
min. The mixture was washed with a saturated solution of NaHCO3 (2 x 50 mL) and 
with a 1 M solution of HCl (75 mL). The organic phase was dried (MgSO4), filtered 
and the solvent evaporated. Flash column chromatography (cyclohexane/EtOAc, 
6:1) afforded the tetrabenzoate 346 (3.7 g, 75%) 
 
1H NMR (CDCl3, 400 MHz): δ 8.20 (d, 2H, J = 7.3 Hz, Harom. Bz), 8.13 (d, 2H, J = 7.3 
Hz, Harom. Bz), 8.04 (d, 2H, J = 7.4 Hz, Harom. Bz), 7.90 (d, 2H, J = 7.4 Hz, Harom. Bz), 
7.65 – 7.58 (m, 2H, Harom. Bz), 7.52 – 7.42 (m, 2H, Harom. Bz), 7.35 (t, 2H, J = 7.8 Hz, 
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Harom. Bz), 7.25 (t, 2H, J = 7.8 Hz, Harom. Bz), 7.09 (d, 2H, J = 9.0 Hz, Harom. OpMP), 
6.74 (d, 2H, J = 9.0 Hz, OpMP), 6.22 – 6.18 (m, 2H, H-2, H-4), 5.88 (dd, 1H, J3,4 = 3.4 
Hz, J2,3 = 10.4 Hz, H-3), 5.45 (d, 1H, J1,2 = 8.0 Hz, H-1), 4.80 (dd, 1H, J5,6a = 7.3 Hz, 
J6a,6b = 10.8 Hz, H-6a), 4.68 – 4.60 (m, 2H, H-5, H-6b), 3.72 (s, 3H, OCH3). 
 
13C NMR (CDCl3, 100 MHz): δ 166.43, 166.11, 166.10, 165.82 (4 x C quat. OAc) 
156.22, 151.63 (2 x Carom. quat. OpMP), 134.20, 133.86, 133.82 (CHarom. Bz), 130.52 
– 130.18 (CHarom. Bz), 129.99, 129.67, 129.38, 12.19 (4 x Carom. quat. Bz), 129.15 – 
128.82 (CHarom. Bz), 119.41, 114.96 (4 x CHarom. OpMP), 101.69 (C-1), 72.36 (C-3), 
72.26 (C-5), 70.19, 68.69 (C-2 and C-4), 62.95 (C-6), 55.96 (OCH3). 
 
CIMS (M+NH4)+: m/z 720. 
 
 
1,6-Anhydro-β-D-galactopyranose (347) 
 
 
 
To the 4-methoxyphenyl 2,3,4,6-tetra-O-benzoyl-β-D-galactopyranoside (346) (7.5 
g, 10.7 mmol) was added a 2.5 M solution of NaOH (200 mL) and the resulting 
mixture was refluxed over 3 days. After cooling to room temperature conc. HCl was 
slowly added until the pH of the reaction mixture reached the value of 3. The water 
was evaporated and the residue extracted with a mixture of CHCl3/MeOH (200 
mL). This extract was filtered through a pad of celite® and the solvents evoparated 
to afford 347[206] (1.1 g, 64%) as a white solid. 
 
1H NMR (D2O, 400 MHz): δ  5.37 (br s, 1H, H-1), 4.46 (app t, 1H, J4,5 = J5,6b = 4.5 Hz, 
H-5), 4.24 (d, 1H, J6a,6b = 7.4 Hz, H-6a), 4.08 (br t, 1H, J3,4 = J4,5 = 4.5 Hz, H-4), 3.88 
(dq, 1H, J1,3 = J2,3 = J3,5 = 1.3 Hz, J3,4 = 4.5 Hz, H-3), 3.71 (t, 1H, J1,2 = J2,3 = 1.3 Hz, H-2), 
3.63 (app dd, 1H, J5,6b = 4.5 Hz, J6a,6b = 7.4 Hz, H-6b). 
 
13C NMR (D2O, 100 MHz): δ 100.93 (C-1), 74.81 (C-5), 72.18 (C-2), 70.91 (C-3), 
64.98 (C-4), 64.21 (C-6). 
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CIMS (M+NH4)+: m/z 180. 
 
 
1,6-Anhydro-(S)-3,4-O-benzylidene-β-D-galactopyranose (348) 
 
 
 
The 1,6-anhydro-β-D-galactose (347) (1.1 g, 6.8 mmol) was dissolved in 
benzaldehyde dimethylacetal (10 mL) and a catalytic amount 10-camphorsulfonic 
acid (0.10 g) was added under argon. After stirring for 17 h at room temperature 
the solution was neutralized by dropwise addition of Et3N. The reaction mixture 
was diluted with ether (100 mL) and washed with water (50 mL). The aqueous 
layer was extracted with ether (2 x 30 mL), the organic layers combined, dried 
(MgSO4), filtered and the solvent evaporated. Flash column chromatography 
(cyclohexane/EtOAc 9:1 then cyclohexane/EtOAc 2:1) gave 348[183] (0.98 g, 58%) 
as a pale yellow oil. 
 
1H NMR (CDCl3, 250 MHz): δ  7.42 – 7.33 (m, 5H, Harom. Ph), 5.74 (s, 1H, H-7), 5.37 
(br s, 1H, H-1), 4.53 – 4.44 (m, 2H, H-3 and H-4), 4.17 (br d, 1H, J5,6 = 6.3 Hz, H-5), 
4.04 – 4.01 (m, 2H, H-2 and H-6a), 3.45 (dd, 1H, J5,6b = 5.6 Hz, J6a,6b = 7.3 Hz, H-6b). 
 
13C NMR (CDCl3, 63 MHz): δ 135.57 (Carom. quat. Ph), 129.02 – 127.94 (5 x CHarom. 
Ph), 103.12 (C-7), 101.14 (C-1), 78.39 (C-5), 72.64 (C-2), 69.84 (C-3), 69.43 (C-4), 
63.80 (C-6). 
 
CIMS (M+NH4)+: m/z 268. 
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1,6-Anhydro-2-O-benzyl-(S)-3,4-O-benzylidene-β-D-galactopyranose (349) 
 
 
 
To a solution of 348 (0.22 g, 2.72 mmol) in dry DMF (5 mL) was added NaH (0.22 
g, 5.44 mmol, 60% w/w) and the solution was heated at 35 °C for 15 min. BnBr 
(0.65 mL, 5.44 mmol) was then added and the resulting mixture stirred overnight 
at room temperature. The reaction mixture was quenched with MeOH (5 mL) and 
concentrated under reduced pressure. The crude product was dissolved in ether 
(30 mL) and washed with water (15 mL). The aqueous phase was extracted with 
ether (4 x 10 mL), the organic layers were combined, dried (MgSO4), filtered and 
the solvent evaporated. Purification by flash column chromatography 
(cyclohexane/EtOAc 9:1) afforded 349[183] (0.90 g, 93%) as a pale yellow oil. 
 
1H NMR (CDCl3, 400 MHz): δ  7.56 – 7.40 (m, 10H, Harom. Ph), 5.85 (s, 1H, H-7), 5.50 
(br s, 1H, H-1), 4.80 (d, 1H, J = 12.0 Hz, CHPh), 4.68 (d, 1H, J = 12.0 Hz, CHPh), 4.65 
– 4.59 (m, 2H, H-4 and H-5), 4.31 (br d, 1H, J3,4 = 6.9 Hz, H-3), 4.12 (d, 1H, J6a,6b = 7.7 
Hz, H-6a), 3.81 (s, 1H, H-2), 3.54 (ddd, 1H, J4,6b = 0.9 Hz, J5,6b = 4.9 Hz, J6a,6b = 7.7 Hz, 
H-6b). 
 
13C NMR (CDCl3, 100 MHz): δ 137. 69, 135.96 (2 x Carom. quat. Ph), 129.90 – 126.66 
(10 x CHarom. Ph), 103.28 (C-7), 100.29 (C-1), 77.02 (C-2), 76.43 (C-3), 72.67 
(CH2Ph), 72.58 (C-4 or C-5), 70.08 (C-4 or C-5), 63.75 (C-6). 
 
CIMS (M+NH4)+: m/z 358. 
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1,6-Anhydro-2,3-di-O-benzyl-β-D-galactopyranose (350). 
 
 
 
LiAlH4 (60 mg, 1.5 mmol) was carefully added in three portions to an ice-cooled 
solution of benzylidene 349 (100 mg, 0.3 mmol) in a mixture of CH2Cl2/Et2O (10 
mL, 1:1) under argon. After 10 min, the reaction mixture was heated to 50 °C, and a 
solution of AlCl3 (120 mg, 0.9 mmol) in Et2O (5 mL) was added dropwise under 
argon. After stirring for 4 h, the reaction mixture was cooled to 0 °C and quenched 
by slowly addition of EtOAc followed by some drops of water. MgSO4 was added, 
the reaction mixture filtered through a pad of celite® and the solvent removed 
under reduced pressure. Purification by flash column chromatography 
(cyclohexane/EtOAc 2:1) gave 350[180] (82 mg, 82%) as a colorless oil. 
 
1H NMR (CDCl3, 400 MHz): δ 7.42 – 7.28 (m, 10H, Harom. Ph), 5.43 (br s, 1H, H-1), 
4.60 (d, 1H, J = 12.4 Hz, CHPh), 4.58 (d, 1H, J = 11.5 Hz, CHPh), 4.57 (d, 1H, J = 12.4 
Hz, CHPh), 4.42 (t, 1H, J4,5 = J5,6b = 4.6 Hz, H-5), 4.34 (d, 1H, J = 11.5 Hz, CHPh), 4.19 
(d, 1H, J6a,6b = 7.4 Hz, H-6a), 4.11 (m, 1H, H-4), 3.77 (app dd, 1H, J2,3 = 1.1 Hz, J3,4 = 
5.7 Hz, H-3), 3.54 (dd, 1H, J5,6b = 4.6 Hz, J6a,6b = 7.4 Hz, H-6b), 3.60 (br s, 1H, H-2). 
 
13C NMR (CDCl3, 100 MHz): δ 137. 80, 137.53 (2 x Carom. quat. Ph), 129.07 – 128.19 
(10 x CHarom. Ph), 100.31 (C-1), 76.34 (C-3), 74.83 (C-2 and C-5), 73.06 (CH2Ph), 
72.73 (CH2Ph), 65.11 (C-4), 63.77 (C-6). 
 
CIMS (M+NH4)+: m/z 360. 
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1,6-Anhydro-2,3-di-O-benzyl-4-O-trifluoromethanesulfonyl-β-D-galactopyranose 
(341) 
 
 
 
To a solution of 2,3-di-O-benzyl-1,6-anhydro-α-D-galactopyranoside (350) (24.0 
mg, 0.07 mmol) in anhydrous CH2Cl2 (2 mL) was added pyridine (0.2 mL) followed 
by slowly addition of trifluoromethanesulfonic anhydride (23.0 μL, 0.14 mmol) at –
10 °C under argon. After stirring 1 h at room temperature, water (5 mL) and CH2Cl2 
(10 mL) were added. The organic layer was separated, dried (MgSO4), filtered and 
concentrated in vacuo. Filtration through a silica gel column (cyclohexane/EtOAc 
4:1) afforded the triflate 341[177] (27.0 mg, 81%) as a colorless oil. 
 
1H NMR (CDCl3, 400 MHz): δ  7.42 – 7.26 (m, 10H, Harom. Ph), 5.40 (br s, 1H, H-1), 
4.20 (t, 1H, J3,4 = J4,5 = 4.6 Hz, H-4), 4.46 (br t, 1H, J4,5 = J5,6b = 4.5 Hz, H-5), 4.58 (d, 
1H, J = 11.7 Hz, CHPh), 4.53 (d, 1H, J6a,6b = 7.5 Hz, H-6a), 4.49 (d, 1H, J = 12.3 Hz, 
CHPh), 4.46 (d, 1H, J = 117 Hz, CHPh), 4.40 (d, 1H, J = 12.3 Hz, CHPh), 3.77 (dq, 1H, 
J1,3 = J2,3 = J3,5 = 1.4 Hz, J3,4 = 5.1 Hz, H-3), 3.75 (dd, 1H, J5,6b = 4.5 Hz, J6a,6b = 7.5 Hz, H-
6b), 3.59 (t, 1H, J1,2 = J2,3 = 1.4 Hz, H-2). 
 
13C NMR (CDCl3, 100 MHz): δ 136.87 (2 x Carom. quat. Ph), 128.65 – 127.93 (10 x 
CHarom. Ph), 118.4 (q, JC,F = 319.89 Hz, CF3), 100.40 (C-1), 78.79 (C-4), 75.77 (C-2), 
73.72 (C-3), 72.66 (CH2Ph), 71.49 (CH2Ph), 71.14 (C-5), 63.09 (C-6). 
 
19F NMR (CDCl3, 376 MHz): δ –75.31 (s, 3F). 
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2,3,4-tri-O-benzyl-1-O-trifluoromethanesulfonyl-6,7,8-trideoxy-5a-difluoro-5a-carba-
α-D-galacto-oct-6-ynopyranose (351) 
 
 
 
To a solution of gem-difluoro carbocyclic derivative 320 (20.0 mg, 0.04 mmol) in 
anhydrous CH2Cl2 (2 mL) was added pyridine (0.2 mL) followed by slowly addition 
of trifluoromethanesulfonic anhydride (10.0 μL, 0.06 mmol) at 0 °C under argon. 
After stirring 2 h at room temperature, water (5 mL) and CH2Cl2 (10 mL) were 
added. The organic layer was separated, dried (MgSO4), filtered and concentrated 
in vacuo. Filtration by a silica gel column (cyclohexane/EtOAc 10:1) afforded the 
triflate 351 (24.9 mg, 100%) as a colorless oil. 
 
1H NMR (CDCl3, 400 MHz): δ 7.27 – 7.16 (m, 15H, Harom. Ph), 5.05 (dt, 1H, J1,2 = J1,Feq 
= 2.8 Hz, J1,Fax = 6.7 Hz, H-1), 4.86 (d, 1H, J = 10.4 Hz, CHPh), 4.81 – 4.71 (m, 4H, 4 x 
CHPh), 4.55 (d, 1H, J = 11.3 Hz, CHPh), 3.94 (dd, 1H, J1,2 = 2.8 Hz, J2,3 = 8.5 Hz, H-2), 
3.87 (t, 1H, J3,4 = J4,5 = 2.8 Hz, H-4), 3.58 (dd, 1H, J3,4 = 2.8 Hz, J2,3 = 8.5 Hz, H-3), 3.15 
(br d, 1H, J5,Fax = 28.7 Hz, H-5), 1.79 (d, 3H, J5,8 = 2.3 Hz, H-8). 
 
13C NMR (CDCl3, 400 MHz): δ 137.93, 137.76, 136.44 (3 x Carom. quat. Ph), 128.50 – 
127.81 (15 x CHarom. Ph), 119.79 (t, 1JC,F = 254.8 Hz, CF2), 80.62 (dd, 2JC,F = 23.0 Hz, 
2JC,F’ = 39.2 Hz, C-1), 80.54 (C alcyn.), 77.94 (C-3), 77.50 (d, 3JC,F = 6.5 Hz, C-2), 75.44 
(d, 3JC,F = 9.4 Hz, C-4), 76.37 (CH2Ph), 76.23 (CH2Ph), 71.29 (C alcyn.), 73.58 
(CH2Ph), 39.21 (t, 2JC,F = 20.3 Hz, C-5), 3.63 (C-8). 
 
19F NMR (CDCl3, 235 MHz) δ  –74.64 (s, 3F), –101.38 (d, 1F, JFeq,Fax = 258.4 Hz, Feq), 
–106.68 (dd, 1F, J5,Fax = 28.7 Hz, JFeq,Fax = 258.4 Hz, Fax). 
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Methyl 4,6-O-benzylidene-α-D-glucopyranoside (352) 
 
 
 
Benzaldehyde dimethyl acetal (4.6 mL, 30.90 mmol) and 10-camphorsulfonic acid 
(0.3 g, 1.55 mmol) were added to a solution of methyl α–D–glucopyranoside (3.0 g, 
15.45 mmol) in dry CH3CN (250 mL). The reaction mixture was stirred overnight 
and a clear solution was obtained. The solvent was removed in vacuo and the 
crude dissolved in CH2Cl2 and washed with a saturated solution of NaHCO3 (3 x 
100 mL). The organic phase was dried (MgSO4), filtered and concentrated under 
reduced pressure. The residue obtained was recrystallised from isopropanol to 
yield methyl 4,6-O-benzylidene-α-D-glucopyranoside 352[207] (4.3 g, 98%) as a 
white solid. 
 
1H NMR (CDCl3, 250MHz): δ 7.49 - 7.36 (m, 5H, Harom. Ph), 5.52 (s, 1H, H-7), 4.79 (d, 
1H, J1,2 = 3.5 Hz, H-1), 4.28 (dd, 1H, J5,6a = 3.8 Hz, J6a,6b = 9.2 Hz, H-6a), 3.90 (t, 1H, J2,3 
= J3,4 = 9.2 Hz, H-3), 3.81 – 3.79 (m, 1H, H-5), 3.74 – 3.62 (m, 2H, H-2 and H-6b), 
3.49 (t, 1H, J3,4 = J4,5 = 9.2 Hz, H-4) 3.46 (s, 3H, OCH3), 3.03 (br s, 1H, OH), 2.47 (br s, 
1H, OH). 
 
 
Methyl 2,3-di-O-benzyl-4,6-O-benzylidene-α-D-glucopyranoside (353) 
 
 
 
Sodium hydride (1.1 g, 28.4 mmol, 60% w/w) was added to a solution of the diol 
352 (2.0 g, 7.1 mmol) in anhydrous DMF (40 mL) at 0 °C. After 30 min, BnBr (3.4 
mL, 28.4 mmol) was added at 0 °C. After stirring 2.5 h at room temperature, MeOH 
(30 mL) was added and the mixture was concentrated under reduced pressure. 
The residue was then diluted with ether (150 mL) and washed with water (80 mL). 
The aqueous layer was extracted with ether (3 x 100 mL), and the organic layers 
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were combined, dried (MgSO4), filtered and concentrated under reduced pressure. 
Purification by flash column chromatography (cyclohexane/EtOAc 6:1) afforded 
the benzylated compound 353[207] (5.45 g, 95%) as a colorless oil.  
 
1H NMR (CDCl3, 250 MHz): δ 7.45 – 7.32 (m, 15H, Harom. Ph), 5.55 (s, 1H, H-7), 4.91 
(d, 1H, J = 11.5 Hz, CHPh), 4.87 – 4.83 (m, 2H, 2 x CHPh), 4.72 (d, 1H, J = 12.1 Hz, 
CHPh), 4.63 (d, 1H, J1,2 = 3.5 Hz, H-1), 4.29 (dd, 1H, J5,6a = 5.0 Hz, J6a,6b = 10.1 Hz, H-
6a),  4.08 (t, 1H, J2,3 = J3,4 = 9.3 Hz, H-3), 3.84 – 3.81 (m, 1H, H-5), 3.71 (app t, 1H, 
J5,6b = J6a,6b = 10.1 Hz, H-6b), 3.61 (t, 1H, J3,4 = J4,5 = 9.3 Hz, H-4), 3.54 (dd, 1H, J1,2 = 
3.5 Hz, J2,3 = 9.3 Hz, H-2), 3.42 (s, 3H, OCH3). 
 
 
Methyl 2,3,6-tri-O-benzyl-α-D-glucopyranoside (354) 
 
 
 
To a ice-cooled solution of methyl 2,3-di-O-benzyl-4,6-benzylidene-α-D-
glucopyranoside (353) (2.3 g, 5.3 mmol) and triethylsilane (6.86 mL, 42.5 mmol) 
in anhydrous CH2Cl2 was added dropwise trifluoroacetic acid (3.16 mL, 42.5 
mmol). After 1 h the reaction mixture was allowed to warm to room temperature 
and stirring was continued for 16 h. The reaction mixture was neutralized by 
dropwise addition of Et3N and concentrated under reduced pressure. Purification 
by flash column chromatography (cyclohexane/EtOAc 6:1) afforded 354[207] (1.9 g, 
77%) as a colorless oil 
 
1H NMR (CDCl3, 250 MHz): δ 7.28 – 7.14 (m, 15H, Harom. Ph), 4.92 (d, 1H, J = 11.4 
Hz, CHPh), 4.68 (d, 1H, J = 12.1 Hz, CHPh), 4.63 (d, 1H, J = 11.4 Hz, CHPh), 4.55 (d, 
1H, J = 12.4 Hz, CHPh), 4.53 (d, 1H, J1,2 = 3.3 Hz, H-1), 4.50 (d, 1H, J = 12.4 Hz, 
CHPh), 4.43 (d, 1H, J = 12.1 Hz, CHPh), 3.70 (t, 1H, J3,4 = J4,5 = 9.1 Hz, H-4) 3.65 – 
3.51 (m, 4H, H-3, H-5, H-6a and H-6b), 3.44 (dd, 1H, J1,2 = 3.3 Hz, J2,3 = 9.6 Hz, H-2), 
3.29 (s, 3H, OCH3). 
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13C NMR (CDCl3, 63 MHz): δ 138.86, 138.11, 138.06 (3 x Carom. quat. Ph), 128.65 – 
127.68 (15 x CHarom. Ph), 98.23 (C-1), 81.51 (C-3), 79.63 (C-2), 75.48 (CH2Ph), 
73.62 (CH2Ph), 73.22 (CH2Ph), 70.72 (C-5), 69.95 (C-4), 69.49 (C-6), 55.31 (OCH3).  
 
CIMS (M+NH4)+: m/z 482. 
 
 
Methyl 2,3,6-tri-O-benzyl-α-D-galactopyranoside (356) 
 
 
 
To a solution of oxalyl chloride (0.5 mL, 5.60 mmol) in anhydrous CH2Cl2 (20 mL), 
was added dropwise DMSO (0.8 mL, 11.20 mmol) at –78 °C under argon. After 15 
min a solution of methyl 2,3,6-tri-O-benzyl-α-D-glucopyranoside (354) (1.3 g, 2.80 
mmol) in anhydrous CH2Cl2 (10 mL) was added dropwise. After 1 h, triethylamine 
(2.2 mL, 15.40 mmol) was added and the reaction mixture was allowed to reach 
room temperature. After 45 min, water was added (15 mL) and the aqueous layer 
was extracted with CH2Cl2 (2 x 20 mL). The organic layers were combined, dried 
(MgSO4), filtered and concentrated under reduced pressure. The crude aldehyde 
was azeotroped with toluene and used without further purification. The product 
obtained was dissolved in EtOH (30 mL) and NaBH4 (0.32 g, 8.40 mmol) was added 
carefully. After stirring for 3 h at room temperature, the reaction mixture was 
concentrated under reduced pressure and purified by flash column 
chromatography (cyclohexane/EtOAc 5:1) to yield 356[208] (0.88 g, 68%), as a 
colorless oil and 354 (0.23 g, 18%) as a colorless oil. 
 
1H NMR (CDCl3, 250 MHz): δ 7.35 – 7.28 (m, 15H, Harom. Ph), 4.86 (d, 1H, J = 11.6 
Hz, CHPh), 4.75 (d, 1H, J = 11.7 Hz, CHPh), 4.73 (d, 1H, J1,2 = 3.6 Hz, H-1), 4.70 (d, 
1H, J = 11.4 Hz, CHPh), 4.66 (d, 1H, J = 11.7 Hz, CHPh), 4.55 (d, 1H, J = 11.8 Hz, 
CHPh), 4.44 (d, 1H, J = 11.8 Hz, CHPh), 4.09 – 4.07 (m, 1H, H-5), 3.97 – 3.94 (m, 2H, 
H-3 and H-4), 3.83 (dd, J1,2 = 3.6 Hz, J2,3 = 9.8 Hz, H-2), 3.61 – 3.58 (m, 2H, H-6a, H-
6b), 3.38 (s, 3H, OCH3). 
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13C NMR (CDCl3, 63 MHz): δ 138.46, 138.26, 138.09 (3 x Carom. quat. Ph), 128.63 – 
127.67 (15 x CHarom. Ph), 98.64 (C-1), 77.89 (C-3), 77.09 (C-4), 75.63 (C-2), 73.88 
(C-5), 73.68 (CH2Ph), 70.75 (CH2Ph), 69.54 (CH2Ph), 69.47 (C-6), 55.49 (OCH3). 
 
CIMS (M+NH4)+: m/z 482. 
 
 
Methyl 2,3,6-tri-O-benzyl-4-O-trifluoromethanesulfonyl-α-D-galactopyranoside (357)  
 
 
 
A solution of methyl 2,3,6-tri-O-benzyl-α-D-galactopyranoside (356) (100 mg, 0.22 
mmol) in anhydrous CH2Cl2 (10 mL) containing pyridine (36.0 μL, 0.44 mmol) was 
cooled to –30 °C and trifluoromethanesulfonic anhydride (56 μL, 0.33 mmol) was 
added under argon. After stirring at –30 °C for 2 h, water (10 mL) and CH2Cl2 (10 
mL) were added. The organic layer was separated and dried over MgSO4. Filtration 
through a short column of silica gel followed by evaporation of the solvent afforded 
the unstable triflate 357[209] (114 mg, 87%) as a colorless oil. 
 
1H NMR (CDCl3, 250 MHz): δ  7.41 – 7.27 (m, 15H, Harom. Ph), 5.42 (d, 1H, J3,4 = 
2.7 Hz, H-4), 4.93 (d, 1H, J = 11.8 Hz, CHPh), 4.86 (d, 1H, J = 12.1 Hz, CHPh), 4.70 (d, 
1H, J = 11.2 Hz, CHPh), 4.68 (d, 1H, J = 12.1 Hz, CHPh), 4.64 (d, 1H, J1,2 = 3.3 Hz, H-
1), 4.61 (d, 1H, J = 11.8 Hz, CHPh), 4.49 (d, 1H, J = 11.2 Hz, CHPh), 4.09 (app t, 1H, 
J5,6a = J5,6b = 6.8 Hz, H-5), 4.01 (dd, 1H, J3,4 = 2.7 Hz, J2,3 = 9.8 Hz, H-3), 3.79 (dd, 1H, 
J1,2 = 3.3 Hz, J2,3 = 9.8 Hz, H-2), 3.63 – 3.54 (m, 2H, H-6a and H-6b), 3.41 (s, 3H, 
OCH3). 
 
13C NMR (CDCl3, 63 MHz): δ 138.06, 137.58, 138.48 (3 x Carom. quat. Ph), 128.71 – 
127.94 (15 x CHarom. Ph), 98.71 (C-1), 83.71 (C-3), 74.80 (C-2), 74.58 (C-5), 73.81 
(CH2Ph), 73.60 (CH2Ph), 73.08 (CH2Ph), 67.27 (C-6), 66.64 (C-4), 55.49 (OCH3). 
 
19F NMR (CDCl3, 376 MHz): δ –73.69 (s, 3F). 
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Methyl 2,3,6-tri-O-benzyl-4-O-methanesulfonyl-α-D-galactopyranoside (358)  
 
 
 
To a solution of 356 (0.3 g, 0.80 mmol) and Et3N (0.3 mL, 2.40 mmol) in anhydrous 
CH2Cl2 (10 mL) was added dropwise methanesulfonyl chloride (0.2 mL, 2.40 
mmol) at 0 °C under argon. After stirring for 4 h at room temperature the reaction 
mixture was quenched with a saturated solution of NH4Cl (10 mL) and the solution 
diluted with CH2Cl2 (10 mL), washed with water, and dried over MgSO4. Removal of 
solvent and purification by flash column chromatography (cyclohexane/EtOAc 6:1) 
afforded 358[210] (0.33 g, 76%) as a yellow syrup. 
 
1H NMR (CDCl3, 400 MHz): δ  7.44 – 7.34 (m, 15H, Harom. Ph), 5.34 (d, 1H, J3,4 = 2.6 
Hz, H-4), 4.85 (d, 1H, J = 12.1 Hz, CHPh), 4.84 (d, 1H, J = 10.6 Hz, CHPh), 4.76 (d, 1H, 
J = 10.6 Hz, CHPh), 4.75 (d, 1H, J1,2 = 4.5 Hz, H-1), 4.74 (d, 1H, J = 12.1 Hz, CHPh), 
4.67 (d, 1H, J = 11.3 Hz, CHPh), 4.54 (d, 1H, J = 11.3 Hz, CHPh), 4.09 (t, 1H, J5,6a = J5,6b 
= 7.1 Hz, H-5), 4.02 (dd, 1H, J3,4 = 2.6 Hz, J2,3 = 10.1 Hz, H-3), 3.81 (dd, 1H, J1,2 = 4.5 
Hz, J2,3 = 10.1 Hz, H-2), 3.70 (t, 2H, J5,6 = J6a,6b = 7.1 Hz, H-6a, H-6b), 3.43 (s, 3H, 
OCH3), 3.00 (s, 3H, CH3, OMs). 
 
13C NMR (CDCl3, 100 MHz): δ 138.37, 138.18, 137.92 (3 x Carom. quat. Ph), 128.93 – 
128.25 (15 x CHarom. Ph), 98.90 (C-1), 78.85 (C-4), 76.35 (C-3), 75.65 (C-2), 74.23 
(CH2Ph), 73.97 (CH2Ph), 73.88 (CH2Ph), 68.73 (C-6), 67.96 (C-5), 56.04 (OCH3), 
39.48 (CH3, OMs).  
 
[α]D20 = +48.7 (c 1.00, CHCl3). 
 
CIMS (M+NH4)+: m/z 560. 
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Methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside (359) 
 
 
 
LiAlH4 (0.4 g, 10.80 mmol) was carefully added in three portions to a solution of 
benzylidene 353 (1.0 g, 2.16 mmol) in a mixture of CH2Cl2/Et2O (50 mL, 1:1) at      
0 °C under argon. After 10 min, the reaction mixture was warmed to 50 °C, and a 
solution of AlCl3 (1.2 g, 8.64 mmol) in Et2O (25 mL) was added dropwise under 
argon. After stirring for 2.5 h, TLC revealed no trace of starting material. The 
reaction mixture was cooled to 0 °C and quenched by slowly addition of EtOAc 
followed by water. MgSO4 was added, the reaction mixture filtered through a pad 
of celite® and the solvent removed under reduced pressure. Purification by flash 
column chromatography (cyclohexane/EtOAc 2:1) afforded the corresponding 
primary alcohol 359[211] (0.8 g, 80%) as a colorless oil. 
 
1H NMR (CDCl3, 400 MHz): δ  7.26 – 7.19 (m, 15H, Harom. Ph), 4.91 (d, 1H, J = 10.9 
Hz, CHPh), 4.80 (d, 1H, J = 11.1 Hz, CHPh), 4.75 (d, 1H, J = 10.9 Hz, CHPh), 4.71 (d, 
1H, J = 12.1 Hz, CHPh), 4.58 (d, 1H, J = 12.1 Hz, CHPh), 4.56 (d, 1H, J = 11.1 Hz, 
CHPh), 4.49 (d, 1H, J1,2 = 3.5 Hz, H-1), 3.93 (t, 1H, J2,3 = J3,4 = 9.3 Hz, H-3), 3.70 – 3.55 
(m, 3H, H-5, H-6a and H-6b), 3.46 – 3.40 (m, 2H, H-2 and H-4), 3.28 (s, 3H, OCH3), 
1.75 (br s, 1H, OH). 
 
13C NMR (CDCl3, 100 MHz): δ 138.79, 138.19, 138.16 (3 x Carom. quat. Ph), 128.50 – 
127.64 (15 x CHarom. Ph), 98.22 (C-1), 81.99 (C-3), 80.05 (C-2 or C-4), 77.48 (C-2 or 
C-4), 75.77 (CH2Ph), 75.05 (CH2Ph), 73.45 (CH2Ph), 70.74 (C-5), 61.89 (C-6), 55.22 
(OCH3). 
 
CIMS (M+NH4)+: m/z 482. 
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Methyl 2,3,4-tri-O-benzyl-6-O-trifluoromethanesulfonyl-α-D-glucopyranoside (360)  
 
 
 
To a solution of methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside (359) (200 mg, 
0.43 mmol) in anhydrous toluene (10 mL) was added Et3N (60.0 μL, 0.43 mmol) 
followed by slowly addition of trifluoromethanesulfonic anhydride (140.0 μL, 0.86 
mmol) at –78 °C under argon. After stirring at –10 °C during 1.5 h, water (10 mL) 
and CH2Cl2 (10 mL) were added. The organic phase was separated, dried (MgSO4), 
filtered and concentrated under reduced pressure. Flash column chromatography 
(cyclohexane/EtOAc 4:1 containing 1% of Et3N) gave the unstable triflate 360[212] 
(167 mg, 65%) as a pale yellow oil. 
 
1H NMR (CDCl3, 400 MHz): δ  7.40 – 7.28 (m, 15H, Harom. Ph), 5.05 (d, 1H, J = 10.9 
Hz, CHPh), 4.96 (d, 1H, J = 11.1 Hz, CHPh), 4.84 (d, 1H, J = 10.9 Hz, CHPh), 4.82 (d, 
1H, J = 11.9 Hz, CHPh), 4.68 (d, 1H, J = 11.9 Hz, CHPh), 4.64 (d, 1H, J1,2 = 3.6 Hz, H-
1), 4.60 (d, 1H, J = 11.1 Hz, CHPh), 4.58 (dd, 1H, J5,6a = 2.0 Hz, J6a,6b = 10.6 Hz, H-6a), 
4.49 (dd, 1H, J5,6b = 5.3 Hz, J6a,6b = 10.6 Hz, H-6b), 4.05 (t, 1H, J2,3 = J3,4 = 9.2 Hz, H-3), 
3.89 (ddd, 1H, J5,6a = 2.0 Hz, J5,6b = 5.3 Hz, J4,5 = 10.1 Hz, H-5), 3.56 (dd, 1H, J1,2 = 3.6 
Hz, J2,3 = 9.2 Hz, H-2), 3.45 (dd, 1H, J3,4 = 9.2 Hz, J4,5 = 10.1 Hz, H-4), 3.41 (s, 3H, 
OCH3). 
 
13C NMR (CDCl3, 50 MHz): δ 138.74, 138.18, 138.10 (3 x Carom. quat. Ph), 129.01 – 
128.15 (15 x CHarom. Ph), 98.53 (C-1), 82.22 (C-3), 80.27 (C-2), 76.94 (C-4), 76.19 
(CH2Ph), 75.46 (CH2Ph), 73.90 (CH2Ph), 70.78 (C-5), 68.69 (C-6), 55.91 (OCH3). 
 
19F NMR (CDCl3, 376 MHz): δ –74.99 (s, 3F). 
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Methyl 2,3,4-tri-O-benzyl-6-O-methanesulfonyl-α-D-glucopyranoside (363) 
 
 
 
To a solution of 2,3,4-tri-O-benzyl-α-D-glucopyranoside (359) (1.4 g, 3.01 mmol) in 
dry pyridine (20 mL) was added dropwise methanesulphonyl chloride (0.7 mL, 
9.02 mmol) at 0 °C under argon. After stirring overnight at room temperature the 
reaction mixture was concentrated under reduced pressure (azeotroped with 
toluene). The crude obtained was dissolved in CH2Cl2 (20 mL) and successively 
washed with a 1 M solution of HCl (10 mL), then with a saturated solution of 
NaHCO3 (10 mL) and finally with brine (10 mL). The organic layer was dried 
(MgSO4), filtered and the solvent removed under reduced pressure. Purification by 
flash column chromatography (cyclohexane/EtOAc 2:1) afforded 363[213] (1.5 g, 
94%) as an amorphous solid. 
 
1H NMR (CDCl3, 400 MHz): δ  7.45 – 7.35 (m, 15H, Harom. Ph), 5.09 (d, 1H, J = 10.9 
Hz, CHPh), 5.00 (d, 1H, J = 10.9 Hz, CHPh), 4.91 (d, 1H, J = 10.9 Hz, CHPh), 4.85 (d, 
1H, J = 12.1 Hz, CHPh), 4.73 (d, 1H, J = 12.1 Hz, CHPh), 4.71 (d, 1H, J = 10.9 Hz, 
CHPh), 4.69 (d, 1H, J1,2 = 3.2 Hz, H-1), 4.45 (dd, 1H, J5,6a = 3.9 Hz, J6a,6b = 11.1 Hz, H-
6a), 4.41 (dd, 1H, J5,6b = 2.4 Hz, J6a,6b = 11.1 Hz, H-6b), 4.10 (t, 1H, J2,3 = J3,4 = 9.6 Hz, 
H-3), 3.93 (ddd, 1H, J5,6b = 2.4 Hz, J5,6a = 3.9 Hz, J4,5 = 9.6 Hz, H-5), 3.61 (dd, 1H, J1,2 = 
3.2 Hz, J2,3 = 9.6 Hz, H-2), 3.58 (t, 1H, J3,4 = J4,5 = 9.6 Hz, H-4), 3.54 (s, 3H, OCH3), 2.99 
(s, 3H, CH3, OMs). 
 
13C NMR (CDCl3, 100 MHz): δ 138.66, 138.09, 137.93 (3 x Carom. quat. Ph), 128.60 – 
127.77 (15 x CHarom. Ph), 98.21 (C-1), 81.88 (C-3), 79.95 (C-2), 77.07 (C-4), 75.80 
(CH2Ph), 75.16 (CH2Ph), 73.47 (CH2Ph), 68.76 (C-5), 68.55 (C-6), 55.54 (OCH3), 
37.53 (CH3, OMs).  
 
CIMS (M+NH4)+: m/z 560. 
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2,3,4,6-Tetra-O-acetyl-α-D-galactopyranosyl bromide (364)  
 
 
 
A 33% solution of hydrobromic acid (19.0 mL, 0.33 mmol) in acetic acid was added 
dropwise to a ice-cooled solution of pentaacetate 293 (10.8 g, 0.03 mol) in glacial 
acetic acid (10 mL). The reaction mixture was allowed to reach room temperature 
and stirred for 3 h. The excess of HBr was taken off under reduced pressure, in a 
vacuo water pomp system equipped with a trap. The remaining solvent was 
evaporated (azeotroped with toluene) and the residue chromatographed 
(cyclohexane/EtOAc 4:1) to afford 364[214] (10.2 g, 89%) as a brown oil. 
 
1H NMR (CDCl3, 400 MHz): δ 6.71 (d, 1H, J1,2 = 4.0 Hz, H-1), 5.53 (dd, 1H, J4,5 = 1.3 
Hz, J3,4 = 3.3 Hz, H-4), 5.41 (dd, 1H, J3,4 = 3.3 Hz, J2,3 = 10.7 Hz, H-3), 5.06 (dd, 1H, J1,2 
= 4.0 Hz, J2,3 = 10.7 Hz, H-2), 5.51 – 5.48 (m, 1H, H-5), 4.20 (dd, 1H, J5,6a = 6.3 Hz, 
J6a,6b = 11.4 Hz, H-6a), 4.12 (dd, 1H, J5,6a = 6.8 Hz, J6a,6b = 11.4 Hz, H-6a), 2.16 (s, 3H, 
OAc), 2.13 (s, 3H, OAc), 2.07 (s, 3H, OAc), 2.02 (s, 3H, OAc). 
 
13C NMR (CDCl3, 100 MHz): δ 170.73, 170.47, 170.31, 170.17 (4 x C quat. OAc), 
88.52 (C-1), 71.44 (C-5), 68.37 (C-3), 68.15 (C-2), 67.36 (C-4), 61.23 (C-6), 21.16 
(CH3, OAc), 21.05 (CH3, OAc), 20.99 (CH3, OAc), 20.97 (CH3, OAc). 
 
CIMS (M+NH4)+: m/z 428. 
 
 
3,4,6-Tri-O-acetyl-1,5-anhydro-2-deoxy-D-lyxo-hex-1-enitol (365)  
 
 
 
A suspension of activated zinc dust (14.3 g, 219 mmol) and N-methylimidazole (2.2 
mL, 27.4 mmol) in EtOAc (100 mL) was refluxed and a solution of 364 (7.5 g, 18.3 
mmol) in EtOAc (20 mL) was added dropwise. The mixture was subsequently 
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heated for 1 h, then filtered through celite®, washed with a 1 M solution of HCl (40 
mL) followed by a saturated solution of NaHCO3 (40 mL). The organic phase was 
dried (MgSO4), filtered and the solvent evaporated. Flash column chromatography 
(cyclohexane/EtOAc 4:1) afforded 365[214] (3.1 g, 63%) as a yellow oil. 
 
1H NMR (CDCl3, 400 MHz): δ 6.36 (dd, 1H, J1,3 = 1.8 Hz, J1,2 = 6.3 Hz, H-1), 5.46 – 
5.44 (m, 1H, H-3), 5.32 (dt, 1H, J2,4 = J4,5 = 1.7 Hz, J3,4 = 4.6 Hz, H-4), 4.62 (ddd, 1H, 
J2,4 = 1.7 Hz, J2,3 = 2.6 Hz, J1,2 = 6.3 Hz, H-2), 4.26 – 4.22 (m, 1H, H-5), 4.18 – 4.09 (m, 
2H, H-6a, H-6b), 2.02 (s, 3H, OAc), 2.00 (s, 3H, OAc), 1.91 (s, 3H, OAc). 
 
13C NMR (CDCl3, 100 MHz): δ 170.74, 170.47, 170.38 (3 x C quat. OAc), 145.69 (C-
1), 99.18 (C-2), 73.08 (C-5), 64.20 (C-3), 63.99 (C-4), 62.22 (C-6), 21.04 (CH3, OAc), 
20.99 (CH3, OAc), 20.90 (CH3, OAc). 
 
CIMS (M+NH4)+: m/z 290. 
 
 
1,5-Anhydro-2-deoxy-D-lyxo-hex-1-enitol (366) 
 
 
 
To a solution of tri-O-acetyl-D-galactal 365 (2.7 g, 9.84 mmol) in MeOH (100 mL) 
was added K2CO3 (70.0 mg, 0.49 mmol), and the mixture was stirred at room 
temperature for 3 h. After the solvent was evaporated, the resulting D-galactal was 
suspended in CHCl3, filtered and concentrated under reduced pressure to give 
366[215] (1.44 g, 100%) as a white solid. 
 
1H NMR (CDCl3, 400 MHz): δ 6.29 (dd, 1H, J1,3 = 1.9 Hz, J1,2 = 6.3 Hz, H-1), 4.59 (dt, 
1H, J2,3 = J2,4 = 2.0 Hz, J1,2 = 6.3 Hz, H-2), 4.36 – 4.34 (m, 1H, H-3), 3.92 (dd, 1H, J5,6b = 
4.5 Hz, J5,6a = 8.0 Hz, H-5), 3.82 – 3.80 (m, 1H, H-4), 3.72 (dd, 1H, J5,6a = 8.0 Hz, J6a,6b 
= 11.8 Hz, H-6a), 3.92 (dd, 1H, J5,6b = 4.5 Hz, J6a,6b = 11.8 Hz, H-6b). 
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13C NMR (CDCl3, 100 MHz): δ 144.29 (C-1), 102.97 (C-2), 77.38 (C-5), 64.96 (C-4), 
64.25 (C-3), 61.65 (C-6). 
 
CIMS (M+NH4)+: m/z 164. 
 
 
1,6-Anhydro-2-deoxy-2-iodo-β-D-galactopyranose (367) and 1,4-anhydro-2-deoxy-2-
iodo-β-D-galactopyranose (368) 
 
 
 
A solution of D-glucal 366 (1.9 g, 13.30 mmol) and molecular sieves 3 Å in dry 
acetonitrile (80 mL) was stirred with warming until the substrate sugar was 
dissolved. Bis(tributyltin) oxide (5.4 mL, 10.70 mmol) was then added and the 
solution heated at reflux for 3 h. After the mixture had cooled to room temperature 
the solvent was evaporated and the remaining residue was dried under high 
vacuum during 1 h. The residue was dissolved in anhydrous CH2Cl2 (50 mL) under 
argon and iodine (6.7 g, 26.60 mmol) was added at 0 °C. After 15 min TLC 
(Toluene/Acetone 1:1) showed the complete conversion of D-galactal into two 
products.The reaction mixture was filtered through a pad of celite® to remove tin 
salts and molecular sieves and washed with a saturated solution of Na2S2O4 (3 x 20 
mL). the organic layer was dried over MgSO4, filtered, the solvent evaporated and 
the residue chromatographed (Toluene/Acetone 3:1) to yield 367[216] (2.3 g, 64%) 
as a yellow oil and 368 (0.68 g, 19%) as a pale yellow oil. 
 
1,6-Anhydro-2-deoxy-2-iodo-β-D-galactopyranose (367) 
 
1H NMR (CD3OD, 400 MHz): δ  5.55 (br s, 1H, H-1), 4.50 (d, 1H, J6a,6b = 7.1 Hz, H-6a), 
4.33 (t, 1H, J4,5 = J5,6b = 4.3 Hz, H-5), 4.31 (dq, 1H, J1,3 = J2,3 = J3,5 = 1.2 Hz, J3,4 = 4.9 Hz, 
H-3), 4.25 (t, 1H, J3,4 = J4,5 = 4.3 Hz, H-4), 4.19 (br s, 1H, H-2), 3.64 (app dd, 1H, J5,6b = 
4.3 Hz, J6a,6b = 7.1 Hz, H-6b). 
 
13C NMR (MeOD, 100 MHz): δ 102.29 (C-1), 75.76 (C-5), 73.99 (C-3), 64.97 (C-6), 
63.41 (C-4), 30.20 (C-2). 
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CIMS (M+NH4)+: m/z 290. 
 
1,4-Anhydro-2-deoxy-2-iodo-β-D-galactopyranose (368) 
 
1H NMR (CD3OD, 250 MHz): δ  5.55 (d, 1H, J1,2 = 2.4 Hz, H-1), 4.79 (br s, 1H, OH), 
4.45 (d, 1H, J2,4 = 1.3 Hz, H-4), 4.15 (d, 1H, J2,3 = 2.4 Hz, H-3), 3.70 – 3.67 (m, 1H, H-
2), 3.66 (dd, 1H, J5,6a = 5.6 Hz, J5,6b = 7.1 Hz, H-5), 3.46 (dd, 1H, J5,6a = 5.6 Hz, J6a,6b = 
11.2 Hz, H-6a), 3.39 (d, 1H, J5,6b = 7.1 Hz, J6a,6b = 11.2 Hz, H-6b). 
 
 
3,4-Di-O-acetyl-1,6-Anhydro-2-azido-2-deoxy-β-D-galactopyranose (369) and 2,4-di-
O-acetyl-1,6-Anhydro-3-azido-3-deoxy-β-D-idopyranose (370) 
 
 
 
A solution of compound 367 (1.1 g, 3.85 mmol) and sodium azide (1.0 g, 15.40 
mmol) in a mixture of DMF/H2O (50 mL, 9:1) was heated at 120 °C overnight until 
the reaction was complete. The solution was concentrated under reduced pressure 
and then purified by flash column chromatography (cyclohexane/EtOAc 2:1 then 
cyclohexane/EtOAc 1:1) to afford a mixture of 2 products with the same Rf. The 2 
products were dissolved in dry pyridine (30 mL) and acetic anhydride (1.5 mL, 
15.40 mmol) was added. After stirring overnight at room temperature the reaction 
mixture was concentrated under reduced pressure (azeotroped with toluene) and 
the residue purified by flash column chromatography (cyclohexane/EtOAc/CH2Cl2 
4:1:1) to afford 369 (0.75 g, 72%) and 370 (0.13 g, 12%) as a colorless oils. 
 
3,4-Di-O-acetyl-1,6-anhydro-2-azido-2-deoxy-β-D-galactopyranose (369) 
 
1H NMR (CDCl3, 250 MHz): δ  5.40 (br s, 1H, H-1), 5.25 (dq, 1H, J1,3 = J2,3 = J3,5 = 1.2 
Hz, J3,4 = 4.7 Hz, H-3), 5.15 (br t, 1H, J3,4 = J4,5 = 4.7 Hz, H-4), 4.44 (t, 1H, J4,5 = J5,6b = 
4.7 Hz, H-5), 4.29 (d, 1H, J6a,6b = 7.3 Hz, H-6a), 3.68 (dd, 1H, J5,6b = 4.4 Hz, J6a,6b = 7.3 
Hz, H-6b), 3.48 (br s, 1H, H-2), 2.06 (s, 3H, OAc), 1.99 (s, 3H, OAc). 
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13C NMR (CDCl3, 63 MHz): δ 169.72, 169.13 (2 x C quat. OAc), 100.11 (C-1), 72.28 
(C-5), 68.11 (C-3), 64.96 (C-4), 64.73 (C-6), 61.92 (C-2), 20.79 (CH3, OAc), 20.55 
(CH3, OAc). 
 
CIMS (M+NH4)+: m/z 289. 
 
2,4-Di-O-acetyl-1,6-anhydro-3-azido-3-deoxy-β-D-idopyranose (370) 
 
1H NMR (CDCl3, 250 MHz): δ  5.46 (br s, 1H, H-1), 4.92 (dd, 1H, J4,5 = 4.0 Hz, J3,4 = 
9.4, H-4), 4.72 (dd, 1H, J1,2 = 1.2 Hz, J2,3 = 9.1 Hz, H-2), 4.63 (t, 1H, J4,5 = J5,6b = 4.0 Hz, 
H-5), 4.10 (d, 1H, J6a,6b = 8.1 Hz, H-6a), 3.86 – 3.76 (m, 2H, H-3 and H-6b), 2.15 (s, 
3H, OAc), 2.14 (s, 3H, OAc). 
 
13C NMR (CDCl3, 63 MHz): δ 169.87, 169.51 (2 x C quat. OAc), 98.94 (C-1), 74.47 (C-
2), 72.48 (C-5), 70.99 (C-4), 65.61 (C-6), 60.50 (C-3), 20.75 (2 x CH3, OAc). 
 
 
1,6-Anhydro-2-azido-2-deoxy-β-D-galactopyranose (371) 
 
 
 
To a solution of 369 (0.5 g, 1.84 mmol) in MeOH (10 mL) was added dropwise a 1 
M solution of NaOMe freshly prepared, until the pH of the solution reached the 
value of 10. After 4 h the mixture was neutralized with acid resin Amberlite® IR 
120 (H+), filtered and concentrated under reduced pressure to afford 371[217] (0.32 
g, quantitative yield) as a white powder. 
 
1H NMR (CD3OD, 400 MHz): δ  5.30 (t, 1H, J1,2 = J1,3 = 1.4 Hz, H-1), 4.29 (d, 1H, J6a,6b 
= 7.2 Hz, H-6a), 4.26 (br t, 1H, J4,5 = J5,6b = 4.8 Hz, H-5), 3.89 (dq, 1H, J1,3 = J2,3 = J3,5 = 
1.4 Hz, J3,4 = 5.1 Hz, H-3), 3.77 (br t, 1H, J3,4 = J4,5 = 4.8 Hz, H-4), 3.48 (app dd, 1H, 
J5,6b = 4.8 Hz, J6a,6b = 7.2 Hz, H-6b), 3.35 (br s, 1H, H-2). 
 
13C NMR (CD3OD, 100 MHz): δ 100.05 (C-1), 74.68 (C-5), 68.86 (C-3), 64.97 (C-4), 
64.51 (C-6), 64.38 (C-2). 
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CIMS (M+NH4)+: m/z 205. 
 
 
1,6-Anhydro-2-azido-2-deoxy-3,4-O-sulfoxide-β-D-galactopyranose (372) 
 
 
 
Diol 371 (100.0 mg, 0.54 mmol) and Et3N (0.3 mL, 2.16 mmol) were dissolved in 
anhydrous CH2Cl2 (5 mL) and the solution was cooled to 0 °C. A solution of SOCl2 
(0.06 mL, 0.82 mmol) in anhydrous CH2Cl2 (1 mL) was added dropwise under 
argon. The reaction mixture was then stirred at room temperature for 2.5 h, 
diluted with CH2Cl2 (5 mL) and washed with cold water (5 mL). The aqueous layer 
was extracted with CH2Cl2 (2 x 5 mL). The organic layers were combined, dried 
(MgSO4), filtered and concentrated. Purification by flash column chromatography 
(cyclohexane/EtOAc 4:1) afforded the cyclic sulphite 372 (95.7 mg, 76%) as a dark 
orange oil. 
 
1H NMR (CDCl3, 400 MHz): δ  5.55 (br s, 1H, H-1), 5.16 (t, 1H, J3,4 = J4,5 = 5.3 Hz, H-
4), 5.05 (app d, 1H, J3,4 = 5.3 Hz, H-3), 4.62 (br t, 1H, J4,5 = J5,6b = 5.3 Hz, H-5), 3.88 
(br s, 1H, H-2), 3.79 (d, 1H, J6a,6b = 8.4 Hz, H-6a), 3.48 (app dd, 1H, J5,6b = 5.3 Hz, J6a,6b 
= 8.4 Hz, H-6b). 
 
13C NMR (CDCl3, 63 MHz): δ 99.99 (C-1), 76.44 (C-3), 74.35 (C-4), 71.44 (C-5), 
64.27 (C-6), 60.47 (C-2). 
 
[α]D20 = +27.8 (c 1.00, CHCl3). 
 
HRCIMS Calcd for C6H11O5N4S (M+NH4)+: 251.0450. Found: 251.0448. 
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1,6-Anhydro-2-azido-2-deoxy-3,4-O-sulfone-β-D-galactopyranose (373) 
 
 
 
H2O (3 mL), RuCl3.3H2O (1 mg) and then NaIO4 (93.0 mg, 0.45 mmol) were added 
to a solution of 372 (50.0 mg, 0.21 mmol) in a 1:1 mixture of CH2Cl2/CH3CN (6 mL) 
at 0 °C. The reaction mixture was stirred at 0 °C for 1.5 h, diluted with CH2Cl2 (5 
mL), and the aqueous phase was extracted with CH2Cl2 (2 x 10 mL). The organic 
extracts were combined, washed with a 5% solution of Na2S2O3 (2 x 5 mL), dried 
(MgSO4), filtered and the solvent removed under reduced pressure. Flash column 
chromatography (cyclohexane/EtOAc 6:1) of the residue gave 373 (44.0 mg, 84%) 
as a brown oil. 
 
1H NMR (CDCl3, 400 MHz): δ  5.52 (br s, 1H, H-1), 5.05 (br t, 1H, J3,4 = J4,5 = 5.9 Hz, 
H-4), 4.94 (dq, 1H, J1,3 = J2,3 = J3,5 = 1.0 Hz, J3,4 = 5.9 Hz, H-3), 4.62 (br t, 1H, J4,5 = J5,6b 
= 5.9 Hz, H-5), 4.34 (d, 1H, J6a,6b = 9.1 Hz, H-6a), 381 – 3.78 (m, 2H, H2 and H-6b). 
 
13C NMR (CDCl3, 63 MHz): δ 99.57 (C-1), 76.74 (C-3), 74.51 (C-4), 70.95 (C-5), 
63.91 (C-6), 59.26 (C-2). 
 
[α]D20 = +44.2 (c 1.00, CHCl3). 
 
HRCIMS Calcd for C6H11O6N4S (M+NH4)+: 267.0399. Found: 267.094. 
 
 
Methyl 2,3-di-O-benzyl-α-D-glucopyranoside (376) 
 
 
 
The methyl 2,3-di-O-benzyl-4,6-O-benzylidene-α-D-glucopyranoside (353) (1.0 g, 
2.20 mmol) was dissolved in a 80% solution of acetic acid (100 mL) and stirred at 
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80 °C during 45 min. The reaction mixture was concentrated under reduced 
pressure (azeotroped with toluene), the crude dissolved in CH2Cl2 (50 mL) and 
washed with a saturated solution of NaHCO3 (3 x 25 mL). The organic phase was 
dried over MgSO4, filtered, concentrated and chromatographed 
(cyclohexane/EtOAc 1:2) to yield 376[218] (0.74 g, 91%) as a white solid.  
 
1H NMR (CDCl3, 400 MHz): δ 7.31 – 7.21 (m, 10H, Harom. Ph), 4.95 (d, 1H, J = 11.5 
Hz, CHPh), 4.69 (d, 1H, J = 12.1 Hz, CHPh), 4.63 (d, 1H, J = 11.5 Hz, CHPh), 4.59 (d, 
1H, J = 12.1 Hz, CHPh), 4.53 (d, 1H, J1,2 = 3.5 Hz, H-1), 3.75 – 3.65 (m, 3H, H-3, H-6a, 
H-6b), 3.54 (dt, 1H, J5,6a = J5,6b = 3.9 Hz, J4,5 = 9.6 Hz, H-5), 3.44 (dd, 1H, J3,4 = 8.5 Hz, 
J4,5 = 9.6 Hz, H-4), 3.42 (dd, 1H, J1,2 = 3.5 Hz, J2,3 = 9.6 Hz, H-2), 3.31 (s, 3H, OCH3). 
 
13C NMR (CDCl3, 100 MHz): δ 139.36, 138.63 (2 x Carom. quat. Ph), 129.31 – 128.62 
(10 x CHarom. Ph), 98.86 (C-1), 81.31 (C-3), 79.83 (C-2), 75.41 (CH2Ph), 73.17 
(CH2Ph), 70.69 (C-5), 70.48 (C-4), 62.51 (C-6), 55.28 (OCH3). 
 
CIMS (M+NH4)+: m/z 392. 
 
 
Methyl 2,3-di-O-benzyl-(R)-4,6-O-(2,3,4,6-tetra-O-benzyl-D-galactopyranosylidene)-
α-D-glucopyranoside (377) 
 
 
 
To a solution of lactone 375 (54.0 mg, 0.10 mmol) and diol 376 (37.0 mg, 0.10 
mmol) in toluene (2 mL) was added TMSOMe (0.14 mL, 1.00 mmol) and a catalytic 
amount of TMSOTf (5 µL) at room temperature under argon. After 1 h of stirring, 
the solvent was removed under reduced pressure. The reaction vessel was leaked 
with argon, and the remainder was again dissolved in toluene. TMSOMe (0.14 mL, 
1.00 mmol) and TMSOTf (5 µL) was added to the solution, and the mixture was 
stirred for further 30 min. The reaction mixture was neutralized with Et3N and 
concentrated under reduced pressure. Purification by flash column 
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chromatography (cyclohexane/EtOAc 2:1) afforded 377[193] (66.0 mg, 74%) as a 
colorless oil.  
 
 
1H NMR (CDCl3, 400 MHz): δ 7.27 – 7.04 (m, 30H, Harom. Ph), 4.81 (d, 1H, J = 11.0 
Hz, CHPh), 4.73 (d, 1H, J = 11.3 Hz, CHPh), 4.72 (d, 3H, J = 11.4 Hz, 3 x CHPh), 4.65 
(d, 2H, J = 11.0 Hz, 2 x CHPh), 4.60 (d, 1H, J = 11.4 Hz, CHPh), 4.56 (d, 1H, J = 12.2 
Hz, CHPh), 4.49 (d, 1H, J = 12.3 Hz, CHPh), 4.47 (d, 1H, J1,2 = 3.5 Hz, H-1), 4.43 (d, 
2H, J = 11.5 Hz, 2 x CHPh), 4.01 (t, 1H, J3,4 = J4,5 = 9.4 Hz, H-4), 3.80 (t, 1H, J2,3 = J3,4 = 
9.4 Hz, H-3), 3.77 – 3.53 (m, 8H, H-5, H-6a, H-6b, H-3’, H-4’, H-5’, H-6’a, H-6’b), 3.47 
(d, 1H, J2’,3’ = 9.5 Hz, H-2’), 3.42 (dd, 1H, J1,2 = 3.5 Hz, J2,3 = 9.4 Hz, H-2), 3.27 (s, 3H, 
OCH3). 
 
13C NMR (CDCl3, 100 MHz): δ 138.12, 138.02, 137.58, 137.49, 137.40 (6 x Carom. 
quat. Ph), 127.83 – 126.87 (30 x CHarom. Ph), 109.91 (C-1’), 98.53 (C-1), 83.02, 
82.01 (C-2’), 79.16 (C-2), 78.94 (C-3), 77.85, 75.84 (CH2Ph), 75.41 (CH2Ph), 75.18 
(CH2Ph), 75.05 (CH2Ph), 74.30 (C-4), 73.83 (CH2Ph), 73.28 (CH2Ph), 73.00, 68.56 
(C-6 or C-6’), 61.98, 61.11 (C-6 or C-6’), 55.28 (OCH3). 
 
CIMS (M+NH4)+: m/z 894. 
 
 
2,3,4-Tri-O-benzyl-6,7,8-trideoxy-5a-difluoro-5a-carba-α-D-galacto-oct-6-
ynopyranosyl bromide (384) 
 
 
 
SOBr2 (5.0 μL, 60.0 μmol) was added dropwise to a solution of alcohol 320 (20.0 
mg, 40.0 μmol) in anhydrous CH2Cl2 (2 mL) at –30 °C under argon. After 30 min 
pyridine (5.0 μL, 60.0 μmol) was added and the reaction mixture stirred for more 
30 min at –30 °C. The mixture was then quenched by addition of a 2 M solution of 
HCl (0.1 mL), diluted with CH2Cl2 (5 mL) and washed with a saturated solution of 
NaHCO3 (3 mL). The organic layer was dried (MgSO4), filtered and the solvent 
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evaporated under reduced pressure. The residue was chromatographed 
(cyclohexane/EtOAc, 8:1) to afford 384 (21.3 mg, 64%) as a pale yellow oil. 
 
1H NMR (CDCl3, 400 MHz): δ 7.38 – 7.28 (m, 15H, Harom. Ph), 4.96 (d, 1H, J = 11.1 
Hz, CHPh), 4.86 (d, 1H, J = 11.4 Hz, CHPh), 4.82 (d, 1H, J = 11.1 Hz, CHPh), 4.79 (d, 
1H, J = 11.8 Hz, CHPh), 4.73 (d, 1H, J = 11.8 Hz, CHPh), 4.72 (d, 1H J = 11.4 Hz, 
CHPh), 4.69 (dt, 1H, J1,2 = J1,Feq = 2.3 Hz, J1,Fax = 4.5 Hz, H-1), 4.27 (dd, 1H, J1,2 = 2.3 
Hz, J2,3 = 8.4 Hz, H-2), 4.02 (br s, 1H, H-4), 3.93 (dd, 1H, J3,4 = 2.8 Hz, J2,3 = 8.4 Hz, H-
3), 3.12 (br d, 1H, J5,Fax = 28.3 Hz, H-5), 1.82 (d, 3H, J5,8 = 2.3 Hz, H-8). 
 
19F NMR (CDCl3, 376 MHz): δ –108.19 (d, 1F JFeq,Fax = 248.6 Hz), –104.83 (d, 1F, 
JFeq,Fax = 248.6 Hz),  
 
[α]D20 = +14.6 (c 1.07, CHCl3). 
 
HRCIMS Calcd for C30H33O3NF2Br (M+NH4)+: 554.1268 (100.0%), 556.1248 
(97.3%). Found: 554.1271 (100.0%), 556.1246 (96.8%). 
 
 
Methyl 2,3-di-O-benzyl-6-deoxy-6-iodo-α-D-glucopyranoside (393) 
 
 
 
Imidazole (410 mg, 6.0 mmol), triphenylphosphine (790 mg, 3.0 mmol) and iodine 
(560 mg, 2.2 mmol) were added to a solution of diol 376 (740 mg, 2.0 mmol) in 
anhydrous toluene (30 mL) at room temperature under argon. After stirring at    
70 °C for 1.5 h, TLC (cyclohexane/EtOAc 2:1) indicated completion of the reaction. 
The reaction mixture was cooled to room temperature and saturated sodium 
thiosulfate (5 mL) was added. After stirring for 5 min, EtOAc (25 mL) was added 
and the organic layer was then washed with water (15 mL), dried (MgSO4), ﬁltered 
and the solvent was removed in vacuo. The residue was puriﬁed by ﬂash column 
chromatography (cyclohexane/EtOAc 9:1) to afford 393[219] (820 mg, 85%) as a 
colorless oil. 
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1H NMR (CDCl3, 400 MHz): δ  7.30 – 7.21 (m, 10H, Harom. Ph), 4.94 (d, 1H, J = 11.3 
Hz, CHPh), 4.68 (d, 1H, J = 12.0 Hz, CHPh), 4.60 (d, 1H, J = 11.3 Hz, CHPh), 4.59 (d, 
1H, J = 12.0 Hz, CHPh), 4.56 (d, 1H, J1,2 = 3.6 Hz, H-1), 3.70 (t, 1H, J2,3 = J3.4 = 9.1 Hz, 
H-3), 3.46 – 3.42 (m, 2H, H-2, H-6a), 3.35 (s, 3H, OCH3), 3.34 – 3.31 (m, 1H, H-5), 
3.21 (t, 1H, J3,4 = J4,5 = 9.1 Hz, H-4), 3.16 (dd, 1H, J5,6b = 7.1 Hz, J6a,6b = 10.6 Hz, H-6b). 
 
13C NMR (CDCl3, 100 MHz): δ 138.59, 137.92 (2 x Carom. quat. Ph), 128.72 – 128.04 
(10 x CHarom. Ph), 98.16 (C-1), 80.78 (C-3), 79.94 (C-2), 75.42 (CH2Ph), 73.71 (C-4), 
73.18 (CH2Ph), 69.85 (C-5), 55.59 (OCH3), 7.12 (C-6). 
 
CIMS (M+NH4)+: m/z 502. 
 
 
Methyl 6-deoxy-2,3,4-tri-O-benzyl-α-D-hex-5-enopyranoside (394) 
 
 
 
Methyl 2,3-di-O-benzyl-6-deoxy-6-iodo-α-D-glucopyranoside (393) (600 mg, 1.24 
mmol) was dissolved in dry DMF (15 mL), BnBr (0.3 mL, 2.48 mmol) followed by 
NaH (198 mg, 4.96 mmol) were then added. After stirring overnight at room 
temperature, TLC (cyclohexane/EtOAc 6:1) indicated completion of the reaction 
and the excess of NaH was decomposed by dropwise addition of MeOH. The 
solvent was removed in vacuo, the remaining residue diluted with ether (150 mL) 
and washed with water (80 mL). The aqueous layer was extracted with ether (3 x 
100 mL), and the organic layers were combined, dried (MgSO4), filtered and 
concentrated under reduced pressure. Purification by flash column 
chromatography (cyclohexane/EtOAc 12:1) afforded the unsaturated compound 
394[137] (454 mg, 82%) as colorless oil.  
 
1H NMR (CDCl3, 400 MHz): δ  7.49 – 7.36 (m, 15H, Harom. Ph), 5.06 – 4.96 (m, 3H, 2 x 
CHPh, H-6a), 4.93 (d, 1H, J = 12.1 Hz, CHPh), 4.90 (d, 1H, J = 11.3 Hz, CHPh), 4.87 (d, 
1H, J = 11.3 Hz, CHPh), 4.83 (app d, 1H, J6a,6b = 1.2 Hz, H-6b), 4.78 (d, 1H, J = 12.1 
Hz, CHPh), 4.75 (d, 1H, J1,2 = 3.4 Hz, H-1), 4.11 (t, 1H, J2,3 = J3.4 = 9.2 Hz, H-3), 4.03 
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(dt, 1H, J4,6a = J4,6b = 1.9 Hz, J3,4 = 9.2 Hz, H-4), 3.72 (dd, 1H, J1,2 = 3.4 Hz, J2,3 = 9.2 Hz, 
H-2), 3.53 (s, 3H, OCH3). 
 
13C NMR (CDCl3, 100 MHz): δ 153.80 (C-5), 138.82, 138.20,  138.12 (3 x Carom. quat. 
Ph), 128.58 – 127.72 (15 x CHarom. Ph), 99.15 (C-1), 96.95 (C-6), 81.29 (C-3), 79.65 
(C-4), 79.44 (C-2), 75.84 (CH2Ph), 74.57 (CH2Ph), 73.68 (CH2Ph), 55.56 (OCH3). 
 
CIMS (M+NH4)+: m/z 464. 
 
 
2,3,4-Tri-O-benzyl-1-O-methyl-α-D-xylurono-5,1-lactone (395) 
 
 
 
Ozone gas was bubbled through a solution of compound 394 (625 mg, 1.40 mmol) 
in CH2Cl2 (100 mL) at –78 °C until the solution obtained a blue/violet coloration. 
Oxygen was then bubbled through the solution for 1 min and then DMS (10 drops, 
until the blue color disappear) was added. The solution was allowed to warm to 
room temperature over a period of 30 min and the solvent was removed under 
reduced pressure to afford 395. The product was used without further 
purification. 
 
1H NMR (CDCl3, 400 MHz): δ  7.40 – 7.29 (m, 15H, Harom. Ph), 5.06 (d, 1H, J = 11.2 
Hz, CHPh), 4.97 (app d, 1H, J1,2 = 1.6 Hz, H-1), 4.79 (d, 1H, J = 12.1 Hz, CHPh), 4.77 – 
4.62 (m, 4H, 4 x CHPh), 4.13 (t, 1H, J2,3 = J3.4 = 7.8 Hz, H-3), 4.01 (d, 1H, J3,4 = 7.8 Hz, 
H-4), 3.73 (dd, 1H, J1,2 = 1.6 Hz, J2,3 = 7.8 Hz, H-2), 3.52 (s, 3H, OCH3). 
 
13C NMR (CDCl3, 100 MHz): δ 169.62 (C-5), 137.67, 137.27, 137.00 (3 x Carom. quat. 
Ph), 128.41 – 127.71 (15 x CHarom. Ph), 100.38 (C-1), 78.95 (C-4), 78.44 (C-3), 76.47 
(C-2), 74.51 (CH2Ph), 74.05 (CH2Ph), 73.43 (CH2Ph), 57.18 (OCH3).  
 
HRESIMS Calcd for C27H32O6N (M+NH4)+: 466.2230. Found: 466.2232 
 
Experimental Part 
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Methyl 2,3,4-tri-O-benzyl-6-deoxy-6,6-difluoro-α-D-xylo-hex-5-enopyranoside 
(396) 
 
 
 
To a solution of lactone 395 (168 mg, 0.37 mmol) in anhydrous THF (20 mL) 
under argon, cooled at –15 °C, was added CBr2F2 (0.17 mL, 1.87 mmol) using a 
cooled syringe. To the vigorously stirred solution was added dropwise HMPT (0.34 
mL, 1.87 mmol), and a dense white precipitate appeared. The reaction mixture was 
stirred at –15 °C during 1 h and then HMPT (0.68 mL, 3.74 mmol) was added and 
the mixture stirred for 2 h at 45 °C. The reaction mixture was concentrated under 
reduced pressure, diluted with ether (30 mL) and washed with water (15 mL). The 
organic layer was separated, washed with a saturated solution of CuSO4 (2 x 15 
mL), dried (MgSO4), filtered and the solvent removed under reduced pressure. The 
residue was purified by flash column chromatography (cyclohexane/EtOAc 12:1) 
to afford 396 (107 mg, 60%) as a colorless oil. 
 
1H NMR (CDCl3, 400 MHz): δ  7.33 – 7.28 (m, 15H, Harom. Ph), 4.83 – 4.80 (m, 3H, 3 x 
CHPh), 4.74 (d, 1H, J = 11.0 Hz, CHPh), 4.67 – 4.64 (m, 2H, H-1, CHPh), 4.59 (d, 1H, J 
= 11.0 Hz, CHPh), 4.08 (dt, 1H, J4,F = J4,F’ = 4.7 Hz, J3,4 = 8.3 Hz, H-4), 3.98 (t, 1H, J2,3 = 
J3.4 = 8.3 Hz, H-3), 3.54 (dd, 1H, J1,2 = 3.3 Hz, J2,3 = 8.3 Hz, H-2), 3.46 (s, 3H, OCH3). 
 
13C NMR (CDCl3, 100 MHz): δ 155.84 (dd, 1JC,F’ = 280.2 Hz, 1JC,F = 294.3 Hz, CF2), 
138.28, 137.93, 137.40 (3 x Carom. quat. Ph), 128.47 – 127.72 (15 x CHarom. Ph), 
113.27 (dd, 2JC,F = 14.8 Hz, 2JC,F’ = 39.6 Hz, C-5), 100.17 (C-1), 78.44 (d, 4JC,F = 1.8 Hz, 
C-3), 78.28 (C-2), 76.12 (d, 3JC,F = 3.7 Hz, C-4), 75.46 (CH2Ph), 73.99 (d, 4JC,F = 2.9 Hz, 
CH2Ph), 73.68 (CH2Ph), 56.64 (OCH3).  
 
19F NMR (CDCl3, 376 MHz): δ –110.96 (dd, 1F, J = 3.9 Hz, JF,F’ = 71.1 Hz), –98.88 (dd, 
1F, J5,Feq = 5.0 Hz, JF,F’ = 71.1 Hz). 
 
[α]D20 = +24.8 (c 1.26, CHCl3). 
 
HRESIMS Calcd for C28H28F2O5Na (M+Na)+: 505.1797. Found: 505.1790. 
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Methyl 2,3,4-tri-O-benzyl-5a-difluoro-5a-carba-α-D-gluco-pentopyranoside (397) 
 
 
 
A 1 M solution in toluene of TIBAL (0.96 mL, 0.96 mmol) was added dropwise over 
a period of 30 min to a solution of 396 (46 mg, 0.096 mmol) in anhydrous toluene 
(3 mL) under argon. After stirring for 4 h at 50 °C the reaction mixture was cooled 
to room temperature and quenched with water (5 mL). EtOAc (10 mL) was added 
and the 2 phases were separated (an emulsion appeared). The aqueous layer was 
extracted with EtOAc (3 x 10 mL), the organic phase filtered through a pad of celite 
and rewashed with a saturated solution of NaHCO3 (20 mL). The organic layer was 
dried (MgSO4), filtered, concentrated under reduced pressure and 
chromatographed (cyclohexane/EtOAc 5:1) to give 397 (35 mg, 74%) as a 
colorless oil.  
 
1H NMR (CDCl3, 400 MHz): δ  7.37 – 7.29 (m, 15H, Harom. Ph), 4.90 (d, 1H, J = 10.5 
Hz, CHPh), 4.86 (d, 1H, J = 10.5 Hz, CHPh), 4.81 (d, 1H, J = 11.7 Hz, CHPh), 4.73 (s, 
2H, 2 x CHPh), 4.67 (d, 1H, J = 11.7 Hz, CHPh), 4.11 – 4.07 (m, 2H, H-3 and H-5), 
3.67 (dt, 1H, J1,2 = J1,Feq = 3.2 Hz, J1,Fax = 6.0 Hz, H-1), 3.63 (s, 3H, OCH3), 3.61 – 3.55 
(m, 2H, H-2 and H-4), 3.28 (d, 1H, J5,OH = 8.6 Hz, OH). 
 
13C NMR (CDCl3, 100 MHz): δ 138.49, 137.73, 137.62 (3 x Carom. quat. Ph), 128.53 – 
127.69 (15 x CHarom. Ph), 117.63 (dd, 1JC,F = 243.4 Hz, 1JC,F’ = 263.5 Hz, CF2), 80.70 
(dd, 2JC,F = 21.1 Hz, 2JC,F’ = 30.62 Hz, C-1), 78.48 (d, 3JC,F = 8.5 Hz, C-2 or C-4), 78.33 
(d, 3JC,F = 9.0 Hz, C-2 or C-4), 77.77 (C-3), 76.17 (CH2Ph), 73.77 (CH2Ph), 72.84 
(CH2Ph), 70.70 (dd, 2JC,F = 21.7 Hz, 2JC,F’ = 30.9 Hz, C-5). 
 
19F NMR (CDCl3, 376 MHz): δ –111.19 (d, 1F, JFeq,Fax = 257.1 Hz), –106.45 (d, 1F, 
JFeq,Fax = 257.1 Hz). 
 
[α]D20 = +12.2 (c 1.75, CHCl3). 
 
HRESIMS Calcd for C28H30F2O5Na (M+Na)+: 507.1954. Found: 507.1953. 
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